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 I  
ABSTRACT 
Investigation of genomic diversity can provide insight into the evolutionary history of 
bacterial species. However, complete genome sequencing is not yet practical for large 
strain collections at the beginning of this project. In this project PCR-based methods to 
investigate the genomic diversity of non-sequenced strains were successfully developed. In 
Escherichia coli, the distribution of two Type III secretion system, ETT2 (E. coli Type 
Three Secretion 2) and Flag-2 (E. coli Flagellar system 2), were surveyed among a 
collection of 79 strains. Remnants of both clusters were found to be present in most strains, 
suggesting that both have a long evolutionary history within E. coli. 
The PCR-based methods were also developed for application as part of genome 
sequencing projects. They were used to explore the co-linear and variable regions between 
Campylobacter jejuni M1 and the genome sequenced strain C. jejuni strain 11168. The C. 
jejuni M1 genome was assembled into thirty-four genomic contigs relative to strain 11168, 
and the size and position of insertions/deletions were characterised. Similar methods were 
used to facilitate the finishing of the genome of Francisella tularensis strain FSC198, 
using sequence information from strain Schu S4. The completed genome sequence of 
FSC198 showed it to be almost identical to that of Schu S4. The two genomes differ at 
only 11 loci, eight SNPs (single nucleotide polymorphisms) and 3 VNTRs (variable 
number tandem repeats). This surprising finding suggested that the European isolate 
FSC198 may be derived from the US laboratory strain Schu S4. 
Two virulence factors, IglA and IglB, from a pathogenicity island of strain FSC198 
were further investigated and found to interact at the protein level. These proteins are 
possibly involved in Type VI secretion, and may represent potential vaccine candidates.  
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CHAPTER ONE  
GENERAL INTRODUCTION 
 2  
1.1 Bacterial genome evolution 
Bacteria must retain their genetic information from one generation to the next. On the other 
hand, bacteria need to evolve strategies allowing the generation of new genetic diversity in 
order to survive and adapt to the continually changing environmental conditions and niches 
in which they live. Therefore, genetic plasticity mirrors different bacterial lifestyles and 
physiological versatilities (Dobrindt and Hacker, 2001). Three main forces are shaping 
bacterial genomes: gene gain, gene loss and gene change. The molecular and genetic 
mechanisms leading to these changes are discussed below.  
 
1.1.1 Point mutations or Single-nucleotide polymorphisms (SNPs)  
Point mutations or SNPs represent the smallest scale of bacterial genome change. 
Evolution caused by point mutations is considered as a slow evolutionary process (Ziebuhr 
et al., 1999). There are two classes of SNPs, referred to as synonymous and 
nonsynonymous SNPs. Nonsynonymous SNPs (nsSNPs), as the name suggests, result in a 
substitution that alter the encoding amino acid and hence provide substrate for evolutionary 
selection. In contrast, synonymous SNPs (sSNPs) or silent SNPs do not change the protein 
structure and are evolutionarily neutral or nearly so (Kimura, 1983).  
 
Mutations in structural genes of putative virulence factors can modify or attenuate the 
encoded proteins and influence their function during pathogenesis. Many of these 
mutations often enable single bacterial clone to become more pathogenic without the 
acquisition of additional genes. This mechanism is due to random mutagenesis which 
offers the bacterium a strong advantage under a selective pressure, and thus represents so-
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called pathogenicity-enhancing (or ‘pathoadaptive’) mutations (Ziebuhr et al., 1999). For 
example, random mutagenesis in the type 1 fimbrial fimH gene of Salmonella typhimurium 
is caused by this mechanism. Mutational variation in the fimH gene can produce different 
increases in cell binding, biofilm formation and host-colonization properties (Boddicker et 
al., 2002; Weissman et al., 2003).  
 
Although slow-evolving, SNPs help to differentiate those bacteria with little genetic 
variety. The approach of SNPs detection is an important typing tool for those genetically 
homologous pathogens, such as Mycobacterium leprae, Mycobacterium tuberculosis, 
Yersinia pestis and Bacillus anthracis, etc (Pallen and Wren, 2007).   
 
1.1.2 Genetic change and repeat units  
The repeat units can be found either dispersed throughout the entire genome or located in 
one genomic area (van Belkum, 1999a). These repeats are either identical (homogeneous) 
or vary in their sequences due to point mutations (heterogeneous). The number of the 
repeat units at a certain locus can vary drastically from strain to strain within a given 
species, and thus they are so-called “variable number of tandem repeats” (VNTRs). The 
mechanism that brings about most of the repeat number variability is due to slipped strand 
misparing (SSM) (Torres-Cruz and van der Woude, 2003). Since stretches of relatively 
short arrays of repeat units exist, aberrant base-pairing often occurs during replication and 
leads to the mutations in the type of insertions and deletions (in-del) of their repeat units 
(van Belkum, 1999b).  
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The roles of the repeat units have been attributed to many biological functions. Many 
genes responsible for virulence from pathogenic bacteria contain the repetitive elements. 
For example, the Staphylococcus aureus gene encoding the immunoglobulin-binding 
protein A harbours a region with repeat units that are 21 nucleotide long (Frenay et al., 
1996). In addition, loss or gain of repeats can occur within the promoter region, where the 
alteration can affect the relative position of flanking promoter components and influences 
transcription (van Ham et al., 1994). Alternatively, variations in the number of repeat units 
can occur in a protein-coding region. This change can lead to drastic alterations in gene 
products and in the expression levels, due to frameshift mutations (van Belkum et al., 1998; 
Sreenu et al., 2003). Such reversible mutations can also cause phase variations, which can 
be exploited by bacteria to switch gene and/or protein expression on or off. Phase variation, 
which imparts greater defensive capability to the pathogens to escape a hostile host 
environment, is a widespread source of intraspecific genotypic and phenotypic variation 
(van Belkum et al., 1998; Pallen and Wren, 2007). For example, in Campylobacter jejuni, 
10-100 of short homopolymeric nucleotide repeats are commonly found in genes encoding 
the biosynthesis or modification of surface structures (Parkhill et al., 2000). These repeats 
can lead to slippage during DNA replication, resulting in phage variation of surface 
properties (Parkhill et al., 2000). Another case can be seen in a thorough analysis of the 
complete genome sequence of Neisseria meningitides MC58 (Tettelin et al., 2000). A 
repertoire of 82 putative phase variable genes was identified in N. meningitides MC58 and 
more than half of these are homopolymeric tracts (Saunders et al., 2000). Phage variable 
structures in Neisseria are critical for them to adapt to local environmental conditions, for 
example, capsule confers serum resistance and affects cell interactions; pili and pilus 
modification affect adhesion; some surface proteins, e.g. PorA, have roles in the formation 
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of surface pores (Saunders et al., 2000). In fact, for many microorganisms, genetic changes 
that occur at repeat unit regions often confer a certain degree of selective advantage and 
aid the pathogens in their adaptation.  
 
Repeat units, if short, are also known as short sequence repeats (SSRs) or micro-satellites. 
They vary in size, but are generally short sequences of less than 30 bp. These short repeat 
units can also be used to assess strain relatedness and strain discrimination. Since repeat 
units evolve at a relatively high speed, they can be used to monitor short term bacterial 
evolution (van Belkum, 1999b). This is particularly useful in strain discrimination for those 
pathogenic bacteria that are genetically very homologous. The experimental assessment of 
the variability in repeat number of different loci is called “multilocus variable number of 
tandem repeat analysis” (MLVA) (Lindstedt, 2005). MLVA is based on the combination of 
the polymorphous nature of the VNTRs and the use of PCR methodology (Le Fleche et al., 
2001). To date, the availability of more than 600 bacterial whole genome sequences allows 
for the design of specific PCR primers aimed at the amplification of the repeat and some 
bordering consensus sequences (van Belkum, 2007). MLVA has been proven as an 
appropriate way to address the genetic diversity of highly monomorphic species such as 
Bacillus anthracis and Yersinia pestis (Le Fleche et al., 2001). And now, MLVA has been 
developed for typing purposes for several bacterial species, such as Francisella tularensis, 
Haemophilus influenzae, Mycobacterium tuberculosis, and enteric pathogens like E. coli 
and Salmonella enterica etc (Johansson et al., 2000; Johansson et al., 2004).    
 
In addition to short repeat units, some genomes contain long sequence repeats, such as 
ribosomal gene clusters, for example, the rrn operons of Salmonella enterica serovar Typhi, 
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or in horizontally acquired DNA, for example, the duplicated Francisella pathogenicity 
island (Liu and Sanderson, 1995; Nano et al., 2004). It is obvious that sequence 
multiplicity could increase expression simply through greater gene dosage. This is 
particularly important for bacterial pathogenesis if the multiplied genes are involved in 
bacterial virulence. Alternatively, repeated sequences can serve as targets for homologous 
recombination, as a consequence of genomic rearrangements such as deletions, 
duplications, and inversions. 
 
1.1.3 Horizontal gene transfer (HGT) and mobile genetic elements 
(MGEs) 
HGT generates rapid and extremely dynamic genomes, rather than evolution through the 
modification of existing genetic information (Ochman et al., 2000). There are three 
fundamentally distinct mechanisms by which HGT can occur: transformation, conjugation 
and transduction. Transformation refers to the process when a cell takes up isolated DNA 
from the environment and has the potential to transfer DNA between distantly related 
organisms. Many bacterial species are naturally competent to uptake DNA, such as 
Bacillus subtilis, Haemophilus influenzae, and Neisseria spp. A second mechanism is 
conjugation, which is defined as the direct transmission of DNA from one cell to another. 
In contrast to transformation, which is DNase-sensitive and does not require cell-to-cell 
contact, conjugation is DNase-resistant and does require cell-to-cell contact. A third 
mechanism is transduction, which is thought to be phage-mediated transfer of genetic 
materials. The role of phages will be discussed later.   
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Bacterial genomes generally consist of stable regions called the “core genome” and 
variable regions, obtained from the “flexible gene pool” (Hacker et al., 2003). The “core 
genome” of a certain species has a fairly homogeneous G+C content and codon usage, and 
often encodes housekeeping functions and carries gene clusters with relatively low 
mutational capacity (Hacker and Kaper, 2000). In contrast, the” flexible gene pool” 
represents the total amount of foreign DNAs available for recipient cells. If genes from the 
“flexible gene pool” were obtained from a source organism with a different mutational bias, 
their G+C content and codon usage will be different from the rest of the genome. Most 
often, these foreign genes are carried by MGEs, which are able to move within or between 
genomes via HGT. The acquisition of sequences from distantly related organisms may 
confer very new phenotypic characteristics on the recipient cell over a short evolutionary 
timescale. In the past few years, there has been growing evidence that HGT has played a 
vital role in the evolution of bacterial genomes (Ochman et al., 2000). 
 
MGEs include plasmids, transposons, bacteriophages, integrons, insertion sequence 
elements and genomic islands. Their size ranges from a few hundred base pairs up to 100 
kb (Dobrindt et al., 2004).  
 
1.1.3.1 Insertion Sequence (IS) elements 
IS elements are small, genetically compact DNA sequences, normally less than 2.5 kb in 
length (Mahillon and Chandler, 1998; Mahillon et al., 1999). The overall structure of most 
IS elements is very similar, and includes a central tansponsase (Tpase) gene flanked by 
inverted repeat (IR) sequences that exactly define the borders of the elements (Mahillon 
and Chandler, 1998). Generally, IS elements encode no functions other than their own 
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translocation, and the central Tpases function to transpose their own elements both within 
and between genomes (Mahillon and Chandler, 1998; Mahillon et al., 1999). The IRs are 
short, between 10 and 40 bp, and often contain the promoter for the Tpase gene at one side 
(Mahillon et al., 1999). In addition, IS elements are also flanked by further short (between 
2 and 14 bp), duplicated direct repeated sequences. However, these direct repeats (DR) 
does not belong to IS elements, but arise from duplication in the recipient DNA at the 
insertion site (Ou et al., 2006). Because of the presence of repeated sequences, IS elements 
can also be regarded as repetitive sequences that are randomly scattered throughout the 
bacterial genome. The presence of two copies of an IS element can lead to homologous 
recombination between them, which results in inversion, deletion or replicon fusion of the 
region between two IS elements (Siguier et al., 2006b). For this reason, IS elements play 
an important role in promoting genome rearrangement.  
 
Over 1,600 different ISs have been identified to date (www-is.biotoul.fr) (Siguier et al., 
2006b). These ISs have been classified into about 20 families, based on similarities and 
conservation in the sequence of their Tpases, genetic organisation and IRs (Mahillon et al., 
1999; Siguier et al., 2006a). In addition to chromosomal DNA, IS elements are also 
commonly found in bacterial plasmids, and are an integral part of many naturally occurring 
bacterial plasmids (Mahillon et al., 1999). The ISs in plasmids function in plasmid transfer 
and integration into the host chromosome. Furthermore, many antibiotic resistance genes 
are often encoded on plasmids and spread within bacterial populations with the aid of ISs 
(Mahillon et al., 1999). Thus, although the basic function of ISs is simply translocation, 
they are involved in other activities to shape genomic variation.  
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In the post-genomic era, complete genome sequences and genomic comparisons provide 
advantages in defining IS classification, understanding mechanisms of distribution and 
identifying their role in evolution. For example, when the first Francisella genome Schu 
S4 was published in 2005, the genome was found to be notable for its large complement of 
IS elements (Larsson et al., 2005). It is now known that about 1 to 5% of annotated 
Francisella genes are transposase genes (Titball and Petrosino, 2007). Five different types 
of IS elements (ISFtu1-ISFtu5) were found in the Schu S4 genome, and are conserved in 
other sequenced Francisella genomes such as OSU18 (Petrosino et al., 2006). More 
surprisingly, ISFtu1 belongs to the IS630 Tc-1 mariner family of transposons, of which 
about 50 copies were found in the Schu S4 genome and 58 copies in the OSU18 genome 
(Larsson et al., 2005; Petrosino et al., 2006). However, the presence of this kind of Tc-1 
transposon is not usual in bacteria, but they are generally found in eukaryotes and have 
been reported in a range of invertebrates such as nematodes and insects (Larsson et al., 
2005). The high level of Francisella IS630 elements was suggested to be acquired 
originally from the infected insect vectors, which commonly mediate Francisella’s 
transmission (Larsson et al., 2005).  
 
The expansion of the transposable elements, particularly IS elements, in bacterial 
pathogens is a recent emerging common feature (Siguier et al., 2006a). This is because IS 
elements facilitate homologous recombination within a genome, a process that can provoke 
large-scale genome rearrangements. These genomic changes often disrupt the ancestral 
gene order, and bring about a high level of gene inactivation and gene loss. Horizontally 
acquired genes have been balanced by gene loss, so that the bacterial genome size will not 
continuously increase. For example, comparison among three members of the Bordetella 
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family, Bordetella bronchiseptica, Bordetella parapertussis and Bordetella pertussis, 
revealed a smaller genome accompanied by more ISs (Parkhill et al., 2003). A similar 
scenario can be seen in the Yersinae, of which a Yersinia pestis CO92 strain shows 
amplification of at least four different ISs: 66 copies of IS1541, 44 copies of IS100 (a 
member of the IS21 family), 21 copies of IS285 (a member of the IS256 family), and 9 
copies of IS1661 (a member of the IS3 family) (Parkhill et al., 2001). Overall numbers 
of IS copies in the CO92 strain are around ten-fold higher than those in another strain, 
Yersinia pseudotuberculosis (Parkhill et al., 2001). In addition, the genome displays 
anomalies in GC base-composition bias, indicating frequent intragenomic recombination 
through ISs (Parkhill et al., 2001). 
 
1.1.3.2 Bacteriophages  
Bacterophages (or phages for short) contain either DNA or RNA enclosed in a protein coat. 
They are simply viruses that infect bacteria. The shapes and sizes of phages are quite 
variable, for example, those that infect E. coli are revealed to be of several types: λ and T4 
with head and tail structures, ΦX174 and MS2 with simple head structures, and M13 with 
filamentous structures, etc (Hendrix, 2003). Prophages refer to phages that are inserted into 
the bacterial DNA and replicate as part of the bacterial chromosome (Freeman, 1951). 
Prophages are often identified as a by-product of bacterial genome sequencing. A 
surprisingly large number of prophages were discovered when an E. coli O157: H7 strain, 
Sakai strain, was genome sequenced in 2001 (Hayashi et al., 2001).  In this case, O157 
Sakai contains 18 prophages or prophage remnants (Sakai prophages, Sp1-18), most of 
which are λ-like phages (Hayashi et al., 2001). These phages account for about 16% of the 
chromosomal DNA of the Sakai genome and half of the strain-specific sequences (Ohnishi 
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et al., 2001). In addition, the Sakai strain contains six large chromosome segments that 
appear to be prophage-like genetic elements (Sakai prophage-like elements, SpLE1-6). 
Similarly, the K-12 genome also contains a total of 11 prophages, prophage remnants and 
phage-related elements (Hayashi et al., 2001). With such a high proportion of phage genes 
in E. coli, phage-mediated gene transfer was thought to play a predominant role in shaping 
the genomic diversity of E. coli.  
 
Phage DNA fulfils a number of criteria for being an ideal vehicle for horizontal gene 
transfer. The residual footprints of prophages are different G+C contents and codon usage 
from the host’s genome, the adjacent tRNA genes and the IS elements in the phage-
essential regions. However, the prophages in bacterial genome sequences are accurately 
recognised through the similarity of their genes to known phage genes. Although phage 
genomes encompass an enormous amount of sequence diversity, their genes appear to be 
highly conserved (Casjens, 2003). For example, all the λ-like phages on the O157 Sakai 
chromosome are very similar and some share identical or nearly identical DNA segments 
of >20 kb (Hayashi et al., 2001). Among the prophages or phage-like elements of K-12, 
three share some sequence homology with the O157 Sakai prophages (Hayashi et al., 
2001). More interestingly, some of the homologous prophages are integrated at analogous 
loci, such as Rac of K-12, Sp10 of Sakai, and CP-933R of another O157 strain, E. coli 
EDL933 (Ohnishi et al., 2001). Are these phage homologies the result of integration by 
different phages at the same bacterial attachment site, or are they the descendants of the 
same progenitor prophage? The first alternative seems unlikely because it rarely happens 
that two independent isolated infectious λ-phages are so identical over complicated regions 
such as Sp10 and CP-933R. It seems more reasonable that Sp10 and CP-933R are 
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descendants of the same original prophage. The same relationship is also seen in other 
prophage pairs, like Sp14/CP-933U, Sp4/CP-933M and Sp5/CP933V (Perna et al., 2001). 
This suggests the presence of a common ancestor of EDL933 and Sakai, and that 
prophages were integrated before their divergence.    
 
Bacteriophages, in order to co-exist with and inhabit the host, often accumulate deleterious 
mutations. Most prophages from sequenced bacterial genomes have shown attenuating 
point mutations, inactivating DNA insertions (often transposases) or progressive DNA 
deletions (Casjens, 2003). This leads to the appearance of defective prophages, prophage 
remnants and isolated prophage genes in bacterial genomes (Casjens, 2003). The 
movement of these defective prophages can be mobilised by transmission of the co-
infecting or helper phages(Dobrindt and Hacker, 2001). For example, the defective 
prophage P4 can be mobilised by the P2 helper phage (Christie and Calendar, 1990). In the 
O157 Sakai genome, P4-like phage (Sp2) and P2-like phage remnants (Sp13) are thought 
to be involved in the transfer of some SpLE elements of O157 (Ohnishi et al., 2001).  
 
The significance of bacteriophages in bacterial pathogenesis is obvious, since many 
important virulence genes are bacteriophage-encoded, such as Shiga toxin (Stx) and Type 
III secretion effectors of Enterohaemorrhagic E. coli, Cholera toxin (CTXΦ) of Vibrio 
cholerae, and Staphylococcal exterotoxin (Φ42) of Staphylococcus aureus (Dobrindt and 
Hacker, 2001; Tobe et al., 2006). The prophages have a widespread role in driving the 
diversification of these bacterial pathogens. 
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1.1.3.3 Genomic Islands  
Genomic islands are referred to as large chromosomal regions that contain a cluster of 
functionally related genes. They are often flanked by direct repeat sequences and are 
located near an integrase or transposase gene and also close to a tRNA gene (Dobrindt et 
al., 2004). Genomic islands encoding virulence factors of pathogenic bacteria have been 
designated "pathogenicity islands" (PAIs) (Hacker et al., 1997). Pathogenicity islands are 
characterised by five features: (i) they are large clusters (10-200 kb in size) present in the 
genomes of pathogenic strains but absent from those non-pathogenic strains of the related 
species; (ii) their G+C content differs from the rest of the host genome; (iii) they are often 
associated with tRNA genes; (iv) they are presumed to be generated by horizontal gene 
transfer; (v) they are recognised by conferring upon the host bacterium a complex and 
distinctive virulence phenotype in a single step (Hacker et al., 1997). An example could be 
taken from a well-characterised pathogenicity island known as the Locus for Enterocyte 
Effacement (LEE). LEE PAIs are found in the genomes of enteropathogenic Escherichia 
coli (EPEC) and enterohaemorrhagic E. coli (EHEC) (Nataro and Kaper, 1998), as well as 
the closely related mouse pathogen Citrobacter rodentium. The LEE gene cluster encodes 
a bacterial Type III secretion system, and can be present on a single horizontally 
transferable plasmid (Deng et al., 2001), or inserted into the EPEC or EHEC genome at 
selC, pheV, or pheU tRNA sites (Jores et al., 2004). The entire LEE is 35.6 kb in size, with 
a GC content of 38.36%, far below the E. coli genomic average (50.8%). LEE-encoded 
proteins are responsible for the development of a characteristic histopathological feature 
known as “attaching and effacing” (A/E) lesions (Frankel et al., 1998).  
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1.2 Bacterial protein secretion systems  
Gram-negative bacteria employ several protein secretion systems to transport proteins 
across the cell envelope and interact with host cells (Hueck, 1998). These systems often 
play important roles in bacterial pathogenicity during host-pathogen interactions. Five 
major secretion systems, numbered from type I to V (or designated as T1SS to T5SS for 
Type 1 to 5 Secretion System) have been well characterised (Henderson et al., 2004). 
Recently, a type VI secretion system has also been described in the study of virulent gene 
secretion from Vibrio cholerae (Pukatzki et al., 2006). By utilising these secretion systems, 
proteins destined for the extracellular environment of Gram-negative bacteria have to cross 
two membranes, the cytoplasmic (inner) membrane and the outer membrane, which are 
separated by the periplasmic compartment. These secretion systems are recognised by a set 
of core components, which build up a secretion device through the cell envelope. 
 
1.2.1 Type I secretion system (T1SS)  
The T1SS was first identified by the secretion of E. coli alpha-hemolysin (HlyA). HlyA is 
mainly produced by uropathogenic E. coli (UPEC). It is an important virulence factor 
owing to its cytolytic and cytotoxic activity against a wide range of mammalian cell types, 
including erythrocytes, granulocytes, monocytes and endothelial cells (Gentschev et al., 
2002). Once HlyA is exported to the plasma membrane of host cells, it causes pore 
formation and release of cytoplasmic contents (Gentschev et al., 2002). Additionally, T1SS 
has been shown to be involved in the secretion of metalloprotease of Erwinia chrysanthemi, 
the leukotoxin of Pasteurella haemolytica, and the adenylate cyclase of Bordetella 
pertussis (Henderson et al., 2004). 
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The translocator of T1SS is made up of three proteins that span the cell envelope: a pore-
forming outer membrane protein (OMP), a membrane fusion protein (MFP) and an inner 
membrane ATP-binding cassette (ABC) protein. Translocation occurs via a Sec-
independent pathway without a periplasmic intermediate. The ABC transporter provides 
energy through ATP hydrolysis, and possibly represents the initial channel across the inner 
membrane (Holland et al., 2005). ABC transporter links with MFP, which spans the initial 
part of the periplasm and forms a continuous channel to the surface with an outer 
membrane protein. In E. coli, the translocation process is triggered by the C-terminus of 
effectors bound to the ABC transporter (HlyB), subsequently causing the assembly and 
interaction between MFP (HlyD) and an outer membrane protein (TolC). But before HlyB 
binding of the effectors, the interaction between HlyB and HlyD was identified. It is worth 
mentioning that the C-terminus of the effector carries a poorly conserved secretion signal, 
which specifically recognises the ABC protein (Delepelaire, 2004). In most cases, the 
secretion signals are not cleaved off during or after secretion. Through this trans-envelope 
complex, the effector molecules are secreted into the extracellular milieu.  
 
1.2.2 Type II secretion system (T2SS)  
The T2SS is widely distributed among proteobacteria. Proteins secreted by T2SS include 
proteases, cellulases, pectinases, phospholipases, lipases, and toxins, many of which 
contribute to pathogenesis in plant or animal cells (Sandkvist, 2001a). The type II pathway 
was first discovered in Klebsiella oxytoca, where it was found to be required for secretion 
of the starch-hydrolysing lipoprotein, pullulanase (PulA). Other well-studied members of 
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this system include the cholera toxin of Vibrio cholerae, exotoxin A of P. aeruginosa, and 
several cell wall-degrading enzymes (Henderson et al., 2004). 
 
T2SS secretes proteins in a two-step Sec-dependent manner. Proteins to be secreted are 
synthesised with N-terminal signal peptides, which allows for Sec-dependent or Tat 
pathway translocation across the inner membrane (Sandkvist, 2001b). After export across 
the inner membrane, signal peptides are removed and proteins undergo further 
modifications. For example, PulA folds into a stable, inner membrane-anchored 
intermediate in the periplasm with at least one disulfide bridge being formed (Francetic 
and Pugsley, 2005). Some evidence showed that a disulfide bond isomerase, DsbA, is 
required to facilitate the formation of the disulfide bond (Thanassi, 2002). The Sec 
machinery is composed of an ATPase, namely SecA, which provides energy for the 
transport of the protein, the signal peptidase removal, and the release of the remainder of 
the protein into the periplasm (Henderson et al., 2004). 
 
Translocation across the outer membrane is mediated by the Type II secretion apparatus or 
secretons, which are made up of 12-15 proteins (Sandkvist, 2001b). These proteins and 
their encoding genes have kept a consensus nomenclature using the letters A to O, and S.  
In Pseudomonas, however, the letters P-Z and A have been used. These genes are 
organised in a single operon with overlapping regions between each other, and are 
transcribed at the same time. The pore-forming protein has been identified as protein D, 
which belongs to a large family of homologous proteins called secretins. These secretins 
share similarity with Type IV pilus biosynthesis, filamentous phage extrusion and Type III 
secretion (Sandkvist, 2001b). The C-terminal domain of protein D is conserved and 
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thought to be embedded in the outer membrane, while the N-terminal domain is variable 
and thought to be exposed to the periplasm and to interact with other components, like 
proteins N, B and C (Sandkvist, 2001b). In Klebsiella and Erwinia, a small outer 
membrane lipoprotein, protein S, is required for stabilisation of protein D. Protein C is 
thought to interact with the integral cytoplasmic membrane components, L and M. Proteins 
L and M form a stable complex, which interacts with protein E. Protein E normally 
remains in the cytoplasm, and functions as a kinase that regulates the secretion process by 
providing energy to promote translocation and assembly of the pilin-like subunits, proteins 
G to K (Henderson et al., 2004). Protein G is likely to be assembled into long pilus-like 
bundles, which could assist in protein secretion. Interestingly, in a Type II apparatus, most, 
if not all, of the components interact to form a multiprotein complex spanning both the 
inner and outer membranes. The homologies between T2SS and Type IV pili suggest they 
are evolutionarily related.  
 
1.2.3 Type III secretion system (T3SS) 
T3SSs are widespread in many gram-negative bacteria pathogenic for animals and plants, 
including Yersinia spp., Salmonella enterica, Shigella flexneri, E. coli, Ralstonia 
solancearum, Pseudomonas syringae, and Chlamydia trachomatis (Hueck, 1998).  Like 
T1SS, T3SS translocates its effector proteins in a Sec-independent manner. The striking 
feature of T3SSs is their ability to target effector proteins directly into eukaryotic cells. 
Therefore, the host and pathogen interact without the interference of the extracellular 
milieu.  
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The structure of the Type III secretion system is built up by about 20-25 proteins spanning 
both the inner and outer membranes of the bacterial envelope. A study from Salmonella 
typhimurium showed a needle-like structure visualised under an electron microscope, 
therefore called a “needle complex (NC)” injectisome (Kubori et al., 1998).  In S. 
typhimurium, the needle complex consists of two parts: a base (or cylinder) spanning both 
membranes and a needle-like projection extending outward from the bacterial surface 
(Kubori et al., 2000). The base contains three T3SS proteins: InvG (a member of the 
secretin family), and two lipoproteins, PrgH and PrgK, while the needle contains one 
protein, PrgI (Kubori et al., 2000). Proteins homologous to components of the needle 
complex are widely distributed among T3SSs in plant and animal pathogenic bacteria. In 
Shigella flexneri, four proteins, MxiD, MxiG, MxiJ and MxiH, which are homologous to 
InvG and PrgH, PrgK and PrgJ, respectively, were responsible for NC composition 
(Blocker et al., 2001). Within them, MxiG and MxiJ are predicted to be inner membrane 
proteins to form the NC base, while MxiD is predicted to be an outer membrane protein, 
forming the outer ring. MxiH is the major needle component, together with another protein, 
MxiI, which serves to cap the external needle tip (Blocker et al., 2001). The function of the 
needle complex is to serve as a hollow channel through which the T3SS secreted proteins 
cross the two bacterial membranes. Interestingly, similarity exists between the architecture 
of the needle complex and the basal components of the flagellar export machinery, 
suggesting both are evolved from a common ancestral secretion system (Blocker et al., 
2003). Therefore, T3SSs were broadly divided into two major groups: flagellar T3SSs, 
which are associated with flagellar biosynthesis, and non-flagellar T3SSs (NF-T3SS, later 
referred to T3SS) (Pallen et al., 2005).  
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Additionally, T3SSs require some proteins called “translocators” that are located on the 
bacterial surface, and which can contact with the host cell membrane and translocate 
another set of proteins into the host cell cytoplasm and across their plasma membrane 
(Ghosh, 2004). For example, the T3SS of Yersinia spp. comprises of about 25 Yop proteins 
as a secretion apparatus, also called Ysc. Among these Yop proteins, YopB, YopD, and 
LcrV are translocators responsible for the exportation of other Yop proteins (intracellular 
effectors) (Cornelis and Wolf-Watz, 1997).  These translocated effectors are usually 
deleterious to the host cell. The effector molecules also vary vastly among different 
bacterial pathogens, even within a pathotype of some species. For example, more than 60 
putative effector genes were identified in the Sakai strain of EHEC O157:H7 (Tobe et al., 
2006).  
 
Many proteins secreted by T3SS also rely on specific T3SS chaperones, sometimes 
described as “bodyguards” for efficient translocation from the bacterial cytosol into host 
cells. The chaperones have been predicted to function to stablise proteins, to prevent 
inappropriate protein-protein interaction and to assist in secretion (Elliott et al., 1999). 
There are two distinct functional classes of chaperone: the class-I chaperones, which bind 
to effectors, and the class-II chaperones, which bind to translocators (Page and Parsot, 
2002). These chaperones are small, about 15-20 KDa in size, and located in the cytoplasm. 
For example, in the LEE T3SS of EPEC, the interaction between a translcoated protein, Tir, 
and an outer membrane intimin (the product of eae) is essential for the formation of A/E 
lesions and virulence. The chaperone, CesT, has been shown to bind and stabilise Tir in the 
bacterial cytoplasm prior to delivery of the complex into host cells (Elliott et al., 1999). In 
addition to secretion, CesT was also identified to as being involved in recruiting multiple 
 20  
type III effectors to the T3SS, including EscN (the membrane-associated ATPase of the 
T3SS) (Thomas et al., 2005). 
 
Interestingly, in some bacteria, such as Salmonella enterica, there exist more than one 
distinct type III secretion systems with different phenotypes (Galan and Collmer, 1999). 
Salmonella Spi-1 is required for the initial interaction with, and invasion of, intestinal 
epithelial cells, whereas Spi-2 is expressed only after S. enterica has gained access to host 
cells, and is required for systemic infections (Galan, 1999; Dobrindt et al., 2004). 
Sequence comparison indicates that the LEE of EPEC and EHEC is similar to the Spi-2 
system (Perna et al., 1998). Many of the Spi-1 genes show significant similarity to the 
mxi/spa invasion genes of Shigella spp. (Hansen-Wester and Hensel, 2001). These 
scenarios suggest that horizontal gene transfer has taken place. 
 
1.2.4 Type IV secretion system (T4SS)  
Like T3SS, T4SSs mediate secretion by direct cell-to-cell transfer of virulence factors from 
many Gram-negative animal, human and plant pathogens, including Agrobacterium 
tumefaciens, Bartonella tribocorum, Bordetella pertussis, Brucella suis, Helicobacter 
pylori, Legionella pneumophila and Rickettsia prowazekii (Baron et al., 2002; Juhas et al., 
2008). T4SSs share many similarities with the ancestral conjugation machinery, for 
instance, the one encoded by the F plasmid. Therefore, T4SSs can contribute to both 
bacterial virulence and genome plasticity and evolution mediated by horizontal gene 
transfer (Juhas et al., 2008).  
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T4SSs deliver both effector proteins and nucleoproteins (protein-DNA complexes), which 
is unique in all types of secretory systems (Christie and Vogel, 2000). The prototypical 
T4SS is that of the Agrobacterium tumefaciens nucleoprotein T-DNA transfer system 
(Baron et al., 2002). This has been studied in most detail and serves as a model system for 
T4SS research. The T4SSs of A. tumefaciens are composed of 12 protein components, 
named the VirB/VirD4 system. These proteins are encoded on the Ti (tumor-inducing) 
plasmid and are responsible for the transfer of oncogenic genes into plant cells (Christie 
and Vogel, 2000). The structures of the T4SS include a secretion channel and a pilus, 
which has functions in motility, adhesion, secretion and DNA transfer. The transferred 
conjugation-intermediate DNA is not naked DNA but single-stranded DNA associated 
with one or more proteins. The genetic makeup of T4SS includes 11 VirB proteins (VirB1-
VirB11) encoded on a single operon, and VirD4 encoded on a separate operon. Among 
these, VirB6, VirB7, VirB8, VirB9 and VirB10 constitute the components of the 
transmembrane channel, whereas VirB2 and VirB5 are pilus components and VirB3 and 
VirB7 are pilus-associated proteins (Christie et al., 2005).  Three nucleoside 
triphosphatases (NTPase), VirB4, VirB11 and VirD4, provide the energy for transfer. In 
addition to T-DNA encoding oncogenic proteins, other effector proteins transferred via the 
T4SS have been identified, including VirD5, VirE2, VirE3 and VirF (Christie et al., 2005). 
VirE2 has been recognised as a single-stranded DNA binding protein. These proteins are 
delivered to the host plant cell, which increases the infectious ability of the bacteria. 
 
VirB/VirD4-like T4SSs were also identified in several other bacteria, including 
Helicobacter pylori, Bartonella henselae and Bordetella pertussis (Christie et al., 2005). 
The cag T4SS of H. pylori secretes CagA, the only virulence factor identified to date. 
 22  
CagA can interact with several host cell proteins, resulting in altered physiology of the host 
cells and an increased chance of successful infection (Stein et al., 2000). In contrast, the 
intracellular Bartonella spp. could deliver several translocated effector proteins, called 
Beps. The Bep proteins are involved in a wide variety of bacterial pathogenesis, including 
activation of pro-inflammfation, apoptosis and cytoskeleton rearrangements (Schulein et 
al., 2005). However, Bordetella pertussis Ptl T4SS delivers pertussis toxin (PT, a A/B 
toxin family) not directly into the host cell but rather into the extracellular milieu (EM) 
(Rambow-Larsen and Weiss, 2004). The B domain of PT interacts with host cell 
glycoprotein receptors at the EM, and mediates translocation of the A domain across the 
host cell membrane (Rambow-Larsen and Weiss, 2004). All of these VirB/VirD4-like 
T4SSs are classified as Type IVA systems. 
 
In contrast, the Type IVB secretion systems resemble those with the archetypal dot (defect 
in organelle trafficking) and icm (intracellular multiplication) gene system from two 
intracellular bacterial pathogens: Legionella pneumophila and Coxiella burnetii. The 
Dot/Icm systems share an extensive similarity with the Tra system of the Incl Collb-P9 
plasmid of Shigella flexneri and are involved in bacterial conjugation (Christie and Vogel, 
2000). The degree of relatedness between Type IVA and Type IVB is very limited. The 
T4SS of L. pneumophila was first identified by screening for mutants defective in 
multiplication in host macrophages (Segal et al., 1998; Vogel et al., 1998). These genes 
were named icm (intracellular multiplication) and dot (defective organelle trafficking) 
genes, and include about 25 genes within two operons. Mutation of these genes imparted a 
variety of bacterial virulence, such as phagocytosis, pore formation in the host cell 
membrane, inhibition of phagosome-lysosome fusion, apoptosis of the host cell and escape 
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from phagosomes  (Segal et al., 2005). Several effector proteins delivered via the T4SS of 
L. pneumophila have been identified. For example, RalF is required for the localisation of 
ARF (ADP-ribosylation factor) on phagosomes containing L. pneumophila; LidA is 
required for the formation of the replicative vacuole; LepA and LepB are required for 
escape of the bacteria from the phagosome; and several Sids proteins (substrates of 
Icm/Dot transporter) are involved in apoptosis (Segal et al., 2005; Juhas et al., 2008). In 
addition, these secretion components and effectors are all regulated by two regulators, 
PmrA and CpxR, suggesting that these Icm/Dot genes are functionally related.  
 
However, in contrast to all other L. pneumophila dot/icm genes, only icmF and dotU have 
homologues in other gram-negative bacteria that do not possess a T4SS. This suggests that 
the icmF-like and dotU-like genes are not necessarily associated with T4SSs. Studies on 
DotU and IcmF showed that the two proteins are localised in the L. pneumophila inner 
membrane. The loss of IcmF caused a reduced level of DotU protein and affected the 
stability of DotU, suggesting that the two proteins interact with each other. Moreover, the 
lack of IcmF and/or DotU affected the stability of three other Dot proteins (DotH, G, and F) 
(Sexton et al., 2004). IcmF mutants appeared to be lysed more rapidly, suggesting a role 
for IcmF in cell surface reorganisation, which results in increased adherence to host cells. 
 
1.2.5 Type V secretion system (T5SS)  
Among all the types of secretory systems, perhaps T5SS is the simplest one. This system 
was first described in the secretion of immunoglobulin A1 (IgA1) protease from Neisseria 
gonorrhoeae (Pohlner et al., 1987). In that experiment, DNA sequencing of a 4.6 kb 
cloned fragment revealed a large open reading frame encoding a 169 KDa precursor of 
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IgA1 protease (Pohlner et al., 1987). A characteristic of the secretion of IgA1 protease is 
that it acquires an active confirmation as its extracellular transport proceeds and it is 
released as a proform from the membrane-bound helper by autoproteolysis (Henderson et 
al., 2004). In other words, this precursor protein directs the transport of IgA1 protease from 
the periplasm to the extracellular milieu, without the involvement of any other accessory 
protein. Therefore, the proteins secreted via T5SSs are also called “autotransporters” 
(Henderson et al., 2004). As shown by work on IgA1 protease, three essential domains are 
required for a typical T5SS autotransporter. An N-terminal signal sequence allows 
targeting of the protein to the inner membrane for its further export into the periplasm. 
Next is the passenger domain, which confers the diverse effector functions of the various 
autotransporters. The C-terminal end of the translocation unit consists of a short linker 
region with an α-helical secondary structure and a β-core that adopts a β-barrel tertiary 
structure when embedded in the outer membrane (Henderson et al., 2004). 
 
The inner membrane translocation has been identified as a Sec-dependent mechanism, in 
which SecB was assumed to be a molecular chaperone. Several studies have identified 
autotransporters with typical signal sequences, including H. pylori AlpA, B. pertussis 
SphB1, and N. meningitidis AspA/NalP proteins (Henderson et al., 2004). During export 
through the inner membrane, the signal sequences are cleaved while the autotransporter 
proteins might exist in a partially folded status in the periplasm. However, the status of the 
protein in periplasm is still controversial. After formation of the β-barrel in the outer 
membrane, the passenger domain inserts into the pore and is translocated to the bacterial 
cell surface. The released passenger domains of the autotransporter proteins are very 
diverse in terms of virulence. They could display enzymatic activity, such as protease, 
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peptidase, lipase, and esterase, mediate actin-promoted bacterial motility, act as adhesins, 
immunomodulatory proteins, toxins or cytotoxins, or permit the maturation of other 
virulence proteins (Henderson et al., 2004).  
 
In addition to the autotransporter T5SS, which is classified as Type Va, two other 
subgroups, Type Vb and Type Vc, have been characterised. In Type Vb, the passenger 
domain and the pore-forming β domain are translated as two separate proteins, rather than 
a single polypeptide in Type Va (Henderson et al., 2004). Therefore, Type Vb also refers 
to a two-partner secretion (TPS) pathway. Type Vc possess a particular outer membrane 
topology, belonging to the Oca (for Oligomeric Coiled-coil Adhesins) family. These family 
members are probably considered as a subfamily of surface-attached oligomeric 
autotransporters, exemplified by Y. pestis YadA (Henderson et al., 2004). 
 
1.3 Bacterial genome sequencing 
1.3.1 Shotgun sequencing 
The commonest method of DNA sequencing known is Sanger sequencing, or chain 
termination sequencing using dideoxynucleotides (Sanger et al., 1977b). The first bacterial 
genome sequence was derived from a laboratory strain of Haemophilus influenzae, and 
was followed by an isolate of Mycoplasma genitalium in the same year (Fleischmann et al., 
1995; Fraser et al., 1995). Prior to the birth of the first bacterial genome sequence of H. 
influenzae, there were doubts about whether the approach of sequencing random pieces of 
DNA and then assembling them into an entire genome could work in practice. Therefore, 
when the project to sequence the 1.8 Mbp H. influenzae genome started in 1994, it was not 
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certain that the whole-genome sequencing strategy would be successful, even though the 
chosen organism had a small genome. However, today the random sequencing phase of a 
genome project is relatively routine and remains widely used, though many “next-
generation” sequencing technologies are emerging (Schuster, 2008).  
 
The whole-genome random sequencing procedure, also referred to as shotgun sequencing,  
was used in the H. influenzae genome sequencing project (Fleischmann et al., 1995). In 
contrast to the traditional ordered sequencing approach, the shotgun procedure obtains 
sequence from randomly broken short fragments. Therefore, no prior knowledge, such as 
genetic or physical maps of the genome, is required. Firstly, the genomic DNA was broken 
into random fragments using a sonicator. Those fragments in the size range 1.6-2.0 kb 
were identified by gel electrophoresis and purified and ligated into a plasmid vector. Then 
the end-sequences from each fragment were determined by Sanger DNA sequencing. At 
this stage, the sequence reads obtained corresponded to six times the length of the H. 
influenzae genome (Fleischmann et al., 1995). Next, using a computer, the overlaps from 
all the fragments were searched and assembled, and the identified matching sequences 
were collected and assembled into contiguous sequences, referred to as “contigs”. 
Typically, before the finishing stage, more than 99% of the genome can be spanned by 
using a shotgun sequencing approach (Fraser et al., 2002). 
 
Once the shotgun library is established and the contigs are assembled, the next step is 
called genome finishing. This includes closing the gaps between contigs, resolving all 
ambiguities and improving overall quality to minimise the possibility of errors in the 
sequence. Currently, genome sequencing is producing shotgun sequence data at a very high 
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rate using advanced sequencing technologies (Hall, 2007). However, genome finishing is 
much more labour-intensive and time-consuming than the shotgun phase. The finishing 
stage is therefore a bottleneck in large-scale sequencing efforts. The sequence data from 
many genomes are now often released unfinished (Pallen and Wren, 2007).   
 
Annotation is another bottleneck in sequencing projects. Annotation of a genome involves 
the description or prediction of the boundaries of genes and other genomic elements, and 
of the function of the gene products (Riley et al., 2006). In the post-genomic era, 
annotating a gene involves the integration of information obtained through genomic 
sequencing efforts, bioinformatic analyses and direct experimental validation. However, 
since both sequence analysis and experimental evidence are constantly expanding, no 
annotation can ever be considered complete (Riley et al., 2006). For example, when the 
genome of Escherichia coli K-12 was initially annotated in 1997, of 4,288 protein-coding 
genes annotated, 38% had no attributed function (Blattner et al., 1997). A functional 
update in 2001 amended the number of gene products to 4,401, of which 19.6% had no 
functional assignment (Serres et al., 2001). The latest version updated that to a total of 
4,506 E. coli annotated gene products, of which 471 were of unknown function, 
representing 10% of E. coli chromosomal genes (Riley et al., 2006). The number of 
functionally unknown genes is continually falling due to characterisation of new gene 
functions, a process facilitated by the release of the annotated genomes of Salmonella, 
Shigella and other closely related organisms. 
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1.3.2 Cost of genome sequencing 
Advances in technology have led to a reduction in the time and money required to 
sequence a genome. However, at the beginning of this PhD project, sequencing a whole 
genome, together with the challenges of genome finishing and annotation, required 
resources that were beyond the scope of a typical laboratory (Gresham et al., 2008). It was 
not yet practical and routine to sequence every individual genome using the traditional 
methods. However, complete genome sequencing remains invaluable in many areas of 
microbial research, and there is constant interest in exploring more and more bacterial 
genomes. Therefore, there was a demand for rapid and cost-effective approaches to 
complete genome sequencing.  
 
Studies on genomic diversity indicate that closely related bacteria share a large proportion 
of their genomic information. Therefore, sequencing an entire genome is essentially a case 
of duplicated effort in those co-linear regions, when most interest is in the regions of 
difference from previously sequenced relatives. Therefore, new methods for efficiently 
detecting genomic variations are required. With such methods, it is possible to reduce the 
sequencing requirement to a tiny fraction of the genome, a capability that is available in 
most modern biology laboratories (Gresham et al., 2008). Today, many finished and 
unfinished genome sequences have been made publicly available, and several databases 
have been established for bacterial genome sequences analyses, some with an emphasis on 
comparative genomics, for example the xBASE server, http://xbase.bham.ac.uk (Chaudhuri 
and Pallen, 2006; Chaudhuri et al., 2008). 
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1.4 Comparative genomics 
Since the first bacterial genome was sequenced in 1995, bacterial genome sequencing has 
been progressing rapidly. At the time of writing, more than 600 bacterial genomes have 
been completely sequenced and made publicly available and nearly 1800 projects are 
ongoing (http://www.genomesonline.org). The area of genomics is one of the most 
dramatic developments in science over the past decade.  
 
After the first two bacterial genomes were sequenced, it was suggested that a comparison 
of the two may indicate the minimal gene set required for bacterial life (Mushegian and 
Koonin, 1996). As both strains were non-infectious, the genome sequences provided 
insights into bacterial biology rather than pathogenicity. On the other hand, as the two 
bacterial genomes were amongst the smallest and not closely related, the estimate is based 
on a simple lifestyle. However, it was clear that survival in different environmental niches 
would require additional genes, for example those associated with pathogenicity. When 
more genome sequences became available and more genomic variations were identified, it 
seemed impossible that “one size fits all” in the entire bacterial domain (Pallen and Wren, 
2007).  
 
Today, with hundreds of bacterial genomes available, what have we learnt from bacterial 
genomics? Firstly, continuously expanding genomic data have provided a foundation for 
various applications, perhaps most significantly for comparative genomics. While analysis 
of a single genome gives biological insights into any given organism, comparative analysis 
of multiple genomes provides substantially more information on the physiology and 
evolution of bacteria, expands better functional annotation for the predicted coding 
 30  
sequences, and identifies new genes (Fraser et al., 2000). Secondly, since most genome 
sequence projects have been targeted to pathogenic bacteria, comparative genomics 
provided a new route for the discovery of bacterial virulence factors. Particularly, in vitro 
culture seems impossible for some obligate intracellular bacterial pathogens, and genomics 
has provided the effective method for the identification of virulence genes (Raskin et al., 
2006).  
 
Comparative genomics sheds light on many genomic variations within closely related 
bacteria. Although the chromosomal organisation among more closely related bacteria is 
more conserved, genomic diversity exists and the extent of it was revealed to be far greater 
than expected even within a single bacterial species (Ohnishi et al., 2002). For example, in 
E. coli, the largest genomes possess over 1 Mb more DNA than the smallest genomes. This 
variation in genome size reflects the genomic composition, which differs vastly within the 
same or related species. The complete genome of E. coli O157:H7 strain EDL933 revealed 
177 strain-specific genes (greater than 50 bp) compared with 234 unique genes (greater 
than 50 bp) in the laboratory strain E. coli K-12 (Perna et al., 2001). This means that the 
two E. coli strains are heterogeneous for more than 25% of their genomes. The identified 
genomic differences can provide insights into biological function, as well as about the 
evolution of bacterial pathogens. Particularly, gene gain or loss, and gene context can 
provide clues to the identity and function of virulence factors. Additionally, genomic 
comparisons with closely related species can accelerate functional annotation of novel 
genes and other features such as gene fusions and pseudogenes (Raskin et al., 2006). 
Increasingly, sequences of closely related genomes are available, meaning that genome 
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differences are minimal, and comparative genomics allows the identification of single 
nucleotide polymorphisms (SNPs).  
 
Technologies for comparing bacteria at genomic, transcriptomic and proteomic levels in 
recent years have been extensively reviewed recently (Binnewies et al., 2006). Here, two 
commonly used methods are summarised.  
 
DNA Microarrays. DNA microarrays have revolutionised comparative genomics since 
the technology was first used for comparing several Mycobacterium bovis vaccine strains 
(Behr et al., 1999). Since then, DNA microarray technology has been widely used for 
comparative analyses of the genome content and genetic variations of different bacterial 
species, including Helicobacter pylori (Salama et al., 2000), Campylobactor jejuni (Dorrell 
et al., 2001),  E. coli (Ochman and Jones, 2000), Staphylococcus aureus  (Lindsay et al., 
2006) and Mycobacterium tuberculosis (Butcher, 2004). Microarrays have become one of 
the commonest methods to quickly reveal the gene contents of many closely related strains 
of a species. This approach is referred to as comparative genome hybridisation (CGH). 
 
CGH studies of this kind employ a microarray containing representations of all the genes 
of a sequenced and annotated reference strain. Labelled DNA from an un-sequenced, but 
related, experimental strain is hybridised to the array (Schoolnik, 2002a). The resulting 
hybridised array will identify genes common to both strains and genes that are present in 
the reference strain but absent in the experimental strain (Schoolnik, 2002b). This 
technique can therefore provide a rapid assessment of the differences between two 
genomes. However, the limitation of this method is that it cannot detect genes present in 
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the experimental strain but absent in the reference strain. Recently, the application of 
multi-strain microarrays has allowed extensive gene coverage of the species by 
incorporating a number of strains, and has been used for investigation of the horizontal 
acquisition or loss of MGEs in related strains of Staphylococcus aureus (Witney et al., 
2005). However, it is clear from pan-genome studies, such as the Streptococcus agalactiae 
“pan-genome”(Tettelin et al., 2005), that the size of bacterial gene pools often greatly 
exceeds the sequenced diversity, so these expanded arrays are still unlikely to identify all 
the genes in the test genome.  
 
Whole-genome PCR scanning (WGPS). WGPS was first used for a systematic PCR 
analysis of genomic diversity among eight E. coli O157 strains (Ohnishi et al., 2002). This 
approach is used for the overall structural comparison of closely related genomes, as 
determined by whole genome amplification using the Long Range PCR technique, when 
the sequence of at least one of these related genomes is available. WGPS provides 
information on gene order and genomic organisation and can rapidly identify regions of a 
test genome that are co-linear with the reference genome. By comparing the amplified 
fragments to those of the reference genome, several important features of a new genome 
could be determined, not only the presence of every target region, but some structural 
changes, e.g. rearrangement, large insertions and deletions. Particularly, the size and 
position of these changes can be identified by comparison with the reference genome.  
 
When compared with CGH using DNA microarrays, WGPS has many advantages for 
comparative genomics among closely related strains. CGH does not provide information 
about gene position or about genes that are absent in the reference strains but these facts 
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can be revealed by WGPS. By sequencing the obtained PCR fragments, one can obtain 
additional genomic information. However, like CGH, one of the drawbacks of WGPS is 
the difficulty in identifying novel regions within a genome. This is because all of the 
primers were designed based on a reference strain. Once the PCR corresponding to a 
certain segment has failed, one cannot discern whether mutations have occurred in the 
primer binding sites or whether a chromosomal deletion or large insertion or rearrangement 
has occurred. 
 
1.5 This Thesis 
At the start of this work, it was clear that there was a pressing need for methods that allow 
rapid, efficient and low-cost assessment and analysis of genomic diversity within bacteria. 
The work presented here includes the development of long PCR-based methods to allow 
comparative genomics studies to be performed on non-sequenced genomes. Case studies 
have been performed in three Gram-negative organisms. 
1.5.1 Escherichia coli 
Comparisons among several complete E. coli genomes discovered two large cryptic 
regions, which are present in some E. coli strains, but not in others. These two 
uncharacterised regions contain genes homologous to those from bacterial T3SSs. The first 
region, ETT2, is similar to Salmonella Spi-1, which encodes a non-flagellar T3SS. The 
second novel gene cluster, Flag-2, is similar to the Vibrio parahaemolyticus lateral 
flagellar system. The aim of this project was to investigate the distribution of both the 
ETT2 and Flag-2 gene clusters within the full phylogenetic diversity of the E. coli species, 
and then to reconstruct the evolutionary histories of these genomic islands.  
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1.5.2 Campylobacter jejuni 
The PCR-based comparative genomic approach was also applied to explore genomic 
diversity within Campylobacter jejuni, comparing the non-sequenced strain M1 with the 
sequenced reference strain, C. jejuni NCTC11168. Long PCR and single-primer PCR were 
used to identify and obtain sequence information from the most dynamic regions of the M1 
chromosome. These approaches represent a shortcut to allow the identification of the core-
genome and variable regions in a non-sequenced strain. 
 
1.5.3 Francisella tularensis 
Another application of the long PCR scanning approach was to guide the finishing process 
for the genome sequencing of the Francisella tularensis isolate, FSC198. Comparison with 
the complete genome of a closely related strain, F. tularensis Schu S4, showed a colinear 
relationship that facilitated the finishing stage of the FSC198 genome. Finishing the 
genome to completion allowed the identification of apparent differences between the two 
genomes, and those regions of discrepancy were subsequently resequenced in both strains. 
The identified single-nucleotide polymorphisms (SNPs) and variable number tandem 
repeat regions (VNTRs) shed light on the relationship between the two strains.  
 
The availability of whole-genome sequences can help to identify potential vaccine 
candidates, an approach called “reverse vaccinology” (Rappuoli and Nabel, 2001). In an 
additional project, genes located within a previously identified pathogenicity island of 
Francisella were characterised to investigate their potential for vaccine development. 
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CHAPTER TWO  
GENERAL MATERIALS AND METHODS 
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2.1 Materials 
All media was purchased from Oxoid and chemicals from Sigma, unless otherwise stated.  
 
2.2 Media 
Luria-Bertani (LB) broth consists of 1% (w/v) tryptone, 0.5% (w/v) yeast extract and 1% 
(w/v) NaCl. Luria-Bertani Agar (LB-A or LA) was made from LB with the addition of 
1.5% (w/v) bacto-agar. LB and LA stock were prepared and autoclaved within the 
department then stored at room temperature until use. LA was re-melted in a microwave 
then cooled to 50oC before pouring plates.  Antibiotics were added as required at a final 
concentration of 100 µg/ml ampicillin (Amp), 50 µg/ml kanamycin (Kan) and 25 µg/ml 
chloramphenicol (Chl) before use. Stock solution of antibiotics were sterilised by filtration 
through a 0.2 µm filter (Millipore, England). SOC broth used in bacterial transformation 
was purchased from Sigma.   
 
2.3 Bacterial strains 
Commercially available bacterial strains used in this study are listed in Table 2-1. Other 
bacterial strains are described in the relevant chapters. 
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Table 2-1 Commercially available bacterial strains used in this study. 
 
Bacterial Strains Genotype Source 
Top 10 F- mcrA ∆(mrr-hsdRMS-mcrBC) 
φ80lacZ ∆M15 ∆lacX74 recA1 
araD139 ∆(araleu) 7697 galU 
galK rpsL (StrR) endA1 nupG 
 
Invitrogen 
BL 21 (DE3) pLysS F-, ompT, hsdSβ(rβ-mβ-), dcm, gal, 
(DE3), pLysS(CmR), tonA 
 
Invitrogen 
DH 5α F-, φ80dlacZ∆M15, ∆(lacZYA-
argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, 
λ
-
, thi-1, gyrA96, relA1 
Sigma 
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2.4 Bacterial growth conditions 
Agar plates for E. coli growth were incubated at 37oC overnight. Liquid cultures were 
inoculated with a loop of pure growth and then incubated at 37oC in an orbital shaker or 
shaking water bath at 220 rpm overnight. The overnight culture was used directly for DNA 
extraction. For mid-logarithmic phase cultures, a small volume of overnight broth culture 
was inoculated into fresh LB broth with a dilution of one into a thousand, and then 
incubated in a shaking incubator for 3-4 hours until an OD600 of 0.5-0.6 was reached. For 
long term storage, 750 µl of an overnight broth culture was mixed with 250 µl of 100% 
(w/v) glycerol in a cryovial and stored at -80oC. 
 
2.5 Transformations 
2.5.1 Heat-shock transformation of chemically competent cells 
Commercially available chemically competent cells used in this study are listed in Table 2-
1. Competent cells were thawed on ice, then 25 µl per transformation was aliquotted into 
ice-cold 1.5 ml microfuge tubes. The transformation reaction was started by the addition of 
1 µl of the desired plasmid to each aliquot followed by gentle mixing. The mixture was left 
on ice for 30 minutes and then heat-shocked in a 42oC water bath for 40 seconds. 500 µl 
SOC or LB broth was added into each tube, and the cells were then incubated at 37oC with 
shaking at 220 rpm for one hour. 50-100 µl of the cells was inoculated onto LB-A plates, 
containing an appropriate antibiotic if required, and incubated at 37oC overnight.   
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2.5.2 Electroporation 
Electro-competent cells were prepared from a 100 ml mid-logarithmic phase culture. The 
culture was centrifuged at 3,000 g in a bench top centrifuge for 10 minutes, the pellet was 
washed 3 times in 10 ml ice-cold, sterile 10% (w/v) glycerol and the cells were then re-
suspended in 200 µl sterile dH2O. The cells were used immediately or stored in aliquots at 
-80oC glycerol.   
 
For each aliquot of 40 µl cells, approximately 200 ng of the plasmid DNA or PCR product 
was added and mixed gently. The cells were left on ice for up to 30 minutes before being 
transferred to an ice-cold sterile electroporation cuvette (2mm-gap, Geneflow). 
Electroporation was performed with a Biorad Gene Pulser under the following conditions: 
1.8 kV, 25 µF, and 600 Ω. Following electroporation, cells were immediately washed out 
of the cuvette with 450 µl SOC or LB broth and transferred to a 1.5 ml microfuge tube. 
The cells were incubated for 1-2 hours with shaking at 37oC. 50-100 µl of the culture was 
then plated onto LB-A plates containing the appropriate antibiotic and incubated overnight 
at 37oC. 
 
2.6 DNA extraction 
2.6.1 DNA preparation 
Bacterial chromosomal DNA was prepared using the DNeasy Kit (Qiagen), following the 
manufacturer’s recommended protocol. The genomic DNA was aliquotted and stored at     
-20oC until use. 
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2.6.2 Plasmid Isolation 
Plasmid DNA was isolated using the QIAprep Miniprep kit (Qiagen) according to the 
manufacturer’s instructions.  
 
2.7 DNA Restriction and modification enzymes 
2.7.1 Restriction Endonuclease digests 
Restriction endonucleases and their buffers were purchased from New England Biolabs 
(NEB) and digests were carried out according to the manufacturer’s instructions. Typically 
a digest reaction was incubated for 1-2 hours at 37oC in a 50 µl volume, using a buffer 
supplied by NEB.  
 
2.7.2 Ligation 
Ligations were carried out with T4 DNA ligase and the buffer supplied by the 
manufacturer (Invitrogen, United Kingdom). Ligation reactions contained an approximate 
1:1 molar ratio of insert to vector in a 10 µl volume, and were performed at 16oC for up to 
8 hours in a PCR machine. A quick ligation was performed using Right-Click 4x DNA 
Ligation MixTM (Yorkshire Bioscience). This kit allows the ligation to complete at room 
temperature in 10 minutes. The reaction requires 100 ng sticky/blunt ended plasmid DNA 
in a 15 µl volume, with a 1:5 ratio of insert to plasmid. The ligation products were checked 
by 0.8% agarose gel electrophoresis and visualised under UV. 
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2.8 Genetic Manipulations by Polymerase Chain 
Reaction (PCR) 
2.8.1 Primer design and synthesis 
Primers were designed using the online Primer3 software (Rozen and Skaletsky, 2000). 
The following guidelines were used for designing primers:  
a) primers are 20-25 bases in length 
b) GC% is about 50% (10-12 Gs and Cs per primer) 
c) melting temperature (Tm) is ideally over 60oC  
d) primer hairpins are avoided 
e) primers with 3’ complementary ends are avoided, as they can result in primer 
dimerisation.  
Primers were usually synthesised by Eurogentec (http://www.eurogentec.com) and 
supplied at a concentration of 100 µMol. When needed urgently, primers were synthesised 
by Alta Biosciences within the University of Birmingham.  
 
2.8.2 PCR conditions and reactions 
Unless otherwise stated, conventional short PCR was performed using Taq DNA 
polymerase (Invitrogen, United Kingdom). Each PCR was set up in a 200µl sterile PCR 
tube in a total volume of 20 µl-100 µl. Each 20 µl PCR reaction contained 1U Taq 
polymerase in 1x PCR buffer (supplied by Invitrogen), 20 ng genomic DNA, 8 pmol of 
each primer, 200 µM each dNTP, and 2 mM MgCl2. PCR conditions were: 30 cycles of 30 
seconds at 94oC, 30 seconds at 60oC and 1 minute at 72oC, followed by 7 minutes 
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extension at 72oC. All PCRs were carried out in a PTC-225 DNA Engine Tetrad thermal 
cycler (Genetic Research Instrumentation, Braintree, UK). 
 
2.8.3 Colony PCR 
Colony PCR was used to screen for appropriately sized inserts using the flanking vector 
primers. Colony PCR was carried out in a 50 µl reaction volume containing either 5 µl cell 
lysate or a single colony selected using a toothpick. The cell lysate was prepared by boiling 
a fresh single colony in 100 µl dH2O for 5 minutes, followed by centrifugation to obtain a 
pellet. The supernatant of the cell lysate was used as the template for colony PCR. 
 
2.8.4 Long Range PCR (LR-PCR) 
Effective and accurate amplification of long DNA targets (particularly exceeding 5 kb) has 
expanded the application of PCR in genetic studies. PCR products of up to 35 kb were able 
to be produced reproducibly using KlenTaq1, a mixture of pfu and Vent or Deep Vent 
(Barnes, 1994). The combination of two DNA polymerases, one of which is a proofreading 
enzyme, reduced the rates of mismatched bases in DNA strands in the PCR reaction 
(Barnes, 1994; Cheng et al., 1994). 
 
KlenTaq1 was kindly provided for this project by Dr Wayne Barnes (Washington 
University, St. Louis, USA). The buffer used was 10 x KLA, which consists of 500 mM 
Tris-HCl (pH 9.2), 160 mM ammonium sulphate, 25 mM MgCl2 and 1% Tween 20. LR 
PCR conditions were: 30 cycles of 10 seconds at 94oC, 30 seconds at 62oC and an 
extension step of 68oC for 10 minutes plus 1 minute for each kb of the PCR product. 
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2.9 Agarose gel electrophoresis 
DNA was analysed by electrophoresis on 0.5-1% agarose gels depending on the size of the 
DNA being loaded at, for example, 0.5-0.7% gels showed good resolution of large DNA 
fragments (more than 5 kb). 50x TAE stock buffer consists of 242 g Tris Base, 57.1 ml 
glacial acetic acid and 100 ml 0.5 M EDTA (pH 8.0) per litre. Agarose was dissolved in 1x 
TAE buffer and melted in a microwave. Once the agarose had cooled to about 50oC, 
ethidium bromide was added to a final volume of 1 µg/ml and the gel was poured. The gel 
was allowed to set for at least 30 minutes, and then transferred to a horizontal 
electrophoresis tank containing TAE buffer, with the gel submerged to a depth of 2-5 mm. 
The sample DNA was mixed with 6x DNA loading buffer [0.25% (w/v) bromophenol blue, 
30% (v/v) glycerol in water] and then added onto the gel. DNA electrophoresis was usually 
performed at 80-100 V for 30 min, but for large fragments (10-15 kb), gels were run at 25 
V for more than 10 hours. DNA was visualised on the UV transilluminator of a Biorad gel 
documentation system.  
 
2.10 PCR purification 
PCR products were purified directly using the PCR Purification Kit (Qiagen) for removal 
of the remaining enzyme and primers following the manufacturer’s instructions. Gel 
extraction was used where multiple bands were visualised by UV. The required DNA band 
was excised with a clean scalpel and purified from the gel using a QIAquick Gel 
Extraction Kit (Qiagen) according to the manufacturer’s instructions.  
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2.11 Automated DNA sequencing 
Sequencing of plasmid DNA or PCR products was performed by robots in the Functional 
Genomics Laboratory, School of Biosciences, University of Birmingham 
(http://www.genomics.bham.ac.uk/). Sequencing reactions consisted of a single primer at a 
final concentration of 300 nM mixed with 200-500 ng of template DNA in a final volume 
of 10 µl. The fully automated process carries out the labelling reaction, the cycle 
sequencing reaction using a Big Dye Terminator Kit (Applied Biosystems) and an MWG 
primeus HT 96 well Format PCR machine, and the sample purification. Finally, the 
sequencing products were obtained by capillary electrophoresis on an ABI 3700 DNA 
analyser with read lengths up to 1000 bp. Genetool LiteTM software and DNAMAN 
software were used to analyse the sequencing data.  
 
2.12 Protein analysis 
2.12.1 Buffers and solutions 
A) Resolving buffer for SDS-PAGE gels 
 
4 x resolving buffer contains 1.5 M Tris-HCl and 0.4% (w/v) sodium dodecyl sulphate 
(SDS) adjusted to pH 8.8. 
B) Stacking buffer for SDS-PAGE gels 
 
 4 x stacking buffer contains 0.5 M Tris-HCl and 0.4% (w/v) SDS adjusted to pH 6.8.  
C) SDS running buffer 
 
The stock of 10x SDS running buffer consists of 30.3 g Tris base, 144 g glycine and 10 g 
SDS per litre of water. The 1x running buffer contains 50 ml of stock buffer in 450 ml 
dH2O.  
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D) SDS gel loading buffer 
 
2 x SDS gel loading buffer consists of 100 mM Tris-HCl (pH 6.8), 200 mM dithiothreitol, 
4% (w/v) SDS, 0.2% (w/v) bromophenol blue and 20% (v/v) glycerol. 
E) Western-blot transfer buffer 
 
10 x western-blot transfer buffer contains 5.8 g Tris, 2.9 g glycine and 0.37 g SDS in 200 
ml methanol and 800 ml dH2O. 
F) Phosphate Buffered Saline (PBS) 
 
10 x PBS contains 80 g of NaCl, 2 g of KCl, 14.4 g of Na2HPO4, and 2.4 g of KH2PO4 in 1 
litre of dH2O, adjust the PH to 7.4.   
G) Western-blot incubation/blocking buffer 
 
Incubation/blocking buffer was made of 5% (w/v) milk powder in 1x phosphate buffered 
saline (PBS) and 0.05% Tween 20 (v/v). 
H) Staining of SDS-PAGE gels  
 
Coomassie blue R250 stain contains 0.2% (w/v) of coomassie blue R250 in 45% (v/v) 
absolute ethanol, 45% (v/v) dH2O and 10% (v/v) glacial acetic acid.  
 
2.12.2 Sodium Dodecyl (lauryl) Sulphate-PolyAcrylamide Gel 
Electrophoresis (SDS-PAGE) 
SDS-PAGE (Laemmli, 1970) has several uses in protein analysis, such as establishing 
protein size, protein identification, and future blotting applications. The gels were made 
from Ultrapure ProtogelTM (Fisher Scientific) containing 30% (w/v) acrylamide and 0.8% 
(w/v) NN’-methylenebisacrylamide.  
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The gels were set up by a 1.5 mm or 1 mm Biorad glass plates. The resolving gel was 
carefully poured into the glass plates avoiding air bubbles. A gap of 20-30 mm was left at 
the top of the gel and overlaid with dH2O to ensure a flat surface and to exclude air. The 
resolving gel was left for about 50 minutes to set, and then the dH2O overlay was removed 
using filter paper. Following that, the stacking gel was poured onto the top of the resolving 
gel and a 15 lane plastic comb was inserted to make the wells. The stacking gel was 
allowed to set for 50 minutes. Samples were mixed with 2x SDS loading buffer and heated 
at 95oC for 5 minutes prior to loading. Molecular weight markers were loaded alongside 
the samples. For further blotting analyses, a pre-stained protein marker (NEB) was loaded. 
The tank was assembled with the gel glass plates and filled with SDS running buffer. Gels 
were run at 170 V until the dye front had reached the bottom of the gel.  
 
2.12.3 Western blot 
Western blot was performed by placing a nitrocellulose membrane (Millipore Immobilon-P) 
on the gel and using electrophoresis to drive the protein bands onto the nitrocellulose 
membrane. Freshly electrophoresed SDS-PAGE gel, filter paper and a sponger were 
dipped into transfer buffer at room temperature for 10 minutes prior to blotting. The 
membrane was pre-soaked in 100% methanol for 30 minutes before soaking in transfer 
buffer. A “sandwich” was assembled consisting of sponger, filter paper, gel and membrane, 
filter paper, and sponger, in order, to allow the use of a transblot system (Bio-Rad). The 
assembly was placed in a tank filled with western-blot transfer buffer. Transfer was either 
carried out overnight at a low voltage (30 V) or for 90 minutes at 100 V. An ice pack and a 
magnetic flea were placed in the tank, which was placed on a stirring block, to avoid 
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overheating. When finished, the membrane was incubated in blocking buffer overnight at 
4oC to ensure blocking of all non-specific protein binding sites on the blots.  
 
To detect the desired proteins, two specific antibodies were used. The procedure was as 
follows:  
1) Incubate with primary antibody (at a 1:500 dilution) in 10 ml blocking buffer for 1 
hour at room temperature.  
2) Wash 3 times for 10 minutes with 1x PBS.  
3) Incubate with the secondary antibody (at a 1:500 dilution) in 10 ml fresh blocking 
buffer for 3 hours at 4oC with gentle shaking.  
4) Wash 3 times for 10 minutes with 1x PBS.  
5) Add a substrate for the horseradish peroxidase (HRP) linked to the secondary 
antibody to develop the protein bands to be visualised.  
6) Add developing solution that contains 3 ml of the substrate 4-chloro-1-napthol (60 
mg dissolved in 20 ml methanol), 10 ml 1x PBS and 20 µl 30% (v/v) H2O2. The 
bands were visualised on the membrane at room temperature.  
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CHAPTER THREE  
DISTRIBUTION AND EVOLUTION OF  
TWO TYPE III SECRETION GENE CLUSTERS 
FROM ESCHERICHIA COLI 
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3.1 Introduction 
3.1.1 Escherichia coli  
Escherichia coli is a widely used model organism in various areas of biology. It is one of 
the most intensively studied and best understood organisms (Donnenberg, 2002). The large 
body of knowledge about E. coli facilitates its use as a model organism. The quotation “all 
cell biologists have two cells of interest: the one they are studying and Escherichia coli” 
(Fred Neidhardt, 1996) illustrates this organism’s special role in biology.  
 
The natural habitat of E. coli is the gastrointestinal tract of warm-blooded animals or 
humans, and most strains are commensal and exist without harming the host (Donnenberg, 
2002). However, the species E. coli also contains a wide range of pathotypes, which cause 
a variety of intestinal and extraintestinal diseases, typically classified as: diarrhoeal disease, 
urinary tract infections (UTI), or bloodstream sepsis and meningitis (Kaper et al., 2004). 
Six well described E. coli pathovars are associated with intestinal diseases: 
enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. 
coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and 
diffusely adherent E. coli (DAEC). Two well characterised pathogenic E. coli are 
associated with extraintestinal infections in humans: uropathogenic E. coli (UPEC) and 
neonatal meningitis E. coli (NMEC) (Kaper et al., 2004). These are often referred to 
together as extraintestinal pathogenic E. coli (ExPEC) (Johnson and Russo, 2002).  
Furthermore, the Shigella spp. is closely related to E. coli from a phylogenetic perspective, 
and is considered as another pathovar within the E. coli species (Pupo et al., 2000). There 
are four recognised Shigella species: S. dysenteriae, S. flexneri, S. boydii, and S. sonnei.  
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3.1.2 E. coli Genomes 
In 1997, the University of Wisconsin completely sequenced the first E. coli genome, E. 
coli K-12 strain MG1655 (Blattner et al., 1997). A second E. coli K-12 strain, W3110, was 
sequenced the same year, but the genome as a whole was not completely sequenced and 
published until more recently (Hayashi et al., 2006). In 2001, the US group and a different 
Japanese group published the complete sequence of two EHEC strains, E. coli O157:H7 
EDL933 and Sakai (Hayashi et al., 2001; Perna et al., 2001), respectively.  
 
The complete genome of E. coli O157 strain EDL933 was compared with E. coli K-12 
MG1655 at the whole genome level. The 5.5 Mb chromosome of E. coli O157: H7 shares 
about 4.1 Mb common sequence with the E. coli K-12 genome (Perna et al., 2001). These 
conserved regions are referred to as the “backbone” or “core-genome”, as they are co-
linear (Donnenberg, 2002). The backbone is punctuated by lineage-specific elements (or 
islands), which account for the genome size difference and many of the phenotypic 
differences among E. coli strains. Genomic comparisons revealed 1.34 Mb of the EDL933 
genome and 0.53 Mb of the K-12 genome are heterogeneous (Perna et al., 2001). 
Interestingly, these strain-specific islands are often found at the equivalent loci of the 
chromosome, indicating the presence of “hot-spots” for the insertion of foreign DNA 
acquired by horizontal gene transfer (Perna et al., 2001).  
 
With the completion of the genome sequence of uropathogenetic E. coli strain CFT073, a 
three-way comparison of E. coli strains CFT073, EDL933 and MG1655 became possible 
(Welch et al., 2002). It became obvious that the conserved core-genome is largely co-linear. 
Currently, it is estimated that all E. coli (including Shigella) genomes share about a 3 Mb 
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conserved core-genome, which represents 65% of the E. coli K-12 MG1655 genome (Yang 
et al., 2005). Apart from this, the remaining genes are highly diverse. However, it is 
noteworthy that most of the strain-specific islands are not obviously associated with 
pathogenicity. Genes with an established role in pathogenicity are not limited to the large 
islands either. For example, only nine large islands (>15 kb) encoded known virulence 
factors when the O157:H7 EDL933 genome was released (Perna et al., 2001). 
 
As genome sequencing has become cheaper and more routine, a range of additional 
genome sequencing projects has been initiated targeting the E. coli species. Genome 
sequences for almost all the E. coli pathotypes, together with all the Shigella species, are 
now publicly available, either as complete sequences or almost-complete drafts. The 
genome projects and sequencing status can be accessed through the NCBI (National Centre 
for Biotechnology Information) database (http://www.ncbi.nlm.nih.gov/sites/entrez). The 
increasing amount of genomes allows additional biological insights to be obtained through 
comparative genomics. An online database (http://xbase.bham.ac.uk/colibase) has been 
established in Birmingham with the aim of facilitating this process (Chaudhuri et al., 2004; 
Chaudhuri and Pallen, 2006). 
 
3.1.3 E. coli phylogenetics and diversity 
To aid in the study of the variety of E. coli strains, the Escherichia coli Reference (ECOR) 
Collection was established by Howard Ochman and Robert Selander in 1984 (Ochman and 
Selander, 1984). The collection consists of 72 standard reference strains isolated from 
humans and 16 other mammalian species from various geographical distributions, and 
includes both pathogenic and non-pathogenic variants (Ochman and Selander, 1984). The 
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ECOR strains could be separated into five major phylogenetic groups, namely A, B1, B2, 
D and E (or unclassified), based on analysis of Multi-Locus Enzyme Electrophoresis 
(MLEE) data using the neighbour-joining algorithm (Herzer et al., 1990). The validity of 
these groups has been supported in numerous later studies (Lecointre et al., 1998; Escobar-
Paramo et al., 2004). More information about the ECOR collection is available from 
Thomas Whittam’s laboratory website (http://foodsafe.msu.edu/whittam).  
 
With the aid of the E. coli strain collections, the phylogenetic relationship between E. coli 
pathotypes and the commensal strains could be drawn. A study based on MLEE analysed 
the genetic distance of E. coli pathotypes within the ECOR collections (Donnenberg and 
Whittam, 2001). The study revealed the existence of two EPEC lineages that are associated 
with infantile diarrhea, EPEC1 and EPEC2, and two EHEC lineages that are associated 
with hemorrhagic colitis, EHEC1 and EHEC2. Both EPEC1 and EHEC1 are highly 
divergent, whereas EPEC2 and EHEC2 are closely related to one another and fall into the 
B1 group of ECOR (Donnenberg and Whittam, 2001).  
 
Recently, a phylogenetic tree based on multi-locus sequence data (MLST) was constructed 
using the ECOR collection, plus a second collection of 78 diarrhoeagenic E. coli strains 
(referred to as the DEC collection) (Whittam et al., 1993), and the other representative 
pathogenic strains of E. coli/Shigella (Escobar-Paramo et al., 2004). The authors of the 
study suggested that a specific genetic background is necessary for the expression and 
maintenance of certain virulence factors (Escobar-Paramo et al., 2004). Such analyses may 
help to determine the positions at which major acquisition of certain virulence factors (VF) 
occurred. According to this study, the strains belonging to EHEC1 are found in ECOR 
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group E, while those belonging to EHEC2 are found in group A. For EPEC, EPEC1 strains 
are in group B2, while EPEC2 strains are in group B1. Many strains with ExPEC virulent 
determinants are classified as being in group B2 (Escobar-Paramo et al., 2004).  
 
3.1.4 Pathogenic E. coli 
Pathogenic E. coli are characterised by the expression of virulence factors, which provide 
an enhanced ability to cause intestinal or extraintestinal disease (Kaper et al., 2004). Many 
virulence factors are encoded on mobile elements, such as plasmids, bacteriophages and 
pathogenicity islands, and acquired through horizontal gene transfer (Ochman et al., 2000). 
Horizontal gene transfer plays an important role in the evolution of pathogenic E. coli 
strains. 
 
However, though lateral gene transfer has the potential to introduce sizable amounts of 
DNA, bacterial genomes do not appear to be growing ever larger in size (Lawrence et al., 
2001). Some commensal E. coli can also undergo deletions, point mutations or other DNA 
rearrangements that can contribute to virulence (Kaper et al., 2004). There is increasing 
evidence that loss of gene function, or genome decay, increases with adaptation to the host 
(Wren, 2000).  
 
3.1.5 E. coli Second T3SS - the ETT2 locus 
With the arrival of two complete genome sequences, E. coli O157: H7 EDL933 and K-12 
MG1655, genome comparisons revealed a second T3SS gene cluster within the E. coli 
species (Perna et al., 2001).  These genes resemble Salmonella SPI-1 and organised in a 
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cluster, first designated as O-island 115 in Blattner's nomenclature (Perna et al., 2001). The 
gene cluster was 16.9 kb in size with a low GC content and was inserted in the tRNA glyU 
of E. coli (Perna et al., 2001). It was thought to be horizontally acquired by O157: H7 
genomes at the time of discovery. In order to distinguish it from the LEE T3SS, it was 
named as ETT2 for E. coli type three secretion system 2 (Hayashi et al., 2001).  
 
Homologous to Salmonella/Shigella “inv-spa” elements, the ETT2 gene cluster has drawn 
interest due to its potential role in pathogenicity in E. coli. A study by Hartleib et al. found 
that ETT2 was ubiquitously distributed among intestinal pathogenic E. coli strains, but not 
among extra-intestinal, non-pathogenic E. coli or other enterics (Hartleib et al., 2003). 
Later, Makino et al. found that the prevalence of ETT2 genes was more common in EHEC 
strains than the LEE-encoded ETT1. They disclosed that ETT2 genes were present in 78 
out of 89 O-antigen serotypes isolated from various pathotypes including EHEC, EPEC2, 
EAEC, and ETEC (Makino et al., 2003). An incomplete ETT2 segment, which was 8.7 kb 
in size, was discovered in a EPEC2 strain, B171-8, (O111: NM). This ETT2 segment was 
sequenced and deposited in GenBank with accession no. AB052736 (Makino et al., 2003). 
Since the non-pathogenic E. coli included in both studies were found not to house any 
ETT2 genes, ETT2 was once considered a new marker for distinguishing between 
pathogenic and non-pathogenic E. coli.   
 
However, these studies did not agree upon the boundaries of the ETT2 gene cluster. 
Makino et al. placed the left boundary at ECs3714 (Sakai genome nomenclature), 
delineating ETT2 as a 17 kb insertion (Makino et al., 2003), whereas Hartleib et al. placed 
the boundary further upstream at ECs3703 (rmbA/yqeH), making the cluster 29.9 kb in 
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length (Hartleib et al., 2003). The boundaries of the ETT2 gene cluster were later defined 
through three independent methods, namely homologies to other T3SS genes, G+C content, 
and genomic comparisons (Figure 3-1) (Ren et al., 2004). The ETT2 island was defined as 
27.5 kb in length, with a lower than average GC content, and had inserted into the 
intergenic region between ECs3702/yqeG and the tRNA glyU gene. The boundaries of 
ETT2 extended beyond O-island 115, suggesting that a remnant of ETT2 was retained in E. 
coli K-12.  
 
A comparison of the ETT2 gene cluster from EHEC with the equivalent region of other 
Escherichia or Shigella genomes revealed the ETT2 gene locus is present, at least in part, 
in the majority of genome-sequenced Escherichia and Shigella strains. Nine of the 12 
genome sequences showed evidence that ETT2 genes have been inserted at the same 
chromosomal site, within the yqeG-glyU intergenic region. By genomic comparisons, two 
genome sequences, EPEC1 strain E2348/69 and UPEC strain CFT073, were identified that 
lacked the ETT2 island in its entirety, and thus presumably represented the ancestral state 
for the species (Ren et al., 2004). An identical 14.6 kb deletion was found in the two K-12 
laboratory strains. Remnants of ETT2 islands were also seen in two of the sequenced 
Shigella genomes. The full complement of ETT2 genes was found in the two genome-
sequenced EHEC strains, EDL933 and Sakai, and EAEC strain 042 (Figure 3-1).  
 
3.1.5.1 ETT2 genes 
Using such analysis, the ETT2 gene locus was shown to contain 35 genes, namely 
ECs3703 to ECs3737 (Sakai nomenclature) from EHEC Sakai strain (Table 3-1). Most 
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Figure 3-1 Schematic representation of genomic analysis of the ETT2 cluster. 
Structures of the ETT2 pathogenicity island in a number of E. coli and Shigella 
strains, and comparisons with regions of Spi-1 and Spi-3 from Salmonella enterica 
serovar Typhimurium are shown. Homologous genes are vertically aligned. Insertions 
relative to the complete ETT2 sequence (as seen in Sakai and EAEC 042) are 
indicated with dashed lines. Dotted lines indicate deletions (Ren et al., 2004). 
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Table 3-1 Genes within the ETT2 gene cluster (Ren et al., 2004). 
 
Gene in Sakai 
strain 
Gene in 
K-12 
Pseudogene(s) Other homologies 
ECs3703  yqeH None  RmbA regulator from Spi-3 
ECs3704 yqeI None MarT from Spi-3 
ECs3705 yqeJ Sakai, EDL933,  
K-12 W3110 
FidL from Spi-3 
 
ECs3706 yqeK None None 
ECs3707 ygeF K-12 W3110,  
K-12 MG1665 
None 
ECs3708 ygeG None SicA-like T3SS chaperone  
ECs3709 ygeH None HilA-like T3SS regulator 
ECs3710 ygeI Sakai, EDL933,  
K-12 W3110 
None 
ECs3711 b2854 K-12 W3110,  
K-12 MG1665 
IagB from Spi-1, PilT from S. 
enterica 
ECs3712 ygeK K-12 W3110,  
K-12 MG1665, 
misidentification of start site in 
EDL933 
SsrB from Spi-2 
 
ECs3713 b2857 Sakai, EDL933,  
 
OrgB, MxiN 
ECs3714 b2858 K-12 W3110,  
K-12 MG1665 None 
ECs3715 b2859 K-12 W3110,  
K-12 MG1665 
PrgA, MxiK 
 
ECs3716/eprH None PrgK 
ECs3717/eprI None PrgJ, MxiI 
ECs3718/eprJ Numerous frame shifts in 
EDL933 
PrgI, MxiH 
ECs3719/eprK Sakai, EDL933 PrgH 
ECs3720/etrA None Transcriptional regulator 
ECs3721/epaS Last three residues missing in 
EAEC 
SpaS 
ECs3722/epaR2 Sakai, EDL933 SpaR 
ECs3723/epaR3  None 
ECs3724/epaQ None SpaQ 
ECs3725/epaP None SpaP 
ECs3726/epaO Sakai, EDL933 SpaO 
ECs3727/eivJ EAEC or Sakai/EDL933 SpaN/InvJ 
ECs3728  None 
ECs3729/eivI None  SpaM 
ECs3730/eivC None SpaI/InvC 
ECs3731/eivA None InvA 
ECs3732/eivE None InvE 
ECs3733/eivG None InvG 
ECs3734/eivF None InvF 
ECs3735 
Absent 
None Inner membrane YjdO/YdcX 
ECs3736 b2863 Different frame shifts in K-12, 
O157, S. sonnei, S. flexneri 2a 
Phosphorylase kinase and 
glucomamylases 
ECs3737 b2862  
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genes are organised in operons, suggesting functional co-ordination. By comparison with 
other T3SS genes, at least four operons are predicted within one ETT2 locus. Many of 
these genes have been predicted to be a Type III secretory apparatus, chaperone, regulator 
or translocator. 
 
Interestingly, three genes from the leftmost extremity of the ETT2 cluster are homologous, 
not to Spi-1 genes but to the Spi-3 pathogenicity island from S. enterica. ECs3703 encodes 
protein exhibiting similarity to RmbA (39% identical over 190 aa), which is a predicted 
cytoplasmic protein belonging to the LuxR family of regulatory proteins. ECs3704 has 
homology with MarT (41% identical over 101 aa), a member of ToxR-like family of 
regulatory proteins (Blanc-Potard and Groisman, 1997). ToxR is a transmembrane 
regulatory protein that is required for the synthesis of cholera toxin in V. cholerae (Miller 
and Mekalanos, 1984). ECs3705 exhibits similarity to FidL (43% identical over 139 aa). 
Both MarT and FidL are predicted to be inner membrane proteins in S. enterica. A recent 
study suggested MarT played a role as a transcriptional activator, and one of its substrates 
was identified as MisL, an IgA homology transporter protein from S. enterica (Tukel et al., 
2007). In Spi-3, misL is located between rmbA and fidL. However, ETT2 has no misL 
counterpart. ECs3703, ECs3704 and ECs3705 appear to be organised in one transcriptional 
unit in the ETT2 locus.  
 
As in S. typhimurium Spi-1, the Type III secretory apparatus is encoded by the inv-spa 
gene cluster and the prgHIJK-orgAB genes. Comparison of the ETT2 locus with  
Spi-1 revealed a generally similar gene complement and organisation. The genes ECs3734-
ECs3729 and ECs3727-ECs3721 represent homologues to the invFGEACIJ-spaOPQRS 
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genes, respectively, predicted to form one large operon at the right hand end of the ETT2 
locus. ECs3734/EivF, the first gene of this predicted operon, is homologous to the 
Salmonella transcriptional regulator InvF. Activation of Salmonella invF results in 
transcription of other inv-spa genes.  S. typhimurium InvH is an important outer membrane 
lipoprotein required for the proper localization of InvG and for the secretion of the 
virulence factor SipC (Daefler and Russel, 1998). However, an invH homologue was found 
to be absent in the ETT2 locus, although a pseudogene to an invH homologue (namely 
eivH) is present in the region between ECs3720 (etrA) and ECs3721 (epaS) (Makino et al., 
2003). The co-expressed proteins InvH and InvG have been characterised as part of the 
functional outer membrane translocation complex in T3SS (Crago and Koronakis, 1998). 
EivC is homologous to InvC, the ATPase associated with Spi-1, and is thought to provide 
the energy for the secretion process of T3SS. The ATPases are highly conserved among all 
T3SSs. The phylogenetic analysis of EivC from ETT2 with its homologues from other 
TTSSs indicated that ETT2 belongs to the Spi-1/Mxi-Spa group of TTSSs (Ren et al., 
2004). EivC from ETT2 shares about 40% identity at protein level with EscN from the 
LEE locus. 
 
Homologues to Spi-1 prgHIJK-orgAB have been found as another predicted operon in the 
ETT2 locus, representing ECs3719-ECs3715 and ECs3713, respectively. All of the six 
genes in Spi-1 are required for S. typhimurium invasion, and their expression is driven by 
the prgH promoter (Klein et al., 2000). ECs3714 has not been shown to have identity with 
Spi-1 or any other T3SS gene. The Salmonella prgHIJK operon encodes components 
required for formation of the supramolecular type III secretion needle complex (NC) 
(Kimbrough and Miller, 2000). Co-expression of PrgH and PrgK forms a ring structure 
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resembling the base of the needle complex, while PrgI forms the needle portion (Lostroh 
and Lee, 2001). Another protein, PrgJ, was suggested to be involved in the assembly of the 
needle portion protein PrgI (Sukhan et al., 2003). However, comparisons of ETT2 
sequences in both the EHEC O157:H7 genome and in Salmonella Spi-1 revealed frame-
shift mutations in several important genes required for invasion and secretion: spaR, prgH, 
and orgB. The mutations in these structure genes would have abolished the function of 
Type III secretion. 
 
In Salmonella, between the inv-spa genes and the prg-org genes are located the genes for 
the Spi-1 secreted proteins: SipBCDA and SptP. The Sip protein complex not only 
comprises a “translocase”, through which effectors can pass into the host cell, but SipB and 
SipC themselves act as effector proteins (Carlson and Jones, 1998). Curiously, the ETT2 
locus has none of these homologues. The immediate questions might be where the ETT2 
effectors are and why this pathogenicity island has eliminated the effectors during its 
evolution. Homology searches of ETT2 genes could not find any other effectors, such as 
Salmonella avrA and Sop genes. However, a sicA-like chaperone gene ECs3708/ygeG is 
present in the ETT2 locus. The functions of the chaperone protein SicA affect the 
expression of several secreted proteins, not only of SipB and SipC encoded on Spi-1 
(Tucker and Galan, 2000), but of SigD and SopE, which are unlinked to Spi-1 (Darwin and 
Miller, 2000). Activation of the sicA gene depends on interaction with the transcriptional 
factor invF. The ETT2 locus contains both SicA-like and EivF/ECs3734 proteins. However, 
the genetic arrangement of the ETT2 sicA-like gene is unlike that in Spi-1, where sicA is 
encoded immediately downstream of spaS and is part of the inv-spa operon. In addition, 
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ECs3708 has a relative low homology to sicA in Spi-1 (37% identity at the protein level 
over a 140 aa stretch). For these reasons, the function of ECs3708 in ETT2 is uncertain. 
 
In fact, immediately downstream of the sicA-like chaperone of the ETT2 locus is a hilA-
like T3SS regulator, ECs3709/ygeH (29% identity at the protein level over a 403 aa stretch). 
Salmonella HilA is a global transcriptional factor encoded on Spi-1, which co-ordinately 
regulates the expression of genes encoding the Spi-1 secretory apparatus and many other 
effectors (Lostroh and Lee, 2001). Besides, activation of InvF also requires HilA. In 
addition, ETT2 encodes another two regulators, ECs3712 and ECs3720/etrA. ECs3712 is 
homologous to SsrB from Spi-2 (32% identity at the protein level over a 209 aa stretch). 
SsrB represents the response regulator of a two-component regulatory system, SsrAB, 
regulating Spi-2 genes. ECs3720/EtrA exerted profound negative effects on gene 
transcription within the LEE locus of EPEC strains (Zhang et al., 2004). However, 
although these regulatory genes are present on the ETT2 locus, the signals that trigger 
ETT2 expression are not clear at this time. 
 
3.1.5.2 Eip gene locus 
In an attempt to locate possible ETT2 effectors, homology searches were carried out 
among the sequenced Escherichia and Shigella genomes available at the time (Ren et al., 
2004). A novel 20.9 kb pathogenicity island containing homologues of the sip effector 
genes was found in the EAEC 042 genome (Figure 3-2) (Ren et al., 2004). The island was 
designated as Eip for E. coli invasion proteins (Ren et al., 2004). Comparative analysis of 
the Eip locus in genome-sequenced strains revealed that it was not as prevalent as ETT2  
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Figure 3-2 Schematic representation of the structure of the Eip island in EAEC strain 
042 (produced by Dr. Chaudhuri). The comparison was carried out with the 
backbone sequence seen in Sakai. eipB and eipD encode proteins that are homologous 
to Salmonella SipB and SipD, respectively (also see Figure 3-1). Between these two eip 
genes lies a third gene, eipX, which shows weak similarity to espD and thus may 
encode an additional secreted translocator protein. In addition, the eip island contains 
genes coding for a novel SicA-like tetratricopeptide repeat chaperone, eicA; a novel 
HilA-like regulator, eilA; and an invasin/intimin-like large outer membrane protein, 
eaeX (Ren et al., 2004). 
 
Effector protein 
Transcriptional Regulator 
Intimin Homologue 
Chaperons 
Backbone gene 
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but was only present in the 042 genome (Ren et al., 2004). Interestingly, EAEC 042 also 
contains the most intact ETT2 identified in any E. coli genome sequenced so far.  
 
The Eip island is found between the E. coli backbone genes, yicM and nlpA, and is inserted 
at the SelC tRNA gene. This novel island is comprised of six genes arranged in tow 
predicted operons. Two homologues of sip effector genes have been identified: eipB 
encodes a protein similar to SipB (20% identical over 527 aa) and eipD encodes a protein 
similar to SipD (31% identical over 266 aa). Between these two eip genes lies a third gene, 
termed eipX, with weak homology to espD from the LEE locus. EspD is a secreted 
translocator protein and plays an important role in forming pore-like structures in the host 
cell membrane (Ide et al., 2001). Since no translocators have been identified in the ETT2 
locus, this finding suggested that the eip island might encode an additional translocator 
protein. In addition,  eipX was also found to encode a product with low level identity (19%) 
to IpaC protein of Shigella flexneri, while IpaC is similar to SipC effector of S. enterica 
(Sheikh et al., 2006). Therefore, eipX was also suggested to encode a SipC-like protein 
product.  
 
Downstream of eipB is a SicA-like chaperone gene, eicA, while upstream of eipD is a 
HilA-like regulatory gene, eilA. The five genes, eicA, eipB, eipX, eipD, and eilA, are 
predicted in an operon (Figure 3-2). In addition, downstream of eilA, but in an opposite 
orientation, is a large gene, eaeX, encoding a product similar to invasin/intimin outer 
membrane protein. Tellingly, the expression of EilA was found to affect the expression of 
at least seven genes, including five genes in the eip locus (eicA, eipB, eipX, eipD, and 
eaeX), as well as two genes in the ETT2 locus (eivF and eivA) (Sheikh et al., 2006). This is 
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explained by the fact that HilA controls a T3SS in S. typhimurium. This finding also 
demonstrated co-expression of the ETT2 genes and eip genes from EAEC strains, even 
though they are distantly located.  
 
3.1.6 The second flagellar system in E. coli - the Flag-2 locus 
Bacterial flagella are complex organelles that provide power for bacterial motility and also 
play a central role in adhesion, biofilm formation, and host invasion. A typical bacterial 
flagellum comprises of six components: a basal body (including MS ring, P ring, and L 
ring), a motor, a switch, a hook, a filament, and an export apparatus (Macnab, 2003). 
Flagellar assembly shares many properties with T3SSs. It initiates from the formation of a 
ring structure in the membrane, and proceeds to formation of a basal body hook and an 
extra-cytoplasmic propeller-like filament (Macnab, 2003). The assembly of this complex 
organelle requires the products of more than 35 genes. Flagellar biosynthesis, assembly 
and regulation have been most studied in Salmonella enterica serovar Typhimurium strain 
LT2 and E. coli K-12 (Macnab, 2003).  
 
A comparison between the E. coli K-12 genome and that of Salmonella enterica revealed a 
small but puzzling difference in the flagellar gene repertoires (McClelland et al., 2000). E. 
coli K-12 possesses an additional pair of divergent and promoter-less flagellar genes, fhiA-
mbhA, which were absent from S. enterica (McClelland et al., 2000). These two genes are 
predicted to encode proteins homologous to the flagellar biosynthesis protein FlhA and the 
flagellar motor protein MotB, respectively. The two genes did not draw much attention at 
the time they were first noted. However, a few years later, genomic comparison of the K-
12 genome with an unfinished genome of EAEC strain 042 revealed something surprising. 
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A large discrepancy, a gene cluster containing 44 genes in the region of the fhiA-mbhA 
gene pair, was found in the E. coli 042 genome but not in the K-12 genome (Figure 3-3) 
(Ren et al., 2005). More strikingly, this gene cluster apparently encoded a novel and 
complete flagellar system, in addition to the conventional peritrichous flagellar system 
(Flag-1). This newly found gene cluster was designated as a second flagellar system in E. 
coli, Flag-2 (Ren et al., 2005). It was very surprising to identify two flagellar systems 
present in one E. coli genome.  
 
The E. coli 042 Flag-2 gene cluster was compared with the other genome-sequenced 
Escherichia/Shigella and Salmonella strains available at the time (Ren et al., 2005). The 
comparison revealed that all other Escherichia/Shigella strains only contained two scar-
genes fhiA-mbhA, the same as in E. coli K-12. However, all S. enterica strains lack the 
entire Flag-2, including the counterparts of the scar genes fhiA and mbhA. The two genes, 
fhiA and mbhA, exhibit over 95% identity to, but appear shorter than, their E. coli 042 
counterparts. This identification allowed the reannotation of fhiA and mbhA as 
pseudogenes. Both K-12 strain MG1655 fhiA and mbhA genes appear to have been 
truncated such that the first 391 and 189 nucleotides of E. coli 042 lfhA and lafU, 
respectively (Ren et al., 2005). This point of deletion is also found in all other available 
Escherichia/Shigella genome sequences with the exception of E. coli 042. It was suggested 
that the entire Flag-2 locus was originally present in the last common ancestor of the 
species, but then deletions occurred (Ren et al., 2005). The genes fhiA-mbhA were the 
remnants of an ancestral Flag-2 locus. 
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Figure 3-3 A, Schematic representation of the Flag-2 gene cluster in E. coli 042 
(produced by Dr. Beatson). B, Schematic representation of the Flag-2 gene clusters of 
other bacteria. The solid black lines indicate the genome fragments in E. coli K-12 
strain MG1655 (11.4 kb), S. enterica serovar Typhi Ty2 (4.9 kb), V. parahaemolyticus 
(11.7 kb region 1 and 23.2 kb region 2 from chromosome 2), Y. pestis CO92 (44.4 kb), 
and Y. pestis KIM (28.5 kb) that are equivalent to the lateral flagellar cluster of E. coli 
042. Homologous genes are vertically aligned. Dotted lines indicate the absent genes 
relative to the E. coli 042 Flag-2 gene cluster (Ren et al., 2005). 
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3.1.6.1 Flag-2 genes 
 
From homology searches and genomic comparisons, E. coli 042 Flag-2 genes showed 
greater similarity to the lateral flagellar genes in Vibrio parahaemolyticus (Table 3-2), than 
to the conventional Flag-1 genes in E. coli. V. parahaemolyticus possesses dual flagellar 
systems adapted for movement under different circumstances, where a single polar 
flagellum propels the bacterium in liquid (swimming) and multiple proton-driven lateral 
flagella enable translocation over surfaces (swarming) (Stewart and McCarter, 2003). In 
addition to V. parahaemolyticus, E. coli 042 Flag-2 gene homologues were discovered in 
other genomes, including two annotated Yersinia pestis  
genomes, Chromobacterium violaceum, Citrobacter rodentium, and Yersinia 
pseudotuberculosis (Ren et al., 2005). The Flag-2 systems among these species are well 
conserved and located in the equivalent positions in the closely related genomes. This 
scenario suggests that the Flag-2 cluster was horizontally acquired by a common ancestor. 
 
The apparent difference between E. coli 042 Flag-2 and V. parahaemolyticus lateral 
flagellar genes lies in the genetic organisation (Figure 3-3). The lateral flagellar gene 
system of V. parahaemolyticus contains a total of 38 genes in two distinct genetic regions 
(Stewart and McCarter, 2003). However, the Flag-2 genes are all organised in a unique 
chromosomal locus. Region 1 of V. parahaemolyticus 1 (~14 kb) includes all of the flg 
genes, encoding many of the structural proteins that are assembled to make the hook basal 
body structure, while Region 2 (~25 kb) includes the fli genes and laf genes, encoding the 
switch, motor, export-assembly, and flagellin genes (Stewart and McCarter, 2003). The 
majority of Flag-2 structural genes (i.e, flg genes counterparts) appear to be intact, as they 
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Table 3-2 Genes within the E. coli Flag-2 gene cluster. 
 
Gene in E .coli 042 E. coli K-12 V. parahaemolyticus Predicted function 
lfhA/Ec042-0245 fhiA flhAL Export, assembly 
lfhB/Ec042-0246  flhBL Export, assembly 
lfiR/Ec042-0247  fliRL Export, assembly 
lfiQ/Ec042-0248  fliQL Export, assembly 
lfiP/Ec042-0249  fliPL Export, assembly 
lfiN/Ec042-0250  fliNL Switch (C ring) 
lfiM/Ec042-0251  fliML Switch (C ring) 
lafK/Ec042-0252  lafK Regulatory 
lfiE/Ec042-0253  fliEL Basal body component 
lfiF/Ec042-0254  fliFL M ring 
lfiG/Ec042-0255  fliGL Switch (C ring) 
lfiH/Ec042-0256  fliHL Export, assembly 
lfiI/Ec042-0257  fliIL Export, assembly 
lfiJ/Ec042-0258  fliJL Export, assembly 
Ec042-0259   Cytidylyl transferase 
Ec042-0260   Glycosyl transferase 
lafV/Ec042-0261   Lysine-N-methylase 
lfgN/Ec042-0262  flgNL Chaperone 
lfgM/Ec042-0263  flgML Anti 28 
lfgA/Ec042-0264  flgAL P-ring addition 
lfgB/Ec042-0265  flgBL Rod 
lfgC/Ec042-0266  flgCL Rod 
lfgD/Ec042-0267  flgDL Rod 
lfgE/Ec042-0268  flgEL Hook 
lfgF/Ec042-0269  flgFL Rod 
lfgG/Ec042-0270  flgGL Rod 
lfgH/Ec042-0271  flgHL L ring 
lfgI/Ec042-0272  flgIL P ring 
lfgJ/Ec042-0273  flgJL Peptidoglycan hydrolase 
lfgK/Ec042-0274  flgKL Hook-associated protein 1 
lfgL/Ec042-0275  flgLL Hook-associated protein 3 
lafW/Ec042-0276  VPA0275 Possible hook-associated 
protein 
Ec042-0277   Unknown (COG4683) 
Ec042-0278   Regulator 
lafZ/Ec042-0279   Transmembrane regulator 
lafA/Ec042-0280  lafA Flagellin 
lafB/Ec042-0281  lafB Hook-associated protein 2 
lafC/Ec042-0282  lafC Chaperone 
lafD/Ec042-0283  lafD Chaperone 
lafE/Ec042-0284  lafE Hook length control 
lafF/Ec042-0285  lafF Unknown 
lafS/Ec042-0286  lafS 28 
lafT/Ec042-0287  lafT H+ motor protein A 
lafU/Ec042-0288 mbhA lafU H+ motor protein B 
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code for proteins with functional counterparts in other organisms. Only one gene, lfgC, was 
identified as a pseudogene in E. coli 042. lfgC encodes a FlgC-like proximal rod protein 
and so is likely to be essential for the production of Flag-2 flagella by E. coli 042. The 
frameshift that occurs in the lfgC gene might cause the inactivation of Flag-2 in E. coli 042. 
Furthermore, genomic rearrangements exist between the two lateral flagellar systems of E. 
coli 042 and V. parahaemolyticus. The homologues to the flg genes of V. parahaemolyticus 
are inserted in between the counterparts of the fli genes and the laf genes in E. coli 042 
(Figure 3-3). 
 
The majority of E. coli 042 Flag-2 protein sequences exhibit 25 to 58% amino acid identity 
with their orthologs in the V. parahaemolyticus lateral flagellar system (Ren et al., 2005). 
Although E. coli 042 Flag-2 contains positional orthologs of all V. parahaemolyticus lateral 
flagellar genes, one exception is motY, which encodes a motor component. MotY is 
thought to localise to the outer membrane for flagella rotation, and is most commonly 
found in sodium-driven polar motility systems (Okabe et al., 2002). MotYL in V. 
parahaemolyticus was suggested to have a function in mobility, but not in the production 
of flagella (Stewart and McCarter, 2003). On the other hand, the Flag-2 locus obviously 
contains additional genes relative to the lateral flagellar system of V. parahaemolyticus. 
Two additional CDSs (Ec042-0259 and Ec042-0260) are found between lfiJ and lfgN in 
the E. coli 042 Flag-2 cluster but are absent in the V. parahaemolyticus genome (Figure 3-
3). Homology searches of these two non-flagellar gene products found that they are often 
clustered together, functioning as part of capsular polysaccharide biosynthesis (Ren et al., 
2005). In addition, two further predicted coding sequences with no counterparts in the V. 
parahaemolyticus lateral flagellar system are found between lfgL and lafA in the E. coli 
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042 Flag-2 cluster, and are referred to as Ec042-0277 and Ec042-0278. Ec042-0277 
encodes a protein with unknown function (COG4683), while Ec042-0278 encodes a 
product predicted to function as a transcriptional regulator. However, the transcription 
cascade of this gene is not clear.  
 
The dual flagellar systems of V. parahaemolyticus can display different expression patterns 
during a change in environment. The lateral flagella are expressed only when the cell 
senses a surface environment, where LafK is responsible for lateral flagellar gene 
expression. In their study, Kim and McCater found that the polar flagellar gene, flaK, could 
be substituted by the lateral flagellar regulator LafK, but not the other way round (Kim and 
McCarter, 2004). Regulation by LafK in V. parahaemolyticus has been demonstrated to be 
dependent on interaction with rpoN (encoding σ54) (Stewart and McCarter, 2003). RpoN 
has not previously been shown to be required for E. coli flagellar systems, whereas the 
FlhDC master operon regulates the peritrichous flagella of many swarming bacteria 
including Escherichia coli and Salmonella enterica serovar Typhimurium (Fraser and 
Hughes, 1999). However, the study of Flag-2 LafK suggests that the Flag-2 system is 
RpoN-dependent in E. coli 042 (Ren et al., 2005).  
 
In the case of the two flagellar systems and the two non-flagellar T3SSs, one might ask 
whether any of the conserved components from one system might interact with and 
complement mutations in components of one of the other systems. If this happens, the 
components from other T3SSs can compensate for the defective genes in ETT2 or Flag-2, 
so that a functional second T3SS would be possible. Although one cannot entirely discount 
this possibility, two lines of argument count against it. 
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Firstly, there is an energy cost to producing these large multi-protein organelles. It is 
therefore unlikely that a bacterial cell would express two such systems at the same time. In 
addition, it also seems likely that each system switches on during a distinct environmental 
condition. For example, bacteria can develop distinct organelles of locomotion to adapt to 
different circumstances such as liquid and viscosity. In fact, as Zhang et al. have shown, 
regulatory components of the ETT2 system are able to inhibit synthesis of the LEE-
encoded system (Zhang et al., 2004). Thus, it is very unlikely that components of one 
system interact with components of another system. 
 
Secondly, although the components of one system are homologous to their equivalents in 
another system, their homologies are relatively low. For example, even the most conserved 
component of these systems, the ATPase, shows only 50% identity at the protein level 
between the homologues from the two flagellar systems and only 44% identity is found 
between EscN and EivC. If protein-protein interactions in these systems are imagined as 
predominantly dependent on congruence between the molecular surfaces of interacting 
partners, even minor changes in sequence are likely to alter the surface properties of the 
proteins and hence their capacity for interactions. Thus, it seems unlikely, although not 
impossible, that proteins from one system can interact with homologues of their usual 
partners in another system.  
 
 
3.1.7 Aims  
Comparative genomics is a powerful tool in revealing bacterial genomic diversity. Using 
this approach, two cryptic gene clusters, ETT2 and Flag-2, were discovered. Both ETT2 
and Flag-2 were surprisingly found to encode bacterial T3SSs (either non-flagellar or 
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flagellar T3SS). Although ETT2 has been investigated previously (Hartleib et al., 2003; 
Makino et al., 2003), only fragments of the gene cluster have been surveyed.  
 
Three aims have been addressed in this project: 
• To develop a rapid and low-cost PCR-based approach used for efficient genomic 
comparisons of two cryptic gene clusters.  
• To understand how widespread the distribution of ETT2 and Flag-2 gene clusters 
are among E. coli strains drawn from the ECOR collection and representatives of 
selected pathotypes.   
• To understand how the ETT2 and Flag-2 clusters have evolved.  
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3.2 Materials and Methods 
 
3.2.1 Bacterial strains 
The 72 ECOR strains were kindly provided by Thomas Whittam and stored in 10% 
glycerol at -80oC. A description of the ECOR strains is available from Thomas Whittam’s 
website (http://foodsafe.msu.edu/whittam/ECOR). Representatives of other pathotypes, 
including NMEC strain E. coli RS218, EAEC strain 042, ETEC strain H10407, EAEC 
strain EAEC25, UPEC strain CFT073, and E. coli strain K-12 and EPEC strain E2348/69 
were kindly provided by Dr Henderson (University of Birmingham, UK), while an 
isogenic non-toxigenic derivative of the E. coli O157:H7 Sakai strain was a kind gift from 
Chihiro Sasakawa (University of Tokyo, Japan). All ECOR strains were incubated in LB 
agar/broth culture at 37oC, while other pathogenic E. coli strains were cultured in LB plus 
appropriate antibiotics. In addition, four strains from Escherichia spp. other than E. coli 
(Escherichia blattae, Escherichia fergunsonii, Escherichia hermannii, and Escherichia 
vulneris) were purchased from the America Type Culture Collection. Genomic DNA was 
extracted using the DNeasy Kit (Qiagen, UK) and stored at -20oC until required.  
 
3.2.2 Primer design 
Primers for the ETT2 study were designed using Primer3 software (Rozen and Skaletsky, 
2000), which is incorporated into the xBASE server (http://xbase.bham.ac.uk/colibase). 
Primers were designed with an optimal length of 22 bp, optimal Tm of 60oC, and optimal 
G+C content of 50%.  A series of primers was designed to amplify each ~5 kb fragment 
that overlapped the regions of interest, with adjacent pairs overlapping by about 200 bp 
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(Table 3-3). Two additional pairs of primers were designed to identify two specific ETT2 
genotypes seen in sequenced genomes, one pair covering the 8.7 kb deletion seen in the 
EPEC2 B171-8 sequence (primers named B171-8-like) and the other pair to identify an 
unoccupied yqeG-glyU intergenic region as seen in the UPEC CFT073 sequence (primers 
named No ETT2) (Table 3-3). These two pairs of primers, centered on the insertion-
deletion (in-del) sites, were aimed to amplify ~200 bp and ~600 bp products, respectively. 
Short PCRs using the B171-8-Like and No ETT2 primer pairs were employed to identify 
the same ETT2 deletion patterns as seen for E. coli strain B171-8 and UPEC strain 
CFT073, respectively. For comparative purposes, a similar experiment was performed to 
investigate the distribution of the LEE cluster among all these E. coli strains. Eight pairs of 
PCR primers were designed to equally cover the whole LEE cluster with short overlaps of 
about 200 bp. However, only short PCRs were performed to examine the overlap regions.  
 
Similarly, in the study of Flag-2, long overlapping PCR primers were designed to amplify 
eight ~5 kb fragments (primers named Flag 1-8) spanning the whole ~35 kb Flag-2 cluster, 
with each fragment overlapping its neighbours by a few hundred base pairs (see Table 3-4). 
One pair of primers (named fhiA-mbhA F/R) was designed to span the E. coli K-12 fhiA-
mbhA remnant of Flag-2. Another two pairs of primers (named fhiA-flanking and mbhA-
flanking) were designed to amplify the flanking regions of the EAEC 042 Flag-2 cluster. 
These primers were designed to amplify from within the genes of fhiA and mbhA to their 
respective flanking sites within the Flag-2 gene cluster, with products of ~600 bp and 
~1,000 bp in size, respectively.  
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Table 3-3 Primers used to detect ETT2 and LEE gene clusters. 
 
Primers Sequence of primer (5’-3’) Gene name Start 
Position 
 
ETT2-1-F GACCCAGCGCACCTGAGTAAGT ECs3693 3697422 
ETT2-1-R AAGAGCGCAGTGTTTTGCCTGT ECs3697 3702420 
ETT2-2-F GTGTGTTACCTCCGGGTCATCC ECs3696 3701930 
ETT2-2-R CGCCGGACGATTTAAAGATGAG ECs3701 3707421 
ETT2-3-F CGCACTGTGGATGCTCTGTCTT ECs3700 3706496 
ETT2-3-R CGACTCATGGATTTGCACCAGA ECs3706 3712367 
ETT2-4-F AATGACCAGGGACGAGCAAATC ECs3705 3711838 
ETT2-4-R TATCCATTGCAAAACCCGCATT ECs3711 3716991 
ETT2-5-F ATGTGCCTAACCCGCTCAAAAA ECs3709 3715986 
ETT2-5-R ACCGACCCTGATCTGGTTGTAA Intergenic region 3721489 
ETT2-6-F GGGAAATTATCAGCAAGCCATGA ECs3719 3720991 
ETT2-6-R GCAGAAGAGAGTGGCAGCTGGT ECs3726 3726481 
ETT2-7-F AGCGCGCCATTTACACGTATCT ECs3726 3725748 
ETT2-7-R TGCACTTGATGCGAGTTGTTCA ECs3732 3731740 
ETT2-8-F GGTGGGCAATGGAATTATGAGC ECs3731 3731190 
ETT2-8-R AAACAGCGGCAGAAACCCACTA Intergenic region 3736743 
ETT2-9-F TCGGTCACCTTTTTGCCAATCT ECs3736  3736360 
ETT2-9-R TCCCGTTAATGGTGCATTCGAT ECs3741 3741865 
ETT2-10-F AATTACGCCTGGCATTTGGTGT ECs3740 3741579 
ETT2-10-R TCAGGCGAACGGTATCGTCATA ECs3744 3746363 
B171-8-Like-F AGACCAGCTGCCACTCTCTTCT ECs3726 3726458 
B171-8-Like-R GCTTGATTTAGGGGGAGAATCC ECs3736 3736081 
No ETT2-F CCTGATCGTGGGTATCCTGT ECs3702  3709433 
No ETT2-R GCTTGCATTTCCAGATTCGT ECs3738 3737548 
LEE-1-F TTAAGGCATCGATGTGTCCTTC ECs4602 4631996 
LEE-1-R GACATCTTGTTCTGCGCCATTA ECs4595 4626190 
LEE-2-F TTTTAAACTGCAGCGACCTTACC Intergenic region 4626387 
LEE-2-R GCCTGAGGATCTGTTTTTGCTT ECs4586  4619398 
LEE-3-F CGGAACTCATCGAAAGGTGTTT ECs4588 4619953 
LEE-3-R CAAAACAAACAAAAACGGAACG ECs4579 4614954 
LEE-4-F GCATTATACGCACCAACTGCAT ECs4579 4615154 
LEE-4-R CGACATCTTGCAACAATGAACA ECs4572 4610159 
LEE-5-F CTGAATGACCGATGGTGCTAAG ECs4573 4610825 
LEE-5-R CCCCATCGTGTACTCACCAATA ECs4568 4605820 
LEE-6-F ACTTCCGCGATCAAGGTAAAAA ECs4568 4606277  
LEE-6-R ACCAGGATTCGACTGCAGCTTA ECs4559 4598150 
LEE-7-F CGACGATTTGGTCGTTGAATAA ECs4559 4599009 
LEE-7-R CTCCCATGCCATAACCAATTTT ECs4533 4580425 
LEE-8-F TTATCGGTCTCAGCACCCCTAT ECs4533 4580516 
LEE-8-R CTTTCGCTCAATGATGTTCCTG ECs4531 4575520 
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Table 3-4 Primers used to detect Flag-2 gene cluster. 
 
Primers Sequence of primer (5’-3’) Gene name Start Position 
 
fhiA-mbhA-F 
(FhiA-F) 
GTTGATCGCCAGAATCATCATC  fhiA 286134 
 
fhiA-mbhA-R 
(MbhA-R) 
ATATTGCGGTTCTGGTCGTCTT mbhA 322732 
 
fhiA-flanking-F 
(LfhB-F) 
TGAAAGTCAGGTGGAAGTGGTC  Ec042-0246  
 
286987 
 
fhiA-flanking-R 
(LfhA-R) 
CCGATGGTCATCAGCACATACT fhiA 286048 
 
mbhA-flanking-F 
(Lafu-F) 
GGATGAGACGGGCTGATTTTAT  mbhA 322507 
 
mbhA-flanking-R 
(Lafu-R) 
GGGACGTTTTTAGGCGTCTTTA Ec042-0287 
 
321991 
 
Flg1-F TTCAAACATATTGCGGTTCTGG mbhA 322739 
Flg1-R GGCGTCACCATGACTTTTACC Ec042-0281 317749 
Flg2-F CGTCCTGAATTTTGCTCATCTG Ec042-0281 318241 
Flg2-R AGCAATGGAAGCTACCCTCAAG Ec042-0275 312750 
Flg3-F GTCATCCTCAGACAGCATCACC Ec042-0276 313333 
Flg3-R CGACAACCTGTATCTGGAAACC Ec042-0270 307812 
Flg4-F GAGGAAACCGAGTTGTCGTTCT Ec042-0271 308794  
Flg4-R GGTCGCAATCTGTGAGGAAATA Ec042-0264  303332 
Flg5-F GCTGATTTGCAGATTCAGAAAGG Ec042-0265  303937 
Flg5-R TGACAGCAAATAACGCAGTTCC Ec042-0260 298459 
Flg6-F TCTGCCGGAAAATATTCAATCC Ec042-0260 298912  
Flg6-R TTATTCCGCTGTGGAAAGATGA Ec042-0254 293922 
Flg7-F GTTGAGGATCCCCTGCAACAT Ec042-0255 294527 
Flg7-R TCATCAGAATCAGCACCTGGAT Ec042-0249   289546 
Flg8-F CCGGGGATATTTTACCCATCTC Ec042-0251  290205 
Flg8-R CCCCCATAATCTTCAACTCCAG fhiA 284693 
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3.2.3 Tiling-path PCR scanning 
In this project, a new PCR-based approach, termed Tiling-path PCR scanning (TP-PCR), 
was developed (Figure 3-4). TP-PCR is essentially a cut-down version of whole-genome 
PCR scanning, which consists of a series of inter-locking PCRs to construct a complete 
tiling path through the region of interest. This PCR approach is a combination of long and 
short PCRs. Long PCRs were performed initially to investigate the region in question. In 
the case of any negative long PCR result by a given primer pair, the relevant short overlaps 
were further surveyed by PCR using the same primer. If both long and short PCRs 
appeared negative, a deletion-scanning long PCR using the primers from the flanking 
regions was performed. The PCR-based nature of this method allows us to investigate the 
presence of ETT2 and Flag-2 in non-sequenced E. coli strains, including well-characterised 
and phylogenetically diverse strains drawn from the ECOR collection, and other 
representatives of selected pathotypes and examples of non-coli Escherichia strains. 
 
 For ETT2, Long PCRs were performed with a KlenTaq mixture (DNA Polymerase 
Technology Inc., St. Louis, Mo.) in the buffer supplied by the manufacturer. Each 20 µl 
Long PCR mixture contained 20 ng of genomic DNA as a template, 8 pmol of each primer, 
and a 250 µM concentration of each deoxynucleoside triphosphate (dNTP). Long PCR 
conditions were 30 cycles of 10 seconds at 94°C, 30 seconds at 62°C, and 10 minutes at 
68°C, followed by a 10 minutes extension at 68°C. For short PCRs, each 20 µl reaction 
mixture contained 1U of Taq polymerase (Invitrogen, United Kingdom) in the buffer 
supplied by the manufacturer, 20 ng of genomic DNA, and a 250 µM concentration of each 
dNTP. Short PCR conditions were 30 cycles of 30 seconds at 94°C, 30 seconds at 62°C, 
and 30 minutes at 72°C, followed by a 7 minutes extension at 72°C. Supplementary Long  
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Figure 3-4 The strategy of Tiling-Path PCR (figure prepared by Professor Pallen).  
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PCRs were performed in a few cases, using TaKaRa LA Taq (Cambrex BioScience Ltd.) 
in the buffer supplied by the manufacturer. For these supplementary PCRs, each 20 µl 
reaction mixture contained 48 ng of template DNA, 4 pmol of each primer, a 200 µM 
concentration of each dNTP, and 1 U of TaKaRa LA Taq, and the reaction conditions were 
30 cycles of 20 seconds at 96°C and 10 minutes at 69°C, with a 10 minutes extension at 
72°C. All PCRs were carried out in a PTC-225 DNA Engine Tetrad thermal cycler 
(Genetic Research Instrumentation, Braintree, United Kingdom). Long PCR fragments 
were analysed by electrophoresis using a 0.7% agarose gel, while short products were 
analyzed using a 1.2% gel.  
 
For the Flag-2 gene cluster, a three-stage PCR strategy was employed to scan isolates for 
the cluster. Initially, both primers of fhiA-mbhA were applied to the 72 E. coli strains in a 
conventional short PCR, aiming to detect the K-12-like fhiA-mbhA genotype. Short PCRs 
were performed using Taq polymerase (Invitrogen, United Kingdom) in the buffer supplied 
by the manufacturer. Second, the primer pairs of fhiA-flanking and mbhA-flanking were 
applied to all strains to detect the pairs of genes at the ends of the 042 Flag-2 gene cluster. 
Finally, tiling-path PCR was used to obtain a complete tiling path through the gene cluster 
in all Flag-2-positive tested strains. Long PCRs were performed by using TaKaRa LA Taq 
(Cambrex Bio Science, United Kingdom) in the buffer supplied by the manufacturer. Any 
negative results obtained by the long PCR were followed up by deletion-scanning PCRs as 
described above. Long and short PCR conditions were the same as those in the ETT2 study 
previously described. 
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3.3 Results 
3.3.1 The ETT2 gene cluster 
3.3.1.1 TP-PCR is used to identify genomic diversity 
In this project, tiling-path PCR proved to be an efficient tool for studying the equivalent 
regions from many related strains. A set of ten long PCR primers was applied to all 72 
ECOR strains, the laboratory strain K-12 and another 7 pathotypic E. coli strains. This 
PCR method, combining long and short PCRs, constructed a complete tiling path across 
the whole ETT2 region. In the majority of E. coli strains, some ETT2 genes were found but 
there appeared to be deletions relative to the complete gene cluster from EAEC 042. From 
the first round of long PCR scanning, the size and position of the deletions could be 
identified (Figure 3-5). In order to eliminate other possibilities, such as the primers 
annealing to the wrong sites, insertions or rearrangements at the region of interest or false-
negative long PCRs caused by PCR conditions and primer point mutations etc, the 
deletion-scanning PCRs surveyed the deleted region using flanking primers. If the 
deletion-scanning PCR works, the strategy is particularly powerful in that the presence of a 
deletion can be confirmed by a positive PCR result, rather than a negative result, which 
could just indicate that the PCR failed for some reason. Deletion sizes were calculated by 
subtracting the deletion-scanning PCR product size from the expected product size from 
the Sakai strain. Small insertions, deletions or the original false-negative PCRs could be 
indicated, as well as the extent of these changes. However, this approach cannot resolve 
deletions followed by insertions, e.g., of IS elements. Using this method, the complete 
tiling path through the ETT2 gene cluster for 68 of 72 ECOR strains and for all of the 
representative pathotype strains has been constructed (Table 3-5).  
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Figure 3-5 Gel images illustrating PCR results for the ETT2 gene cluster. Strains, 
from top to bottom: O157 Sakai strain (complete ETT2 gene set), ECOR1 (a B171-8-
like strain with an 8.7 kb deletion), K-12 (14.6 kb deletion), and CFT073 (UPEC, with 
no ETT2, and 27.5 kb deletion). Lanes, from left to right: molecular weight markers 
(HyperLadder I; Bioline, UK), 5 kb amplicons obtained with ETT2 TP-PCR primer 
pairs 1 to 10 (see Table 3-3 for details), negative control (DNA, no primers) (Ren et al., 
2004). 
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Table 3-5 Distribution of ETT2 gene cluster PCR fragments among E. coli strains. 
 
Strain  
 
Category 
 
ETT2 LPCR 
pattern a  
indel-
specific 
PCR 
results b   
Conclusions from deletion-spanning 
PCRs c   
E2348/69 EPEC 
CFT073 UPEC 
RS218 NMEC 
ECOR 23 ECOR A 
ECOR 51, 52, 
54, 55, 56, 
57, 59, 61, 
62, 63, 
64, 65, 66 
ECOR B2 
 
EPEC1-like 
 
ETT2 absent 
 
ECOR 4 ECOR A 
++-------+ 
 
EPEC1-like, 
with 
2.4 kb 
insertion 
 
ETT2 absent and something else 
inserted next to glyU or ~25kb 
deletion in ETT2 between 3F and 9R 
H10407 ETEC 
EAEC25 EAEC 
ECOR 1, 2, 3, 
5, 6, 7, 8, 9, 
10, 11, 12, 
15, 18, 22, 
24, 25 
ECOR A 
 
ECOR 26, 27, 
28, 29, 30, 
32, 33, 34, 
45, 58, 67, 68 
ECOR B1 
 
ECOR 39 ECOR D 
ECOR 45 ECOR B1 
EPEC2-like 
 
8.7 kb deletion as in EPEC2 strain 
B171-8 sequence 
 
ECOR 14 ECOR A 
++++++--++ 
 
EPEC2-like, 
with 
1 kb 
insertion 
8.7 kb deletion as in B171-8 
sequence, with ~1 kb insertion 
ECOR 13, 20, 
21 
~23 kb deletion between 3F and 9R 
ECOR 19 
ECOR A 
 
~30 kb deletion between 2R and 10F 
ECOR 53 ~30 kb deletion between 3F and 9R, 
i.e. ETT2 absent 
ECOR 60 
ECOR B2 
 
ECOR 69 ECOR B1 
++-------+ 
Unresolved deletion between 2R and 
10F 
ECOR 16 ECOR A ++-+-----+ Unresolved deletion between 2R and 
4F 
~18 kb deletion between 4R and 9R 
ECOR 17 ECOR A +++------+ 
Negative 
 
22 kb deletion between 4F and 9R 
ECOR 38 ECOR D ++-----+++ ~21 kb deletion between 3F and 7R 
ECOR 35 
 
ECOR D 
 
+++-++---- 
 
No deletion between 3R and 5F, 
Unresolved deletion after 6R 
ECOR 31 ECOR E ++----++++ ~15 kb deletion between 2R and 7F 
K-12 Laboratory ++++----++ 
 
18 kb deletion as in K-12 sequence 
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ECOR 36 ECOR D +++-++--+- No deletion between 3R and 5F, 
8 kb deletion between 7F and 8R 
Unresolved deletion after 9R 
ECOR 40 No deletion between 3R and 5F 
6 kb deletion between 6F and 7R 
ECOR 41 
ECOR D 
 
 
+++-+--+++ 
 
No deletion between 3R and 5F 
4 kb deletion between 6F and 7R 
ECOR 70 ECOR B1 ++++++---+ ~5 kb deletion between 6R and 9R 
ECOR 72 ~5 kb deletion between 7F and 8R 
ECOR 71 
ECOR B1 
ECOR 42, 43 ECOR E 
++++++--++ 
~8 kb deletion between 6R and 9F 
ECOR 37 ECOR E +++++-++++ ~3 kb deletion between 6R and 7F 
ECOR 48 +++-++++-+ No deletion between 3R and 5F, 
No deletion between 8R and 10F 
i.e. EHEC1-like 
ECOR 44, 
46, 47, 49, 50 
ECOR D 
+++-++++++ No deletion between 3R and 5F 
i.e. EHEC1-like 
O157 EHEC ++++++++++ no deletions detected, i.e EHEC1-like 
042 EAEC ++++++++++ no deletions detected, i.e EHEC1-like 
 
a
 The ++----++ notation indicates the Long PCR results from ten long PCR reactions; “+” 
represents the positive PCRs in that region, and “-”represents the negative PCRs.  
 
b
 An 200 bp PCR was used to detect a deletion point identical to that seen in B171-8 (EPEC2-
Like), while an 600 bp PCR was used to detect a CFT078-like vacant ETT2 insertion point 
(EPEC1-Like). Negative means that both indel-specific PCRs failed to give a product.  
c
 When the indel-specific PCRs failed to resolve a deletion, deletion-scanning long PCRs were 
performed with forward and reverse primers from the sets flanking the deletion. The full ETT2 
gene clusters are indicated in bold.  
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Four strains, ECOR-16, -35, -36, and -69, remained unresolved by PCR alone, after using 
various combinations of primers. It seems likely that large insertions or rearrangements 
might have occurred in these strains, but to be certain, more detailed information is 
required, either from DNA sequencing or other fragment analysis.  
 
3.3.1.2 The distribution of the ETT2 locus is largely congruent with E. coli known 
phylogeny 
The pattern of the results from the ETT2 TP-PCR was very striking. Firstly, unlike the 
previous study (Makino et al., 2003), the ETT2 gene cluster was surveyed by sampling a 
wide diversity of examples from the E. coli species, including both pathogenic and 
commensal strains. Surprisingly, the ETT2 locus is present in the majority of these E. coli 
strains, either complete or in part. Secondly, using the known phylogeny ECOR strains as a 
backbone, the distribution of ETT2 was surprisingly found to be non-random, but instead 
largely congruent with the major phylogenetic divisions (A, B1, B2, D and E), as deduced 
by multilocus enzyme electrophoresis (MLEE) and other methods (Lecointre et al., 1998) 
(Figure 3-6). The majority of E. coli strains fell into only three predominant ETT2 patterns, 
i.e. divided into three ETT2 genotypes: “no ETT2” genotype, 8.7 kb deletion genotype, 
and full ETT2 genotype (Figure 3-6). It is very interesting to contemplate how these ETT2 
genotypes arose. The good correlation of the ETT2 locus with the ECOR phylogenetic 
divisions hints that the ETT2 cluster could be a new phylogenetic marker.  
 
The 8.7 kb deletion was seen in the already sequenced ETT2 cluster from an EPEC2 strain, 
B171-8 (Makino et al., 2003). This deletion was centred on 7 bp repeats (CC/ATCATT), 
suggesting a mechanism for the deletion. Surprisingly, this 8.7 kb deletion represents the 
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Figure 3-6 TP-PCR results superimposed on the phylogenetic structure of E. coli. The 
tree was constructed by Dr Chaudhuri, obtained by neighbor-joining analysis of the 
ECOR MLEE data (available at http://foodsafe.msu.edu/whittam/ecor). Branches 
containing one of the three most common genotypes are highlighted by bold, dotted 
or grey lines. Filled circles indicate strains with eip clusters (Ren et al., 2004). 
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most common ETT2-genotype, including the majority of the A and B1 ECOR groups. In 
order to confirm whether the deletion was identical (to within a few base pairs) to that in 
B171-8, short PCRs of ~ 200 bp across the deletion site were performed on all 72 ECOR 
strains and other representative pathogenic E. coli strains. The results showed that 17 of 25 
ECOR group A strains, 12 of 16 ECOR group B1 strains, and the pathogenic strains 
H10407 (ETEC) and EAEC25 (EAEC) have identical deletion points (Figure 3-7). These 
strains are classified as an EPEC2-like genotype. 
  
The “no ETT2” genotype accounts for the second largest group, mainly found in ECOR 
group B2 strains. In these strains, only those long PCRs annealing to the E. coli backbone 
regions worked. The absences were confirmed by performing a short 600bp PCR across 
the ETT2 insertion point (ECs3702-ECs3738), as seen in UPEC strain CFT073. 13 of 15 
ECOR group B2 strains, two strains (ECOR 4 and 23) from ECOR group A, and the 
pathogenic strains CFT073 (UPEC) and RS218 (NMEC) showed identical deletion points 
(Figure 3-7). A complementary experiment examined the ETT2 region from the sequenced 
EPEC 1 strain E2348/69. The TP-PCR pattern was the same as seen for UPEC CFT073, 
also with the same deletion points (data not shown). In all these strains the entire ETT2 
region is absent, and they are classified as an EPEC1-like genotype.  
 
Apparently intact ETT2 gene clusters were found in 6 of 10 ECOR group D strains, to 
which EAEC 042 was shown to be most closely related in a previous study (Escobar-
Paramo et al., 2004). Within these six ECOR group D strains, four are commensals, 
suggesting that the intact ETT2 is not necessarily associated with a virulent phenotype.  
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Figure 3-7 Indel-specific short PCRs for detecting (A) EPEC2- like, and (B) EPEC1-
like genotype strains. The first two gels show the results for ECOR strains from 200 
bp PCRs across the deletion seen in strain B171-8, using primer pair “B171-8 like” 
(Table 3-3). The second two gels show the results for ECOR strains from 600 bp 
PCRs across the ETT2 insertion site with primers “no ETT2” (see Table 3-3 for 
details). Positive results are labeled with ECOR strain numbers or pathotypes.  
 
 
 
 
(A) 
(B) 
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Nearly intact ETT2 gene sets were found in the remaining ECOR group D strains and 
ECOR group E strains. The two sequenced EHEC O157:H7 strains (EHEC 1) have been 
previously shown to be closely related to ECOR group E (Escobar-Paramo et al., 2004). 
The strains containing an intact ETT2 are named EHEC1-like genotype. Interestingly, the 
distribution of the eip gene cluster was found to correlate well with those EHEC1-like 
strains. The 13 eip-positive ECOR strains encompassed 11 of the 12 group D strains and 2 
of 5 E strains (Figure 3-6).  
 
In addition to the ECOR collection, both the ETT2 and eip gene clusters were surveyed in 
a collection of 43 freshly collected local blood culture isolates of E. coli and 36 freshly 
collected local urine contaminants from patients with no laboratory evidence of urinary 
tract infections (presumably representing commensal strains of E. coli). A series of short 
PCRs using the overlapping primers were performed (A. Fivian, BSc project). ETT2 was 
detected in 16 of the 43 (37%) bloodstream isolates and 10 of the 36 (28%) commensal 
isolates (data not shown). These results indicated the high prevalence of ETT2 in human E. 
coli. The eip gene cluster was present in 7 of the 15 ETT2-positive bloodstream isolates, 
and 6 of the 10 ETT2-positive commensal isolates.  
 
Surprisingly, the eip cluster was present in all six ECOR strains with EHEC 1-like 
genotypes but absent in the two genome-sequenced O157:H7 strains. From the studies on 
both the ECOR strains and the clinical strains, the eip cluster was not found in any isolate 
that lacked the ETT2 gene set. Furthermore, both the ETT2 and eip gene sets have no 
obvious link to bacterial virulence. However, the distributions of the ETT2 and eip gene 
clusters are correlated, suggesting a functional relationship between the two regions.  
 89  
3.3.1.3 The ETT2 locus was acquired after the divergence of ECOR group B2 
The distribution of the ETT2 locus was found to correspond well with the phylogeny as 
determined in previous studies (Escobar-Paramo et al., 2004) (see Figure 3-6). The 
“known” phylogeny has been determined by MLST, amongst other methods. Based on 
several lines of evidence (Lecointre et al., 1998), the ECOR B2 group is thought to have 
been the first to diverge from the other E. coli lineages, followed by the divergence of 
group D.  Consistent with the MLST-derived branching pattern, the ancestral status was 
assigned to the “no ETT2” genotype - all 15 ECOR strains belonging to the B2 group, 
EPEC1 strain E2348/69, which is known to be extremely divergent from other groups, and 
UPEC strain CFT073, which is closely associated with the B2 group. Except for two 
ECOR group B2 strains (ECOR-53 and -60), all these strains were confirmed to have the 
same deletion points using a short PCR (Figure 3-7), suggesting the ETT2 locus was 
inserted into the lineage only once. 
 
Both EPEC and EHEC exist as two lineages, which have been predicted by previous 
studies based on the MLEE data (Donnenberg and Whittam, 2001). Although EPEC1 and 
EHEC1 are highly divergent, EPEC1 appears to have diverged first. The authors suggested 
that EHEC1 strains diverged from other E. coli strains after the divergence of the EPEC1 
strains. In this study, the EPEC1 strain falls into the “no-ETT2” genotype, which is closely 
affiliated with the B2 group, whereas EHEC1 strain falls into the complete the ETT2 
genotype, which is close to the D group. These results were in line with the fact that the B2 
group is the deepest branching group followed by the D group, as predicted by MLST 
(Lecointre et al., 1998).  Using an MLST phylogenetic tree as a backbone, the ETT2 locus 
was suggested to enter an ancestral E. coli strain sometime after the divergence of the B2 
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group (and the EPEC1 strain) but before the divergence of the D group (and the EHEC1 
strain).   
 
The presence of the ETT2 genes was examined in four non-coli Escherichia spp. (E. 
blattae, E. fergunsonii, E. hermannii, and E. vulneris) by performing overlapping short 
PCRs. These species are most closely related to E. coli. The results showed that all four 
Escherichia spp. possessed no ETT2 (data not shown), suggesting that the ETT2 gene loci 
has never entered into other species rather than E. coli. Furthermore, the ETT2 gene cluster 
was always found at the same chromosomal location, within the yqeG-glyU intergenic 
region. In contrast, LEE can be inserted into selC, pheV, or pheU (Jores et al., 2004). 
These results support the idea of a single insertion event subsequent to the divergence of 
group B2.  Contrary to the previous claims (Makino et al., 2003), the ETT2 gene cluster 
was not an insertion in EHEC strains but a deletion in E. coli K-12 strains, with a remnant 
persisting in the E. coli K-12 region.  
 
The whole ETT2 locus entered into the species E. coli only once, but the accumulated 
deletions occurred afterwards. The deletions were possible because that the ETT2 locus 
does not provide any selective advantage, and the genetic decay of this region was forced. 
However, in a study on ETT2 regulators, the authors surprisingly found that two regulatory 
genes, ECs3720 or etrA and ECs3734 or eivF, from the ETT2 cluster in EHEC O157:H7 
have negative regulation effects (Zhang et al., 2004). The deletion of these two genes leads 
to greatly increased secretion of proteins encoded by the LEE cluster and to increased 
adhesion to human intestinal cells (Zhang et al., 2004). This suggested that ETT2 may 
have retained a regulatory role and cross talk to the other T3SS’s. Therefore, ETT2 may 
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have had an ancestral function that has been lost in some or all strains. It appears that the 
effects of regulatory genes can outlive widespread decay of other genes in a functionally 
coherent gene cluster in order to increase the bacterial infection (Zhang et al., 2004).  
 
3.3.1.4 The ETT2 locus was not a functional T3SS 
Several findings from this study suggest that the ETT2 locus does not encode a fully 
functional virulence-related T3SS in E. coli strains. The ETT2 genes were found equally 
distributed among pathogenic and commensal strains, in that 50 of 72 ECOR strains 
contain ETT2-associated genes. For comparison, the ECOR collection for fragments of the 
LEE cluster was surveyed by using five short PCRs. Only two strains were positive for 
LEE fragments, namely ECOR25, an ECOR group A strain from a healthy dog (four of 
five fragments were positive), and ECOR37, an ECOR group E strain from a healthy 
marmoset (all five fragments were positive) (data not shown). Unlike ETT2, the LEE 
cluster was mostly absent from the genomes of commensal E. coli strains.  
 
In addition, many ETT2 genes carry mutations and deletions, raising the possibility that a 
functional T3SS has been degraded. Of the sequenced E. coli genomes, an intact ETT2 
gene cluster was only seen in EAEC strain 042. A comparison of the 042 ETT2 genes with 
their homologues in Spi-1 could not identify any inactivating frameshift mutations. In both 
EHEC strain EDL933 and Sakai strains, though the complete ETT2 gene clusters were 
present, pseudogenes and frameshift mutations were apparent that would prevent the 
expression of a functional ETT2-encoded T3SS (see Table 3-1). The eip locus is also 
absent from two of EHEC strains. EAEC strain 042 may retain the ability to encode a 
functional T3SS, but its in vivo role is as yet unknown.  
 92  
3.3.2 The Flag-2 gene cluster 
Similar to the study on the ETT2 cluster, the distribution of the Flag-2 gene cluster was 
surveyed among the ECOR collection and another seven representatives of E. coli strains. 
In this study, three rounds of PCR were employed aimed at identifying the strains 
containing the Flag-2 cluster. Firstly, PCR across the fhiA-mbhA boundary was performed 
on all strains. A positive PCR result was obtained for 57 strains (~80%) from the ECOR 
collection, the E. coli K-12 strain and five pathogenic E. coli (E. coli RS218, E. coli 
CFT073, ETEC strain H10407, EAEC strain 25 and E. coli O157:H7 Sakai strain). This 
means they all possessed the same two-gene scar seen in K-12 (Figure 3-8A). Fifteen 
ECOR strains (~20%) and EAEC strain 042 gave a negative result with this PCR (ECOR-1, 
-3, -4, -5, -12, -17, -24, -35, -36, -48, -49, -50, -64, -65, and -67). A negative PCR result 
can occur for several reasons, such as point mutations in the primers, poor quality primers, 
or genetic changes like a large insertion or rearrangement etc. There is also the possibility 
that a full length Flag-2 gene cluster is harboured at this site.  
 
In order to know whether the Flag-2 genes were present in this region, a second round of 
PCR was performed that targeted both ends of the full Flag-2 cluster. Two pairs of primers 
were designed to obtain two PCR products, spanning from either fhiA or mbhA to their 
flanking genes within the Flag-2 locus. Very interestingly, these PCRs provided 
complementary results to the first round: the 57 ECOR strains and another 6 representative 
E. coli strains with the K-12 genotype showed negative results as expected, whilst the other 
15 ECOR strains and EAEC strain 042 gave positive results (Figure 3-8 B). The results 
suggest that 15 ECOR strains might possess the full Flag-2 gene cluster like EAEC 042, 
although they do not eliminate the possibility of an internal deletion in the Flag-2 cluster.  
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Figure 3-8 Gel images illustrating the identification of the Flag-2 genes of E. coli. (A) 
PCR scanning with the primer pair fhiA-mbhA. A 600 bp PCR product indicates that 
fhiA and mbhA are fused, as in E. coli K-12. Negative results suggest the presence of 
intervening sequence between fhiA and mbhA. (B) PCR scanning with primers fhiA-
flanking. An 1,000 bp PCR product indicates the presence of a full-length fhiA 
flanking gene within the Flag-2 locus, as in E. coli 042. PCR was carried out on all 72 
ECOR strains plus E. coli RS218, EAEC strain 042, E. coli CFT073, ETEC strain 
H10407, EAEC strain 25, E. coli K-12, and E. coli O157:H7 Sakai. PCR mixtures 
were loaded on a 1.0% agarose gel alongside HyperLadder I MW markers (Bioline, 
United Kingdom). Lanes corresponding to Flag-2-positive strains are labeled 
according to ECOR strain number or pathotype.   
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Next, interest was focused on the 15 ECOR strains to find out whether they have an EAEC 
042-like genotype. Eight pairs of long PCR primers were used to survey the ~35 kilobase 
cluster. Using TP-PCR, a complete tiling path through the entire Flag-2 locus was 
constructed for these 15 ECOR strains and EAEC strain 042 (Table 3-6). Most long PCRs 
were positive for the 15 ECOR strains. According to the long PCR pattern, the ECOR 
strains that were found to harbour the Flag-2 gene cluster could be divided into four types: 
type 1, including ECOR-4, -49, and -50;  type 2, including ECOR-1, -3, -5,  -12, -17, -24, -
64, -65, -67; type 3, including ECOR-35 and -36; and type 4, including ECOR-48 (Table 
3-6). Although none of them were positive for all eight long PCRs, the following deletion-
scanning PCR using the flanking primers showed that actually they all possess the 
complete Flag-2 region (Figure 3-9). Unlike the ETT2 gene cluster, no large scale 
insertions, deletions, or rearrangements occurred in any of the Flag-2 clusters from these 
15 ECOR strains compared to the 042 genotype. The existence of four types of long PCR 
patterns suggested they might have some point changes compared to the EAEC 042 
genome, like SNPs at the primer sites, which would produce negative long PCRs.  
 
Fifteen ECOR strains, accounting for 20% of the ECOR collection, contain the full Flag-2 
gene cluster. The majority of E. coli strains have lost almost all the Flag-2 genes, but 
possess an identical fusion gene (fhiA-mbhA) between the remnants of the counterparts 
from the ends of the Flag-2 cluster. Although most strains lack the Flag-2 cluster, a sizable 
minority (about one fifth) of E. coli strains has retained the Flag-2 cluster.  It was assumed 
that the Flag-2 cluster was present in the last common ancestor of all E. coli strains but had 
undergone a single deletion. However, unlike the ETT2 gene cluster, the distribution of 
Flag-2 is not congruent with the established phylogeny of E. coli strains. Flag-2 gene 
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Table 3-6 E. coli strains from the ECOR collection that possess an apparently intact 
Flag-2 gene cluster. 
 
Isolate Group H antigen* Flag-2 long 
PCR pattern 
ETT2 genotype 
ECOR-4 A HN Absent 
ECOR-49 D NM Complete 
ECOR-50 D HN 
++-+++++ 
 
Complete 
ECOR-1 A HN Partial 
ECOR-3 A NM Partial 
ECOR-5 A NM Partial 
ECOR-12 A H32 Partial 
ECOR-17 A NM Partial 
ECOR-24 A NM Partial 
ECOR-64 B2 NM Absent 
ECOR-65 B2 H10 Absent 
ECOR-67 B1 H43 
+--+++++ 
 
Partial 
ECOR-35 D NM Partial 
ECOR-36 D H25 
+---++++ 
 
Partial 
ECOR-48 D HM ++--++++ Complete 
*HN, non-typeable with standard antisera; NM, non-motile strain; HM indicates a form of 
non-typeable motile strain in which multiple H antisera reacted. 
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Figure 3-9 Deletion-scanning PCR of 15 ECOR strains for the presence of the Flag-2 
gene cluster. Lanes M1 and M2 contained a high molecular weight DNA marker 
(Invitrogen) and the positions of the 15, 20, and 25 kb markers are indicated on the 
right. The ECOR strain numbers (see text and Table 3-6) are indicated at the top of 
the gel. 
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clusters are more common in ECOR group A but are randomly distributed throughout all 
four groups. It remains a mystery why the Flag-2 cluster was purged out from many E. coli 
strains. Additionally, short PCRs using overlapping primers were performed on the four 
non-coli Escherichia spp. and showed that all four of them possessed the K-12-like 
genotype. The presence of the Flag-2 cluster at identical sites in E. coli and its close 
relative non-coli Escherichia spp. and Citrobacter rodentium, combined with its absence 
from S. enterica, suggests that it was acquired by horizontal gene transfer after the former 
three species diverged from Salmonella.  
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3.4 Discussion 
 
3.4.1 The need to maintain an energetic program of genome sequencing 
 The studies on both the ETT2 and Flag-2 gene clusters presented here emphasise the 
importance of maintaining an energetic program of genome sequencing within a taxonomic 
group. ETT2 was discovered in the second published E. coli genome (Perna et al., 2001), 
but its presence in whole or part in the majority of genome-sequenced Escherichia/Shigella 
strains, including a remnant in the initial K-12 genome, was not immediately apparent until 
multiple sequences were available. A fragment of sequence from the EPEC2 strain O111: 
NM B171-8, which was not subjected to complete genome sequencing until recently, 
suggested the presence of an 8.7 kb deletion within ETT2, centred on a 7 bp repeat. This 
deletion pattern has been found across ECOR groups A and B1 and represents the most 
prevalent form of ETT2. Even more strikingly, Flag-2 was not discovered in the first 10 
Escherichia/Shigella genome sequences. Without a comparative viewpoint, the presence of 
the fhiA and mbhA genes in K-12 was puzzling. It was not until sequencing of the 042 
genome that their presence as remnants of a complete flagellar system was determined.   
 
3.4.2 A single strain like K-12 is not the archetype for a whole species 
The study on the ETT2 cluster revealed that an identical 14.6 kb deletion within ETT2 was 
present in both sequenced E. coli K-12 strains. Initially, there was an implicit assumption 
that the non-pathogenic strain K-12 represented the ancestral state, and that the genomes of 
pathogenic E. coli would consist of the K-12 genome with additional pathogenicity 
determinants. This assumption led to several misunderstandings about the origins of the 
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ETT2 gene cluster. Though E. coli K-12 has long been used as a model strain and 
possesses one of the smallest E. coli genomes, it is unsafe to conclude that it represents the 
ancestral state for the whole species or a minimal E. coli genome. In fact, remnants of both 
islands studied in this chapter, an ~12 kb fragment of ETT2 and the two gene scar 
representing the edges of Flag-2, were found in both E. coli K-12 genomes.  
 
Prior to this study, it was possible that ETT2 was formed by a single insertion with 
subsequent gene loss or by assembly of the largest ETT2 gene cluster from the smaller 
gene clusters by gene acquisition. The latter hypothesis now seems less plausible. Firstly, 
conservation in gene order between ETT2 and Spi-1 and other T3SS genes was observed. 
This is inconsistent with multiple independent gene acquisitions, which would be unlikely 
to keep the same gene order in several generations. Secondly, it was observed that the 
indels often had the same deletion boundaries (Figure 3-7). These boundaries are often 
marked by truncated genes, suggesting deletion rather than insertion. This observation is 
contrary to the initial hypothesis that the ETT2 gene cluster is an insertion into the glyU 
tRNA site in E. coli O157:H7 relative to E. coli K-12.  
 
3.4.3 Tiling-Path PCR is an effective technique for comparative 
genomics 
In this study, tiling-path PCR was developed and used to investigate two large pathogenic 
islands (ETT2 and Flag-2, approx. ~50 kb and ~35 kb in size, respectively). These methods 
allow the study of the distribution of entire pathogenicity islands by performing several 
long inter-locking PCRs. Previous studies (Hartleib et al., 2003; Makino et al., 2003) have 
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given a misleading picture since they only examined discontinued fragments of the region 
of interest. Tiling-path PCR can provide information about the full length of the island. 
 
The advent and development of long range PCR makes the study of large genetic regions 
more effective and less expensive(Barnes, 1994). Tiling-path PCR can be considered a 
reduced form of whole-genome PCR scanning, pioneered by Tetsuya Hayashi to study E. 
coli O157  genomic diversity (Ohnishi et al., 2002). In whole-genome PCR analysis, 
hundreds of primers aim to amplify about 10-20 kilobase fragments overlapping with the 
adjacent fragment at both ends by a few hundred base pairs. Recently, software like 
GenoFrag (Ben Zakour et al., 2004) was developed to facilitate the design of primers 
optimised for whole-genome PCR scanning (also see Chapter 5). With such software 
packages, the primers are automatically obtained when the user inputs several fixed 
parameters, such as the primer length, G+C%, primer Tm, and the lengths of overlaps. If 
most of these primers are designed to anneal to the regions on the bacterial chromosomal 
backbone, they are easily applied to all the strains within the same species. This could 
greatly reduce the cost and time for comparisons of large numbers of strains within a 
species. 
 
The TP-PCR approach provides information on gene order and genomic organisation and 
can rapidly identify regions of a test genome that are co-linear with the reference genome. 
However, once a certain segment failed to yield a PCR amplicon, one could not discern 
whether a chromosomal deletion or large insertion or rearrangement had occurred. Under 
these circumstances, the use of a single-primer PCR walking approach (Karlyshev et al., 
2000) could be beneficial, as it allows direct sequencing from the known chromosome into 
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the unknown region (refer to Chapter 4). These methods will be of use in investigating the 
gene content of large strain collections whilst the complete genome sequencing of such 
collections remains impractical or economically unrealistic.  
 
3.4.4 Sampling the full range of phylogenetic diversity within a species 
 
One would not have expected that the distribution of the ETT2 locus would be so well 
organised in the E. coli strains. The surprise came from two important aspects of this 
project: first, sampling a wide diversity of samples from the species E. coli, including both 
pathogenic and commensal strains; second, a complete tiling-path was constructed across 
this region.  
 
From the studies on ETT2 and Flag-2, the need to adopt a comparative approach using the 
full phylogenetic diversity of strains was emphasised. In the previous study on ETT2, the 
authors sampled certain serotypes from pathogenic E. coli only (Makino et al., 2003). Here, 
the study sampled seventy nine well-validated and phylogenetically diverse strains, 
including both pathogenic representatives and commensal strains. With such a survey, 
there is less risk of misunderstanding the prevalence of a new gene cluster among the 
whole species. Investigations of this nature may help to shed light on the evolutionary 
processes of new genomic islands relative to the phylogeny of the genomic backbone. The 
distribution of ETT2 in the majority of commensal E. coli strains casts doubt upon its 
previous implication as a virulence factor.  
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The complete Flag-2 cluster contains genes encoding products sufficient for flagellar 
motility. However, with the exception of one strain of E. coli 042, most genome-sequenced 
Escherichia/Shigella strains only possess two gene scar, and all Salmonella strains have 
none of the genes at all. When the Flag-2 cluster was investigated in the whole range of 
phylogenetic strains, the entire gene cluster was found in another fifteen ECOR strains. 
The presence of Flag-2-like gene clusters in fifteen ECOR strains, Yersinia pestis, Yersinia 
pseudotuberculosis, and Chromobacterium violaceum suggests that the coexistence of two 
flagellar systems within the same species is more common than previously suspected. This 
poses a question about the possible function of the Flag-2 gene cluster in E. coli. However, 
a phenotype associated with the Flag-2 gene cluster has not yet been demonstrated in any 
of these strains. 
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CHAPTER FOUR  
IDENTIFICATION OF GENOMIC DIVERSITY 
BETWEEN TWO CAMPYLOBACTER JEJUNI 
STRAINS 
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4.1 Introduction 
Since Campylobacter jejuni was recognised as a human pathogen in the 1970s, it has 
become the leading bacterial cause of food-borne gastroenteritis in many industrialised 
countries (Sahin et al., 2002). The bacteria can penetrate through the epithelial layer by 
first attaching to and then invading the epithelial cells and then causes diarrhoea 
(Nachamkin et al., 1998; Hofreuter et al., 2006). Infections caused by C. jejuni vary from 
mild, non-inflammatory, self-limiting diarrhoea to severe, inflammatory, bloody diarrhoea 
lasting for several weeks (Wassenaar and Blaser, 1999). In addition, C. jejuni is associated 
with the development of the neurological disorder Guillain-Barré syndrome (GBS) 
(Nachamkin et al., 1998). The consumption of contaminated meat, particularly poultry, 
accounts for the majority of human infections caused by C. jejuni (Wassenaar and Blaser, 
1999). C. jejuni can be rapidly transmitted between adjacent animals due to its low 
infectious dose. Efforts to reduce campylobacters in the food chain have been largely 
concentrated at the poultry farm level (Newell et al., 2001). 
 
Because of the lack of genetic information, the virulence mechanisms of C. jejuni have 
been poorly understood for more than 20 years. The first complete genome sequence of a 
Campylobacter jejuni strain, NCTC 11168, was released to the public in 2000 (Parkhill et 
al., 2000). C. jejuni 11168 has a relatively small genome of 1,641,481 base pairs in size, 
and a relatively low GC content of 30.6%. The genome contains 1654 predicted coding 
sequences (CDS), of which the average size is nearly 1 kb. C. jejuni is a very dense 
genome as 94.3% of genes encode for proteins. Recently, re-annotation of the whole 
genome reduced the total number of CDS from 1654 to 1643 (Gundogdu et al., 2007). Re-
 105  
annotation was carried out using a new annotation database, where more currently 
available Campylobacter genomes are incorporated.  
 
The protein coding genes of the Campylobacter genome were rarely organised into 
operons or clusters, however, some large regions with a very low GC content were 
discovered. Three such large gene clusters were identified to code for important surface 
structures in C. jejuni strains. These included CDSs Cj1135-Cj1148 representing genes 
encoding the lipooligosaccharide (LOS), CDSs Cj1412-1442 corresponding to the genes 
encoding the encapsular polysaccharide (EP), and CDSs Cj1305-Cj1345, which code for 
flagellar modification (Parkhill et al., 2000). Most of the hypervariable sequences in the 
genome are coincident with the genetic loci for LOS biosynthesis, EP biosynthesis and 
flagellar modification, and much research effort has been focused on them. The lower-
than-average GC content of these regions of the C. jejuni genome suggested these genes 
were acquired through horizontal gene transfer. The “hot-spots” for the frequent 
integration of diverse genetic materials were suggested in the C. jejuni genomes (Hofreuter 
et al., 2006).  
 
Recently, more complete genomes from the species have become publicly available (Table 
4-1). Genome comparison between C. jejuni and its closely related genome Helicobacter 
pylori indicated that the three genetic loci relating to surface structures are unique in C. 
jejuni but absent in H. pylori (Parkhill et al., 2000). Comparison between C. jejuni NCTC 
11168 and the further two complete C. jejuni genomes, C. jejuni strain RM1221 (Fouts et 
al., 2005) and C. jejuni subsp. jejuni 81-176 (Hofreuter et al., 2006), showed that LOS, 
flagellin, and the capsule represent hypervariable regions in all three C. jejuni genomes.  
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Table 4-1 Current C. jejuni genomes sequenced or in progress. 
 
Campylobacter 
jejuni strains 
 
Sequence 
status 
Length 
(Mbs)  
Proteins Number 
of RNAs 
GenBank 
Accession 
number 
Campylobacter 
jejuni 11168 
 
complete 1.6 1634 56 AL111168 
Campylobacter 
jejuni RM1221 
 
complete 1.8 1838 56 CP000025 
Campylobacter 
jejuni subsp. 
doylei 269.97  
 
complete 1.8 1731 61 CP000768 
Campylobacter 
jejuni subsp. 
jejuni 81-176  
 
complete 1.6 1653 54 CP000538 
Campylobacter 
jejuni subsp. 
jejuni 84-25  
 
Assembly 1.67162 1748 46 AANT00000000 
Campylobacter 
jejuni subsp. 
jejuni CF93-6  
 
Assembly 1.6763 1757 46 AANJ00000000 
Campylobacter 
jejuni subsp. 
jejuni CG8486 
  
Assembly 1.6 1425 NA AASY00000000 
Campylobacter 
jejuni subsp. 
jejuni HB93-13 
  
Assembly 1.69479 1710 NA AANQ00000000 
NA Currently not annotated 
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The variation lies in sequence divergence among the predicted gene products, and also the 
presence/absence of specific genes within these loci (Hofreuter et al., 2006).  
 
One of the most surprising features of the C. jejuni genome is that it contains almost no 
insertion sequences or phage-associated sequences and very few repeat sequences (Parkhill 
et al., 2000). Therefore, the genome sequencing revealed very few mechanisms to generate 
genetic diversity. However, the diversity of C. jejuni strains has been demonstrated at both 
the genotypic and phenotypic levels (Wassenaar and Blaser, 1999). C. jejuni also contains 
a wide variety of clones within the species (Wassenaar and Blaser, 1999).  In order to 
know more about C. jejuni  genetic diversity, whole-genome microarray comparison was 
used shortly after the genome was finished (Dorrell et al., 2001).  
 
Primers for a whole-genome PCR microarray were designed to represent each CDS of the 
published C. jejuni NCTC 11168 genome from 2000. Up to 30 NCTC 11168 loci were 
discovered to be either absent or highly divergent among 11 C. jejuni strains from diverse 
origins (Dorrell et al., 2001). Many of these divergent regions were characterised as being 
involved in the biosynthesis of surface structures including flagella, LOS and the capsule 
(Dorrell et al., 2001). In contrast, about 80% of C. jejuni NCTC 11168 genes are conserved, 
the so-called “core genes”, mainly representing those for housekeeping functions such as 
metabolic, biosynthetic, cellular, and regulatory processes (Dorrell et al., 2001).  
 
However, as noted before, there are several drawbacks to the use of whole genome DNA 
microarrays for comparative genomics: in particular, point mutations, small deletions, gene 
rearrangements, and novel genes will not be detected. We speculated that whole genome 
 108  
PCR scanning techniques might overcome this limitation, building on the success of 
similar methods in the study of two E. coli gene clusters, ETT2 and Flag-2 (see chapter 3). 
In addition, a modified version of single primer PCR is also developed to identify the novel 
genes absent from the reference strain. This study aims to use PCR-based methods to 
analyse a novel genome, of the C. jejuni strain M1, in comparison with the reference strain, 
NCTC 11168. The C. jejuni strain M1 was first isolated from an abattoir by Diane Newell 
and colleagues (Veterinary Laboratories Agency, Weybridge, UK). 
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4.2 Materials and Methods 
4.2.1 Bacterial strains 
C. jejuni strain M1 was a gift from Professor Duncan Maskell (University of Cambridge). 
The strain was stored at -80oC in 1% (w/v) proteose peptone water containing 10% (v/v) 
glycerol until required. The strain was routinely grown from frozen on 10% (v/v) blood 
agar plates, kindly provided by Professor Charles Penn (University of Birmingham). To 
prepare DNA, a small amount of material from the frozen culture was scraped onto blood 
agar plates and incubated overnight at 42oC in a microaerobic atmosphere [85% (v/v) N2, 
7.5% (v/v) CO2, 7.5% (v/v) O2]. Genomic DNA was extracted using a DNAeasy Kit 
(Qiagen, UK) and stored in aliquots at -20°C. 
 
4.2.2 PCR Primers 
The PCR primers used in this study were kindly provided by Professor Brendan Wren 
(London School of Hygiene and Tropical Medicine). A total of 1731 pairs of primers were 
originally used for a whole genome DNA microarray. They were designed to represent all 
the initially identified CDSs from the C. jejuni NCTC 11168 genome project (Parkhill et 
al., 2000). The primers were provided at a concentration of 50 µMol and stored in 96-well 
plates. Unfortunately, two plates containing both the forward and reverse primers 
corresponding to CDSs Cj0106 to Cj0202 were not available from Professor Wren’s stock. 
The PCR scanning for these genes was therefore not included in this project. The missing 
primers were not resynthesised, because of a competing project from Sanger Institute (UK).  
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4.2.3 Tiling-Path PCR  
Two adjacent genes were combined into each PCR amplicon in order to construct a 
complete tiling-path through the whole genome (Figure 4-1). In other words, in generating 
every PCR product, the left primer was from the upstream gene and the right primer was 
from the opposite strand of the adjacent downstream gene. That means that the tiling-path 
was constructed by amplifying every gene once as the downstream gene in the first PCR, 
then secondly as the upstream gene in the next PCR. PCR products ranged from 500 bp to 
3 kb in size. All PCRs were amplified using Taq polymerase (Invitrogen, UK) according to 
the manufacturer’s instructions. The PCR master reagent (containing Taq, 10x buffer, 
Mg2+, dNTPs, and dH2O) was prepared by hand, but the mixing of the master reagent with 
each individual primer was automatically performed using a robot (Functional Genomics 
Laboratory, University of Birmingham). This enabled the processing of 384 (4 x 96) PCRs 
a day. The PCR conditions were: 30 cycles of 30 seconds at 94°C, 30 seconds at 55°C and 
1 minute at 72°C, followed by a 7 minute extension at 72°C.  
 
Gel electrophoresis and PCR purification for the large number of PCRs in this project were 
facilitated by high-throughput methods. Gel electrophoresis was performed using a 96-well 
horizontal gel tank, and the PCR products were loaded using a multichannel pipette. The 
QIAgen MinElute 96 UF PCR purification kit was used for high-throughput PCR clean up. 
 
4.2.4 Long Single-Primer PCR 
Any unsuccessful PCR was followed up by a deletion-scanning PCR (DS-PCR) using the 
flanking primers to confirm the presence of a deletion or genome-specific island (also see 
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Figure 4-1 The whole-genome tiling-path PCR strategy used to analyse the C. jejuni 
M1 strain.  A.  Each gene is illustrated by a block arrow. Primers are labelled as F 
and R relative to each gene, in which the genome sequenced strand primer was called 
F and the other primer R.  B. Two adjacent genes are combined into one PCR 
amplicon as illustrated.  C. Deletion-scanning PCR was used to confirm the region 
corresponding to the failed PCR.  For this purpose, one could also use the primers 
1F+3F or 2F+4F in this example. 
 
1F 1R 2F 2R 3R 3F 4R 
1F 2R 
2F 3F 
4F 
3R 4F 
PCR1 
PCR2 failed 
PCR3 
Deletion-Scanning PCR 
1F 4F 
A. 
B. 
C. 
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Chapter 3). Single-primer PCR approaches have been demonstrated to allow chromosomal 
walking from the known region into the unknown chromosome (Karlyshev et al., 2000). A 
modified Single-Primer PCR (SP-PCR) protocol was developed using long PCR 
techniques to give products of 5-10 kb in length (Figure 4-2).  Long SP-PCR was 
performed using TaKaRa LA Taq polymerase (Cambrex Bio Science Wokingham, Ltd) 
according to the manufacturer’s instructions using the buffer supplied. Long SP-PCR 
reaction conditions were: an initial 2 minutes hot start at 96ºC followed by three steps: the 
first 30 cycles were 20 seconds at 96ºC, 30 seconds at 60ºC and 10 minutes at 72ºC, then 
the following 2 cycles were: 20 seconds at 96ºC, 30 seconds at 30ºC and 10 minutes at 
72ºC, and the final 30 cycles were: 20 seconds at 96ºC, 30 seconds at 60ºC and 10 minutes 
at 72ºC. This was followed by 10 minutes extension at 72ºC.  
 
4.2.5 Sequencing of long SP-PCR products 
For SP-PCR sequencing, the gel purified long SP-PCR product was cloned into a pCR® 2.1 
vector (TA Cloning® Kit, Invitrogen, UK) and grown on X-gal LB plates (Figure 4-2). To 
select the correct clone for sequencing, firstly, three white colonies from each cloning were 
selected for plasmid DNA prep (QIAprep spin miniprep kit, Qiagen, UK). Secondly, PCR 
was performed on each plasmid DNA using two primers. The forward one is the primer 
used for SP-PCR, while the reverse primers were designed using the opposite strand to 
anneal around a few hundred base pairs downstream of the SP-PCR primer binding site 
(Table 4-2). Once PCR confirmed an insertion in that region, sequencing was subsequently 
carried out from both directions using the vector primers (M13 forward and reverse 
primers). New primers can be designed from the derived sequences successively until the 
gap is closed. 
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I. Principle for long Single-Primer PCR. 
II. Sequencing strategy: the SP-PCR product is cloned into a TA vector and sequenced using the 
M13 plasmid primers 
 
Figure 4-2 Long single-primer PCR and the sequencing strategy used to analyse the large genomic 
discrepancies between two Campylobacter genomes. 
Perform PCR using the 
SP-primer and reverse 
SP primer to confirm 
the correct clone 
 
primer from arbitrary sites 
on opposite strand 
SP-PCR primer edge of known region adjacent unknown region 
amplified many 
single strands 
30 cycles of PCR with high annealing temperature  
2 cycles of  PCR with low annealing temperature  
30 cycles of PCR with high annealing temperature  
amplified 
junction regions 
 114  
Table 4-2 Primers used for long single-primer PCR in the C. jejuni study.  
 
Regions of 
differences 
(RD) 
SP-PCR 
originating 
from  
SP-primer Reverse SP-primer 
Cj0028 ATCGGGTTTAAATTGGCATGAA TTCCAGCAGCACCTTTATGG RD-1 
Cj0034c GCCATAGTTTTGGCAAGTTTGA TCCGCTTCGACTTCTTTTTGA 
Cj0054c TTGTGAAAAAGCACCTTCGTTG Not required* RD-2 
Cj0059c GCGATAATGCTTAGCGAAGAGC TTTGAACGCCGAAGTTACCA 
Cj0289c TTGGAACAAAGGCCACGATATT ATTTGGCGCTTCAGATCAAT RD-3 
Cj0300c ATGCGTGCCAATTTACAAGATG Not required 
Cj0304c TGCGTTTTAAATCAAGCCATTG Not required RD-4 
Cj0309c GTGAAATTTTTGGCGTGGTGAT ATTACCCCACCAGCGGTTC 
Cj0479 TGGTAATTGCAGGAAAAGGTGA CAATCACAGCCGCATTTTT RD-5 
Cj0487 GGAGTTTCTTGCGAAAAACCAT GGAAGTAATGCACACGAGCAA 
Cj0564 TTGCGAATGCATGGAGTGTTAT Not required RD-6 
Cj-0571 AAAGCCTTGATCGAGTTTTGGA Not required 
Cj0615 GTGCTTTAGTGGGTGGGCTTAC TCGCCTATAGCCCCTGCTAA RD-7 
Cj0619 AGCAACAATGCGAGCAAAAATA ATGGCATGGGGAGTATTTGC 
Cj0742 TGAAAATGATGGTGATTTTTCTGG TATCCGCACTTCCCTCACCT RD-8 
Cj0757 CGAAAAAGAAGCGTGGAATTTT AAAAACTGCGCATCCACCTT 
Cj0775c GGCAAAATCACTTCTTTGTCCA CATGATGGCGCTTTAAGTGA RD-9 
Cj0778 TATCATCGCCTAAAGCCTTTGC TGGTGCAGGACAAGTTGGAC 
Cj1024c GCTTCTTGGCTGAGCTGTTTTT AAATGGCGAATTTCGTTCAG RD-10 
Cj1030c TGGCCTTAGGCTTTGGTTTTAG ACAGGAGGAAGCTCGCTAGG 
Cj1049c TATCTTGCCACCACAAAGGCTA TTTTTGGCGATTTTTGGTTT RD-11 
Cj-1055c GCCCCTTTAAGCATGTGGCTAT CAGCCAAATTAAGCCCAAAA 
Cj1134 GCAAAATCAAAACACCACCAAA TTTGTCTTATGCCGCCTTTT RD-12 
Cj1146c TGATTTGCTTTGCTTTGATGCT TCTTCGCCATAACTCAAACG 
Cj1295 ATGCAAAACACGATGAAAATGG GCACAAAGCCTGCTTTAACA RD-13 
Cj1312 ATATCAGTTCCACCCATGCAAA TGCCTATGCAAAAGCAAGTG 
Cj1316c TTTTGGATCACGCTTGATATGG GGTGTTTGTGATGCTTGTCG RD-14 
Cj1342c AATTCTTCATCGCCTCGTTTTT TTTTACCGGAATTCCCATGC 
Cj1548c ACTGCTACGCTTGAGCCTTCTT GCAGGGGTTGGTTGTATGGT RD-15 
Cj1562 AAAGGTTTGTTTCCTTTTGTTCA CATCGACTTCATTTGCAAGC 
Cj1676 GCAAAATTCCTGGTACACTTGG TCCTGCAAAGTCGTTTTTCG RD-16 
Cj1680c TTTTAGCCCTAAGGATGCAAAA AACATTAGCCACACCCTCTTT 
Cj1721c AACCCAAATATCCACCTGCAAC TTGGGTTTAAAAGCGGGTTA RD-17 
Cj0001 AAGCTTGCATTTCCAACTGCTT ATGAAGTGCAAAGCGGAAAT 
*Not required: the sequencing data was obtained before the reverse SP-primers were designed. 
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4.3 Results 
4.3.1 Co-linear regions between C. jejuni M1 and C. jejuni NCTC 11168  
In total, 1559 PCRs were carried out on genomic DNA of C. jejuni M1 in this project. The 
high throughput techniques of robotic PCR, gel electrophoresis, and purification were 
demonstrated to have been used to improve productivity for a project of this size. The first 
round PCR produced over 80% positive PCR products, using genomic DNA from C. jejuni 
M1, with the expected sizes calculated from C. jejuni NCTC 11168. 
 
When a single PCR or a few continuous PCRs failed during the initial scanning, further 
PCR studies were undertaken using various combinations of primers flanking that region. 
One example is shown in Figure 4-3. The deletion-scanning PCRs were shown to be a 
useful tool in discovering any deletions or insertions. Using this method, nearly 40% (113 
genes) out of the initial negative PCRs (304 genes) were confirmed. Deletion-scanning 
PCR showed 10 regions with obvious insertions, with the largest insertion being up to 10 
kb, and 5 regions with deletions ranging from 1 to 5 kb (Figure 4-4). 
 
Concurrent to this work, ten large islands in the C. jejuni M1 genome were discovered by 
the Sanger Institute, by the construction and sequencing of BAC (bacterial artificial 
chromosome) clones (Parkhill, personal communication). Interestingly, seven of the ten 
regions corresponded with the regions identified by the author’s genome-tiling PCR. In 
addition, several insertions and deletions in regions not covered by the BAC clones were 
identified by deletion-scanning PCR. 
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Figure 4-3 A. Gel images illustrating the Tiling-Path PCR analysis of the C. jejuni M1 
strain. The PCR amplicons represent the CDSs from Cj0001 to Cj0032. PCR 
products were loaded on a 1.0% agarose gel with Hyper Ladder I MW markers with 
the l kb bands marked (Bioline, United Kingdom). Lanes corresponding to the 
negative amplicons are labelled according to CDS numbers (in abbreviation). B. 
Deletion-scanning PCR confirmed the initial negative results. Using the Cj0007 
forward primer and Cj0009 reverse primer confirmed a ~4 kb PCR product. 
A. 
 07    08     09                        28    29     30    31    32 
B. 
1kb 
1kb 
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At this stage, twenty two single genes failed to be amplified from the C. jejuni M1 strain. 
In addition, seventeen large discrepancy regions were identified in the M1 genome when 
compared to the genome of C. jejuni NCTC 11168 (Figure 4-4). The regions which were 
successfully amplified from the genomic DNA of C. jejuni M1 were inferred to be 
genetically co-linear to C. jejuni NCTC 11168. By the final stage, 1368 genes from C. 
jejuni M1 were confirmed to be co-linear to C. jejuni NCTC 11168, which accounts for 
83.2% of the C. jejuni NCTC 11168 genome. 
 
4.3.2 Identification of genomic discrepancy between two genomes 
The seventeen regions that showed obvious discrepancy between the two genomes were 
named regions of differences (RD) in this study. In some of these regions, up to 30 
continuous primer pairs did not amplify. The previously identified variable regions, 
including genes encoding the capsular biosynthesis locus, flagellar region and 
lipooligosaccharide locus (LOS), were also within the RDs of the M1 strain. These regions 
correspond to the large regions of low G+C content (Parkhill et al., 2000).  In order to 
further understand these variable regions, long single-primer PCR was used to survey the 
unknown regions from the known chromosome. 34 primers for long single-primer PCR 
were designed from both extremes of every region. All long single-primer PCRs worked 
and products up to 10 kb in size were obtained (data not shown).  
 
For effective sequencing, PCR products were cloned into a TA vector with X-gal selection. 
Three white colonies from each cloning procedure were chosen and plasmid DNA was 
extracted for sequencing. Using this approach, it is possible to obtain sequence data from 
both strands using the vector primers. Five plasmid insert DNAs, which represent 
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chromosomal walking fragments originating from Cj0054c, Cj0300c, Cj0304c, Cj0564 and 
Cj0571, provided sequence data.  However, we were unable to obtain sequence data from 
the rest of the plasmids. Unfortunately, this project could not be finished due to funding 
constraints and because of a competing project in the Sanger Institute. However, the work 
presented here demonstrates a series of easy, quick PCR approaches to identify large 
genomic discrepancies between an uncharacterised genome and a sequenced reference. 
From the data generated in this project, it is possible to construct a representation of the C. 
jejuni M1 genome consisting of 34 contigs (Table 4-3).  
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Table 4-3 Assembled C. jejuni M1 genomic contigs relative to C. jejuni NCTC 11168. 
 
Contig  Successful scanning 
PCRs, suggesting 
colinear regions 
Comments* 
1.  Cj0001-Cj0028 Cj0028-Cj0034c PCR failed.  
SP-PCR from Cj0028 to Cj0034c worked. 
No direct sequence available. 
2.  Cj0034c-Cj0054c 
Cj0059c-Cj0072c 
Cj0054c-Cj0058 PCR failed.  
SP-PCR and sequence suggest Cj0055c, 0056c, 0057 absent 
Cj0072c PCR failed.  
Pseudogene. 
3.  Cj0073c-Cj0290c 
Cj0300c-Cj0304c 
Cj0309c-Cj0394c 
Cj0290c-Cj0299 PCR failed.  
SP-PCR and sequence from Cj0300c suggest Cj0296c, 0297c, 0298c, 
0299 absent.  No direct sequence from Cj0290c. 
Known molybdenum transport region in 81-176. 
Cj0304c-Cj0308c PCR failed.  
SP-PCR and sequence from Cj0304c suggest Cj0305c, 0306c and 0307 
absent. 
Cj0394c PCR failed.  
4.  Cj0395c-Cj0479 
Cj0491-Cj0500 
Cj0501-Cj0564 
Cj0479-Cj0490 PCR failed.  
SP-PCR and sequence showed Cj0479 close to Cj0491, suggesting 
Cj0480-Cj0490 are missing.  
This is supported by H. pylori comparison. 
Cj0500-Cj0501 PCR failed.  
Deletion-scanning PCR showed >10kb insertion = BAC Region 1. 
Cj0564-Cj0570 PCR failed.  
SP-PCR from Cj0564 and Cj0570 worked, but no direct sequence 
obtained.  
Known region of difference in RM1221 and 81-176. 
5.  Cj0570-Cj0615 
Cj0619-Cj0627 
Cj0630c-Cj0662c 
Cj0615-Cj0618 PCR failed.  
SP-PCR and sequence from both directions suggest the deletion of 
Cj0617, 0618. 
Cj0627-Cj0629 PCR failed.  
Deletion-scanning PCR showed ~2.5kb deletion. 
Cj0662c PCR failed. 
6.  Cj0663c-Cj0684 
Cj0685c-Cj0736 
Cj0740-Cj0742 
Cj0684 PCR failed.  
Deletion-scanning PCR showed ~10kb insertion within Cj0684. 
Cj0736-Cj0739 PCR failed.  
Deletion-scanning PCR showed 7kb insertion = BAC Region 2. 
Cj0742-Cj0755 PCR failed.  
SP-PCR no sequence obtained.  
7.  Cj0757-Cj0767c Cj0767c PCR failed.  
8.  Cj0768c-Cj0769c 
Cj0770c-Cj0775c 
Cj0769c-Cj0770c PCR failed.  
Deletion-scanning PCR showed ~5kb insertion = BAC Region 9. 
Cj0775c-Cj0777 PCR failed.  
SP-PCR and sequence showed no difference in this region but gap not 
closed. 
9.  Cj0778-Cj0779 Cj0779 PCR failed. 
10.  Cj0780-Cj0786 Cj0786 PCR failed. 
11.  Cj0787-Cj0788 Cj0788 PCR failed. 
12.  Cj0788-Cj0794 Cj0794 PCR failed. 
13.  Cj0795cCj0796c Cj0796c PCR failed. 
14.  Cj0797c-Cj0800c Cj0800c PCR failed. 
15.  Cj0800c-Cj0803 Cj0803 PCR failed. 
16.  Cj0803-Cj0830 Cj0830 PCR failed. 
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17.  Cj0831c-Cj0862c 
Cj0863c-Cj0895c 
Cj0862c PCR failed.  
Deletion-scanning PCR showed ~1.5kb small deletion. 
Cj0895c PCR failed. 
18.  Cj0896c-Cj0936 
Cj0937-Cj0972 
Cj0972-Cj1021c 
Cj0936 PCR failed.  
Deletion-scanning PCR showed ~4kb insertion within Cj0936 = BAC 
Region 8. 
Confirmed by 81-176 comparison. 
Cj0972-Cj0975 PCR failed.  
Deletion-scanning PCR showed ~2kb insertion = BAC Region 3. 
Cj1021c PCR failed. 
19.  Cj1022c-Cj1024c Cj1024c-Cj1029c PCR failed.  
SP-PCR and sequence showed Cj1024c close to Cj1028c and Cj1029c; 
and Cj1030c close to Cj1025c and Cj1026c. Possible rearrangement, but 
gap not closed. 
20.  Cj1030c-Cj1047c Cj1047c PCR failed. 
21.  Cj1048c-Cj1049c Cj1049c-Cj1054c PCR failed.  
SP-PCR and TA clone worked, no direct sequence obtained.  
22.  Cj1055c-Cj1128c Cj1128c PCR failed. 
23.  Cj1129c-Cj1134 Cj1134-Cj1148 PCR failed.  
Known LOS region. 
24.  Cj1149c-Cj1295 Cj1295-Cj1311 PCR failed.  
SP-PCR and sequence from Cj1312 generated ~400 bp novel sequence. 
Gap not closed. 
25.  Cj1312-Cj1316c Cj1316c-Cj1341c PCR failed.  
Known Flagellar region. 
26.  Cj1342c-Cj1359 
Cj1360c-Cj1364c 
Cj1366c-Cj1413c 
Cj1359 PCR failed.  
Deletion-scanning PCR showed ~2kb insertion within Cj1359 = BAC 
Region 4. 
Cj1364c-Cj1365c PCR failed.  
Deletion-scanning PCR showed ~4kb deletion. 
Cj1413c-Cj1415c PCR failed.  
Known Capsule Biosynthetic Locus. 
27.  Cj1416c-Cj1419c Cj1419c-Cj1448c PCR failed.  
Known Capsule Biosynthetic Locus. 
28.  Cj1449c-Cj1505c Cj1505c PCR failed. 
29.  Cj1506c-Cj1519 Cj1519 PCR failed. 
30.  Cj1519-Cj1548c Cj1548c-1561 PCR failed.  
SP-PCR and sequence from Cj1548c found novel sequence.  
31.  Cj1562-Cj1583c 
Cj1586-Cj1601 
Cj1601-Cj1676 
Cj1680c-Cj1686c 
Cj1583c-Cj1585c PCR failed.  
Deletion-scanning PCR showed >10kb insertion = BAC Region 10. 
Confirmed by 81-176 comparison. 
Cj1601-Cj1602 PCR failed.  
Deletion-scanning PCR showed ~1.5kb deletion. 
Cj1676-Cj1679 PCR failed.  
Deletion-scanning PCR showed ~5kb deletion. This is confirmed by 
RM1221 comparison.  
Cj1686c-Cj1687 PCR failed.  
Deletion-scanning PCR showed ~7kb insertion. 
Confirmed by 81-176 comparison. 
32.  Cj1688c-Cj1714 Cj1714 PCR failed. 
Deletion-scanning PCR showed ~3kb insertion. 
33.  Cj1714-Cj1721c Cj1721c-Cj1729c PCR failed.  
SP-PCR, sequence not available. 
34.  Cj1731c-Cj0001  
*All failed PCRs or clusters used for assembling M1contigs are marked in bold. Regions which were 
identified in the Sanger BAC sequencing project are indicated in red. Regions corresponding to known 
variable regions in other strains of the species are indicated in blue.  
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4.4 Discussion   
Campylobacter jejuni is an important food-borne human pathogen. However, 
understanding of the genetics, physiology and virulence of this organism remains poor. 
The existing control and prevention in the food chain are focused at the level of the poultry 
farm (Newell et al., 2001). The virulence mechanisms of this organism and the sources and 
transmission routes of human campylobacteriosis are not fully understood.  All of these 
have greatly hindered the design of disease prevention strategies. C. jejuni represents a 
variety of genotypically diverse species (Wassenaar and Blaser, 1999). Therefore, it is 
necessary to distinguish between C. jejuni strains from different sources, for a further 
understanding of its sources of infection and transmission routes.  
 
The availability of the C. jejuni NCTC 11168 complete genome sequence has not only 
shed light on the genetic features of this species, but also provided the basis for the 
application of post-genomic techniques. The genome sequence identified several large 
gene clusters with an unusually low GC content, suggesting they had been acquired by 
horizontal gene transfer. However, the sequence of the genome revealed few mechanisms 
by which genetic diversity can be generated. Because of this, there is interest in 
investigating the mechanisms of genotypic diversity by characterising more C. jejuni 
strains. 
 
The approach described here can be used for whole genome comparison amongst closely 
related bacteria, where at least one has been completely sequenced. This approach is based 
on existing PCR techniques, together with the newly modified long single-primer PCR. 
This allowed the easy identification of co-linear regions, as well as the detection and 
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characterisation of any large difference. The two Campylobacter strains, C. jejuni M1 and 
NCTC 11168, were found to be closely related, sharing at least 83.5% of the C. jejuni 
NCTC 11168 genes. 
 
Use of a single-primer PCR chromosome walking approach has been reported previously 
(Karlyshev et al., 2000). The published approach also allowed direct sequencing of the 
PCR products with a nested primer. However, this approach was restricted to fragments of 
a few hundred bp and it was unclear whether it would scale-up to long-PCR conditions 
(Karlyshev et al., 2000). In this project, a modified version of the SP-PCR protocol, using 
the conditions and enzymes used for long-PCR, was devised. The results demonstrated that 
it was possible to obtain single-primer PCR products up to 10 kilobases in length. This 
greatly extends the utility of the approach for chromosome walking. Furthermore, these 
PCR amplicons could be cloned into selected plasmids and sequenced with the vector 
primers, which allowed sequencing from both orientations. However, good-quality 
sequence is still restricted to about 1 kilobase. In other words, sequence read-length was 
limited by the sequencing reaction rather than the SP-PCR.  
 
From the data obtained in this study, the genome of C. jejuni M1 has been assembled into 
34 contigs. The next target is to close the gaps, which would reveal all the genetic 
differences between the two genomes. Though full gap closure was not possible within the 
limitations of this project, the sequence data and PCR results obtained have provided some 
useful information for further research. For example, the genes Cj0054c-Cj0058 were not 
successfully amplified by genome-tiling PCR. When sequence was obtained originating 
from both Cj0054c and Cj0058, it showed a gap of about 150 bp between Cj0054c and 
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Cj0058, suggesting the deletion of genes Cj0055c, Cj0056c, and Cj0057. In another case, 
sequence was obtained from both ends of the region between Cj1024c and Cj1030c. The 
sequence originating from Cj1024c corresponded to the genes Cj1028c and Cj1029c, while 
the sequence originating from Cj1030c corresponded to Cj1025c and Cj1026c. This 
suggested the possibility of a rearrangement within this region. However, further studies 
are required to confirm these rearrangements in the C. jejuni M1 genome. 
 
In summary, the advantage of using genome-tiling PCR is that all the insertions/deletions 
are indicated by their size and position and these results have provided at least preliminary 
information on the genome organisation of a novel strain, C. jejuni M1.  
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CHAPTER FIVE  
GENOME SEQUENCING OF THE EUROPEAN 
FRANCISELLA TULARENSIS SUBSPECIES 
TULARENSIS ISOLATE FSC198 
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5.1 Introduction 
5.1.1 The bacterium Francisella tularensis and the disease tularaemia 
Francisella tularensis is a small gram-negative bacterium and a facultative intracellular 
pathogen. It causes a zoonotic and infectious disease, tularaemia, among humans and 
animals. It was isolated in 1911 from rodents suffering from a plague-like disease in Tulare 
County, CA (USA) (Gliatto et al., 1994).The disease has not been demonstrated to be 
directly transmissible between humans, whereas rodents, hares and rabbits are important 
sources of human infections (Ellis et al., 2002). The true reservoir of the bacterium in the 
environment is as yet unknown.  
 
The most common infectious route is a bite from anthropod vectors, such as ticks, flies, 
and mosquitoes, which have been previously infected. The infection can be acquired 
through the skin or mucous membrane, but the most severe form of the disease is caused 
by inhalation of an aerosol containing bacteria. Indeed, inhalation of as few as 10 colony-
forming units (CFU) is sufficient to cause disease in humans (Riley et al., 1995). The 
respiratory form is the most dangerous tularaemia and there is up to 30% mortality in the 
absence of antibiotic therapy (Dennis et al., 2001). Outbreaks are rare but can involve a 
large number of cases. For example, almost 700 cases of respiratory tularaemia were 
reported in one outbreak in Sweden in 1966-1967 (Dahlstrand et al., 1971).  
 
Given its infectious nature, ease of dissemination and the capacity to cause severe illness 
and death, this organism has been considered as a potential biological weapon since the 
1950s. It is known to have been developed as a bioweapon by Japan, the United States and 
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the USSR (Christopher et al., 2005). Moreover, in the post-Cold War era, it is included 
among the top six agents showing a potential threat to public health if used as a 
bioterrorism weapon (Harris, 1992). Unfortunately, there is no licensed vaccine available 
so far (Titball and Oyston, 2003). Though the live vaccine strain (LVS) has been 
demonstrated to provide protective immunity against tularaemia, the mechanism of 
attenuation and protection is not known (Tarnvik, 1989; Sandstrom, 1994). This has led to 
the withdrawal of the UK and USA licensing for vaccine use of this strain. The need to 
develop a safe and licensable vaccine to protect against tularaemia, particularly the 
respiratory form of the disease, has led to increased interest in this organism in recent years. 
 
Francisella is classified as a member of the γ-subgroup of the proteobacteria (Forsman et 
al., 1990). The genus Francisella contains two well-recognised species, F. tularensis and F. 
philomiragia, in addition to a number of tick endosymbionts. F. philomiragia is an 
opportunistic pathogen, and virulent only in immunosuppressed or near-drowned 
individuals (Hollis et al., 1989). F. tularensis can be divided into four recognised 
subspecies: tularensis (formerly known as F. tularensis type A), holarctica (formerly F. 
tularensis type B), mediasiatica and novicida. The classification sometimes includes an 
additional subspecies as holarctica variants found in Japan (Svensson et al., 2005) are 
intermediate to F. tularensis subsp. tularensis and the other F. tularensis subsp. holarctica 
isolates. These subspecies are distinct from each other in both virulence and geographical 
distribution. Two subspecies, tularensis and holarctica, cause disease in humans: the 
former causes diseases with high mortality whereas the latter is highly infectious but shows 
moderate virulence. The LVS is an attenuated variant of F. tularensis subsp. holarctica. F. 
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tularensis subsp. novicida causes diseases in mice similar to those caused by subsp. 
tularensis in human (Anthony et al., 1994).  
 
F. tularensis is widely distributed in the Northern hemisphere, and the different subspecies 
show restricted geographical ranges. F. tularensis subsp. tularensis strains are 
predominantly found in North America, while F. tularensis subsp. holarctica strains are 
found in Europe and Asia, and to a lesser extent in North America. F. tularensis subsp. 
mediasiatica is primarily found in central Asia and the former USSR, while F. tularensis 
subsp. novicida was thought to be restricted to North America, but there has been a report 
of isolates found in Australia (Whipp et al., 2003).  
 
5.1.2 Complete genome sequences of Francisella strains 
The molecular basis of Francisella infection has been poorly understood for many years 
due to a lack of genetic tools. Prior to this project, only two complete genome sequences 
from Francisella isolates were available.  The first was from a highly virulent F. tularensis 
subsp. tularensis strain Schu S4 (Francisella strain collection number FSC237). This strain 
was originally obtained from an ulcer from a case of tularaemia in Ohio in 1941. Since 
then, it has been adopted widely for use in laboratory studies.  The second genome 
sequence was obtained from the LVS. This strain was originally obtained through multiple 
passage of a virulent F. tularensis subsp. holartica isolate. The LVS genome was 
completed at Lawrence Livermore National Laboratory in 2006 
(https://maple.lsd.ornl.gov/microbial/ftul_lvs/).  
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The genome of F. tularensis strain Schu S4 is small (about 1.9 Mb), with an overall G+C 
content of 32.9%. There are 1,804 predicted CDSs (including pseudogenes), of which 302 
are unique to F. tularensis (Larsson et al., 2005). The genome is characterised by a high 
proportion of inactivated genes, which have been degraded by insertions, deletions, and 
substitution mutations. More than 10% of the CDSs in the Schu S4 genome are 
pseudogenes or gene fragments, among which 14% are due to disruption by IS elements. In 
addition, a large number of IS elements scattered throughout the genome is another feature 
of the F. tularensis genome. The presence of a large number of IS elements and 
pseudogenes also disrupts more than half of the predicted metabolic pathways.  
 
The F. tularensis Schu S4 genome sequence revealed two identical regions of 33.9 kb in 
size. The origin of this duplicated region is not clear since no known homologues were 
identified. The 25 genes encoded within the duplicated region represent a possible 
pathogenicity island, showing the potential to contribute to virulence (Larsson et al., 2005). 
Homologues of some of the genes within the pathogenicity island have been suggested to 
encode a new secretion system in a recent study (Pukatzki et al., 2006).  
 
5.1.3 The European subspecies tularensis strains 
Although the usual assumption is that Francisella tularensis subspecies tularensis is 
confined to North America, several isolates from Europe were reported in the 1980s to be 
as highly pathogenic as subspecies tularensis strains. These strains were first recorded 
during a survey of 155 Francisella strains isolated over the years 1978-1996 from small 
mammals, fleas, ticks and mites in Slovakia (Gurycova, 1998). Seventeen strains isolated 
from mites and fleas were found to have the ability to ferment glycerol and glucose, were 
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positive for citrulline uridase, and sensitive to erythromycin (Gurycova, 1998). These 
biochemical properties are typical of subspecies tularensis but not of subspecies holarctica. 
Two of the strains isolated from mites, originally designated as SE219 and SE221, 
exhibited a high pathogenicity for domestic rabbits, which is considered the most 
important property of F. tularensis subsp. tularensis, in contrast to other subspecies of F. 
tularensis. Therefore, these 17 strains (15 strains from fleas and 2 strains from mites) were 
classified as F. tularensis subsp. tularensis.  
 
Interestingly, the subspecies tularensis strains were isolated initially from four species of 
fleas and two years later from two species of mites within the region of the Danube river 
basin near Bratislava (Gurycova, 1998).  Over the following two years, isolates of F. 
tularensis subsp. tularensis were recovered repeatedly from fleas and mites captured in this 
region. The reason for the presence of these strains in the region is unknown. The isolates 
SE219 and SE221 were deposited in the Francisella strain collection (FOI, Umea, Sweden) 
and are known as FSC198 and FSC199 respectively. A further isolate, strain Sev-23, was 
obtained during a later survey from Ixodes spp. ticks in South East Austria in 1990, and 
again identified as F. tularensis subsp. tularensis (D. Gurycova, unpublished). These 
findings of subspecies tularensis strains in Europe could have serious epizootic 
implications.  
 
Though the four subspecies of F. tularensis are distinct in virulence, biotypes and 
geographical distribution, they are highly similar in gene content and have greater than 
95% DNA sequence identity (Nano et al., 2004). Recently, a study using variable-number 
tandem repeats (VNTRs) at multiple loci was performed to assess the genetic relationships 
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among 192 F. tularensis isolates, representing all the recognised subspecies (Johansson et 
al., 2004). VNTRs, also known as short sequence repeats (SSR) or micro-satellites, have 
been used as high-speed molecular clocks for monitoring microbial genome evolution (van 
Belkum, 1999a). VNTR loci normally have multiple copies of a small repeat unit of about 
10-30 bp. The number of repeats present at a given genomic site is highly variable between 
strains, because these unstable repeats lead to slippage during DNA replication. Some 
experiments have shown the promise to discriminate individual strains from those species 
with little genomic variation, e.g., Mycobacterium tuberculosis and Bacillus anthracis 
(Keim et al., 2000; Mazars et al., 2001). 
 
Johansson et al. applied twenty-five informative VNTR markers throughout the whole 
physical map of F. tularensis Schu S4. The 192 F. tularensis isolates were identified as 
120 different genotypes (Figure 5-1). VNTR analysis revealed a great difference in genetic 
diversity between the subspecies tularensis and holarctica (Johansson et al., 2004). F. 
tularensis subsp. tularensis is highly diverse, and is enough to be divided into two 
genetically distinct groups, arbitrarily designated: clade A.I and A.II.  Clade A.II was 
significantly less diverse than clade A.I. Clade A.I was found predominantly in the mid-
West of America and included 29 North American isolates (Johansson et al., 2004). 
Strikingly, two Slovakian strains are grouped into the clade A.I sub-population, and are 
most closely related to the laboratory strain Schu S4 (Figure 5-1). 
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Figure 5-1 Genetic relationships among global F. tularensis isolates based on allelic 
differences at 25 variable-number tandem repeat (VNTR) markers (reproduced from 
Johansson et al., 2004). The tree was constructed using the neighbor-joining 
algorithm and rooted using F. tularensis subsp. novicida isolates. Two Slovakian 
strains were grouped into the Clade A.I sub-population, belonging to subsp. tularensis. 
The close relationship between Schu S4 and the two Slovakian strains is highlighted 
by oval. 
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5.1.4 Aims 
The complete genome sequence of subspecies tularensis strain Schu S4 shed light on the 
genetic content of F. tularensis (Larsson et al., 2005). A second genome sequence from 
subsp. holarctica strain LVS is also available (NCBI accession number NC_007880; 
GenBank accession number AM233362). The collection of more complete Francisella 
genomes will help in the understanding of this organism, and will aid in the determination 
of the function of unknown genes. Because of the lack of any licensed vaccine for this 
etiological agent, F. tularensis is still a threat to public health, and therefore, there is an 
increasing need to discover vaccine candidates. The genome sequencing and comparative 
genomic studies can benefit the potential development of a defined vaccine strain.  
 
Since the 1980s, several strains belonging to subspecies tularensis have been isolated from 
Europe. However, little is known about their origin and they remain an enigma  (Gurycova, 
1998). The VNTR study revealed that these European subsp. tularensis strains were most 
closely related to the Schu S4 laboratory strain (Johansson et al., 2004). However, any 
explanation for their close relationship remained speculative because no other genetic 
information on the European subsp. tularensis strains was available. Therefore, the aim of 
this project was to examine their close relationship by obtaining the complete sequence of 
one of the genomes, and one of the Slovakian isolates, FSC198, was chosen as the 
sequencing target.  
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5.2 Materials and Methods 
5.2.1 Bacterial strains 
The genomic DNA of F. tularensis strain FSC198 was kindly provided by the Health 
Protection Agency (HPA; Porton Down, UK). The genomic DNA from F. tularensis subsp. 
tularensis Schu S4 strain and subsp. novicida U112 strain were kindly provided by the 
Defence Science and Technology Laboratory (Porton Down, UK).  
 
5.2.2 Shotgun sequencing and genome assembly 
Shotgun sequencing data was prepared and obtained from the HPA. The shotgun 
sequencing library was obtained by randomly shearing the FSC198 DNA into 1-2 kb 
fragments, which were then ligated into the pLEXX AK double-insert vector (Chaudhuri et 
al., 2007). The shotgun library resulted in sequencing reads at a level of 10x 
theoretical coverage. Initial assembly of the sequence gave 68 contigs but included 
numerous misassemblies due to IS elements (R. Chaudhuri, personal communication). At 
this stage, PCR and sequencing strategies were then applied to complete the final genome 
assembly and the genome finishing (see Figure 5-2).  
 
5.2.3 Whole genome PCR scanning 
As the previous study showed, FSC198 is a close relative of Schu S4 (Johansson et al., 
2004). To investigate any difference in genome organisation between the two strains, 
whole genome PCR scanning was applied to DNA from FSC198 using primers designed 
for Schu S4. One hundred and nineteen primer pairs were automatically designed using the  
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Figure 5-2 The strategy used to obtain the complete sequence of the F. tularensis 
subspecies tularensis FSC198 genome.  
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program GenoFrag (Ben Zakour et al., 2004) (primers are listed in Appendix I). The 
primers were designed to produce ~17 kb fragments with overlaps of a few hundred base 
pairs.  
 
Long PCRs were performed using TaKaRa LA Taq (Cambrex Bio Science, Wokingham, 
UK) as previously described (Ren et al., 2004). Regions were assumed to be colinear to the 
equivalent region of Schu S4 if long PCR amplification was successful. Any large 
differences, such as deletions or insertions, could be revealed by long PCR scanning. 
 
5.2.4 Gap closure 
The genome finishing stage consisted of gap closure and resolution of ambiguous sequence. 
Gap closing PCRs were performed using primers designed based on the Schu S4 genome, 
and followed by direct sequencing with both PCR primers. Twenty five pairs of PCR 
primers were designed to yield 1-1.5kb products, spanning each gap (Table 5-1). The 
sequencing results obtained were assembled into the FSC198 genome. 
 
5.2.5 Resolution of sequence ambiguities 
To resolve the ambiguous positions, 353 PCRs, including 9 long PCRs, were employed 
(primers are listed in Appendix II). The regions representing the multiple copies of IS and 
large repeats were included to ensure that the sequences of each repeat region were 
independent. The large repeated regions included two copies of the 33.9 kb pathogenicity 
island within the genome. Large repeats were resolved by long PCR to amplify each 
specific repeat, and then short PCR products were obtained from within the long PCR  
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Table 5-1 Primers used for Gap closure. Gene names and nucleotide position numbers of 
each primer are specified relative to the F. tularensis Schu S4 genome.  
 
Primer 
Name 
Sequence of primer (5’-3’) Gene name Start 
Position 
GAP1-F GGGTGGTAGAACAGTAGGTGCT tufA 151181 
GAP1-R TAGGACTCGAACAACTTCACCA nusG 152302 
GAP2-F TAACCACCACGAACGTGATTAG rpsA 199799 
GAP2-R GTCGCCACCATATAAAACAACA ddlB 200808 
GAP3-F TGATAGCCAAACATCTGTATTTC Intergenic region 462253 
GAP3-R CACTGTTATCAAGCATATTTGGTG FTT0447c 463351 
GAP4-F TGTGTCTTTCGTGAGATAAAGC coaD 598922  
GAP4-R AGTCGCACCATTATCCTGAAT fopA1 600006 
GAP5-F GTGGTACGCTCAATGTCAAAAG lon 646585 
GAP5-R AGCAACATATGCTCTACTACCAA FTT0628 647573 
GAP6-F GAGGATTTACTTCAAAGAGGGCT FTT0663 682060 
GAP6-R TGGCAATCCATATAGTAAAGGC hdc 683079 
GAP7-F GCATCAGCTTTAGAAATGTTTGG ispD 729862 
GAP7-R TGTACTCTATTGGTCTAAATAGCGA sdaC1 730932 
GAP8-F CAGTGATATAGAGCATCAAAAGA Intergenic region 744147 
GAP8-R TGATACAAAGATACGTACAAGTTTT Intergenic region 745292  
GAP9-F TTTTGAGCATGATTAGAAAATA Intergenic region 780378 
GAP9-R GAAATAACTAGAAACTTACCCATTCAA recF 781521 
GAP10-F TTCTAAGCTAGTATTATAAATTTGTTG yjjV 781849  
GAP10-R ACGGTCCTTGCTTTTCAATAA glyS  783010 
GAP11-F TCAAAGTTGCACCTAGTTTAAT FTT0796 815587 
GAP11-R TGTTTGATTAATAACAGATTCTAAA FTT0798 816743  
GAP12-F ATGCAACAACATCATAGCATCC ans 822295 
GAP12-R CAACTTTGCAAATGATTGAT Intergenic region 823450 
GAP13-F ATCAAAAAGCCAGTTTAGCTGC FTT0868c 879125 
GAP13-R TCTTGCCACATATACTGAAATCG FTT0869 880126 
GAP14-F TTCGGCATTATTAGATTCGCTT FTT0881c 889368 
GAP14-R TTCTCAAGTCTATGTACAGCTTCCTT FTT0882 890457 
GAP15-F GGCAAATATTAAAAATTATGGCAAA FTT0944 955092 
GAP15-R AAAATTGCTGTTTCTAATTCAA FTT0944 956195 
GAP16-F GGTAGCATCGCAACAATACTCA FTT0944 956274  
GAP16-R TTTTCTATTTGTTTGATTAGTTCCA FTT0945 957357 
GAP17-F TTTCATCAGCATTTGCATCAAT FTT0981 992870  
GAP17-R GAAGCAATAATTATAACTACAAAAGA FTT0982  994003 
GAP18-F CGACTTAATTCCTTGTAGCCCA FTT1007c  1020110 
GAP18-R TTTCATCAATATAAAGTTGAGCTG FTT1009 1021271 
GAP19-F AAAAACTCAAAACTCCAAAAA FTT1089 1099430 
GAP19-R AGGAGAGTTTTGGCATTCCTC FTT1091 1100615 
GAP20-F TTGTGAAACTGGAATTGTTTTAGG dedA2 1239896 
GAP20-R CATTGTTACTAAAGAAAAATGCCAAA dedA1 1241017 
GAP21-F TGGATCTTCTAAGAGGGAAAAA FTT1319  1347030 
GAP21-R CAAGCATGTGAGATATGCCAGT FTT1321 1348270 
GAP22-F TGCAGACCCAGCAATATCTAAA FTT1666c 1734994 
GAP22-R TTGTTATAGCCGTGTGAAAAAT FTT1667 1736061 
GAP23-F TTTAAGTCCTTGTGGCTTCTCA Intergenic region 1759181 
GAP23-R CCATTAAGGTTGTCAATTTGGT FTT1691 1760609 
GAP24-F AAAATTTAGCAAACAATCAA Intergenic region 1875891 
GAP24-R CCTATGTTAGGTTTGAGAGTTAAT Intergenic region 1876899 
GAP25-F CCTATTTTATTCAAATCAGCGA Intergenic region 1886410 
GAP25-R CCAGCTAGACCGAATAAGGTTG trpG2 1887442 
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product. These short PCR products were sequenced directly on both strands using the PCR 
primers. All the sequencing data obtained were assembled into FSC 198 genome. 
 
5.2.6 Genome comparison  
Upon final assembly, whole genome comparison of Schu S4 and FSC198 was performed. 
The comparisons revealed a number of Single Nucleotide Polymorphisms (SNPs).  DNA 
fragments including these SNPs were all PCR amplified and re-sequenced from both the 
Schu S4 and FSC198 strains to determine whether the apparent differences represented 
true SNPs or errors in one of the genome sequences. In addition, to examine the diversity 
among European subspecies tularensis isolates, the confirmed SNPs and the VNTR 
differences identified in the previous study (Johansson et al., 2004) were also sequenced in 
strains FSC 199 and Sev-23. These sequence data were provided by the HPA. 
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5.3 Results 
5.3.1 No large differences are revealed by whole genome PCR scanning  
The initial assembly from the original HPA shotgun sequences resulted in 30 large contigs 
(R. Chaudhuri, unpublished observations). Alignments with the Schu S4 genome indicated 
an extremely close relationship between FSC198 and Schu S4. 119 primer pairs were 
designed to span the whole genome of F. tularensis Schu S4, and these primers were used 
to perform long PCR scanning on the genomic DNA of F. tularensis FSC198. All but two 
of these PCRs were successful and yielded products of the expected size (data not shown). 
Given the initial assembly and data from the previous VNTR study (Johansson et al., 2004), 
it was concluded that there were no large differences between the two genomes. Based on 
this observation, the Schu S4 genome sequence was used to facilitate the finishing of the 
FSC198 genome.  
 
5.3.2 Genome finishing 
To finish the genome, the focus was on gap closure, removing low quality regions and 
resolving multiple copies of IS elements and large repeats. Gap closure was performed by 
PCR and subsequent sequencing using the PCR primers. Each PCR generated a product no 
longer than 1.5 kb. Because the first ~100 base pairs of the sequencing reads are not 
reliable, the annealing sites of PCR primers were selected to be at least 200 base pairs from 
the gap. The fidelity of the gap sequences was confirmed by sequencing both strands of the 
PCR products. The 25 gap regions were all closed by PCR and sequencing in this project. 
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5.3.3 SNPs and VNTRs 
As the project progressed, it became increasingly clear that the genomes of FSC198 and 
Schu S4 were virtually identical. Whole genome sequencing here also led to an approach 
for detecting SNPs. Upon final assembly, the two genomes were found to be different at 
forty apparent SNPs. Most of these apparent SNPs modified the sequence of the encoded 
proteins. Re-sequencing the SNP loci in both genomes suggested that the majority of the 
discrepancies were due to errors in the published Schu S4 sequence rather than genuine 
differences. These were found to correspond to regions of poor sequence coverage from 
the Schu S4 sequencing project (M. Forsman, personal communication). Only eight SNPs 
were confirmed finally (Table 5-2). All the SNPs are non-synonymous, suggesting that 
adaptive evolution is responsible. Similarly, VNTRs were different at five loci, including 
three loci identified in Johansson’s study (Johansson et al., 2004). However, only three 
were confirmed following re-sequencing of these loci in both genomes (Table 5-3). Again, 
the results revealed that sequence errors appeared in the published Schu S4 genome. 
 
To further investigate the diversity of the European isolates of F. tularensis subspecies 
tularensis, the eight true SNPs identified in this study, and the twenty five VNTR loci 
identified previously (Johansson et al., 2004), were sequenced in the other available 
European strains, FSC 199 and Sev-23. Three of the eight SNPs that distinguish FSC198 
from Schu S4 were also identified in FSC199 and Sev-23 (Table 5-2). This suggests that 
all three European isolates share a common ancestor after their divergence from the Schu 
S4 strain. When sequencing the twenty five VNTR loci, the same three loci identified in 
FSC198 were also variable in FSC199 and Sev-23 (Table 5-3), but there were differences 
between the three strains. This suggests that the three European isolates are distinct from 
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Table 5-2 Single nucleotide differences identified between the FSC 198 genome and 
the published Schu S4 sequence and confirmed by re-sequencing (reproduced from 
Dr. Chaudhuri). The bases at the equivalent loci in strains FSC 199, Sev-23 and LVS 
are also shown. The SNPs relative to Schu S4 that are conserved in all three 
European strains are highlighted in red. 
 
Locus Schu S4 
coordinate 
FSC 198 
coordinate 
Schu S4 
base 
FSC 198 
base 
FSC 199 
base 
Sev-23 
base 
LVS 
base 
Effect in FSC 198 
S1 390291 390243 C T T T C FTF0387 substitution A→V 
S2 621878 621830 C T C C C FTF0602c 
substitution V→I 
S3 639511 639463 C A C C C FTF0620 substitution A→E 
S4 701628 701580 G T T T G SthA substitution Q→K 
S5 911511 911463 C T T T C FTF0903 substitution R→C 
S6 1007564 1007516 G C G G G YbhO substitution E→D 
S7 1008149 1008101 G A G G G YbhO substitution M→I 
S8 1134418 1134369 G A G G G MetN substitution M→I 
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Table 5-3 Variable number tandem repeat (VNTR) differences between the FSC 198 
genome and the published Schu S4 sequence confirmed by resequencing (reproduced 
from Dr. Chaudhuri). The number of tandem repeats at each locus for strains FSC 
199, Sev-23 and LVS are also shown. VNTR loci are numbered as in Johansson’s 
study (Johansson et al., 2004). 
 
Locus Schu S4 
coordinate 
FSC 198 
coordinate Repeat Unit 
Schu S4 
copy no. 
FSC 198 
copy no. 
FSC 199 
copy no. 
Sev-23 
copy no. 
LVS 
copy no. 
M8 8266 8266 aagatatttgtagaaa 4 5 5 5 2 
M3 308635 308650 aataaggat 21 14 25 28 13 
M10 1283659 1283610 aagatatttgtagaaa 18 11 11 10 2 
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each other, but more closely related to each other than to Schu S4.   
 
Additionally, the eight identified SNPs and three VNTR differences were investigated in 
another subspecies of F. tularensis, the subsp. holarctica strain LVS. Interestingly, all 
eight SNPs showed identical residues between LVS and Schu S4, but the VNTRs are 
distinct from each other (Tables 5-2 and 5-3). The SNP results suggest that the Schu S4 
genome has the ancestral genotype at these positions, and that the differences in the 
European isolates are due to substitutions that have occurred in that lineage.  
 
5.3.4 Complete genome sequence of FSC198 
The complete genome sequence of F. tularensis subspecies tularensis strain FSC 198 is 
1,892,616 bp in length, with a GC content of 32.36% (see Figure 5-3) (Chaudhuri et al., 
2007). An online comparative genomics database (http://xbase.bham.ac.uk/ftbase/) has 
been developed, allowing effective comparison among the up-to-date sequenced 
Francisella genomes. Genome sequencing shows that the European isolate FSC198 is 
almost identical to the US laboratory strain Schu S4. 
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Figure 5-3 Circular representation of the complete genome sequence of FSC198 
(reproduced from http://xbase.bham.ac.uk). Predicted coding sequences are coloured 
according to their GC content. The inner circle indicates the positions of SNPs (red) 
and VNTR differences (blue) relative to the published Schu S4 genome sequence. SNP 
and VNTR loci are numbered as in Tables 5-2 and 5-3, respectively (Chaudhuri et al., 
2007). 
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5.4 Discussion 
Interest in the bacterium Francisella tularensis has been greatly increased in recent years 
to counter its potential application as a bioterrorist agent. The subspecies tularensis is 
particularly troublesome because of its ability to cause incapacitating, potentially fatal 
disease and to spread via aerosolization. It has the potential to threaten the public health 
system in the event of an outbreak. F. tularensis was traditionally considered endemic only 
within the Northern Hemisphere, with F. tularensis subsp. tularensis restricted to North 
America. However, there have been reports of several isolates belonging to F. tularensis 
subsp. tularensis from Central Europe (Gurycova, 1998) and an isolate of F. tularensis 
subsp. novicida from Australia (Whipp et al., 2003).  These indicate that either the 
geographical distribution of F. tularensis is more pervasive than originally thought or that 
the pathogen is spreading. The European isolates of F. tularensis subsp. tularensis have 
remained an enigma since first being isolated in the 1980s. There is considerable interest in 
discovering how these highly virulent subspecies tularensis strains were introduced into 
Europe. For this purpose, one of the isolates, FSC198, has been investigated by whole 
genome sequencing.  
 
The genome sequencing reported here revealed that the genomes of FSC198 and Schu S4 
are almost identical. Only eight SNPs and three VNTRs were confirmed that distinguished 
the two strains. Both SNPs and VNTRs can be used as molecular markers for efficient 
genotyping. SNPs represent the smallest-scale variation in bacterial genomes and can occur, 
in theory, anywhere in a genome. For this reason, it is very unlikely that the same change 
happens in two separate lineages in a short space of time. In contrast, VNTR changes can 
happen at only a small number of sites due to variations in repeat copy. However, these 
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sites can change frequently and allow more variations than a single base change (there are 
only four bases).Therefore, both SNPs and VNTRs are useful in distinguishing between the 
two genomes and characterising their genetic distance. Particularly, they have vital value to 
those species with little genetic variation, e. g. Mycobacterium tuberculosis, Yersinia pestis 
and Bacillus anthracis (Keim et al., 2000; Mazars et al., 2001;Gutacker et al., 2002; 
Touchman et al., 2007). Furthermore, if two genomes share some SNPs and VNTRs, it 
implies a shared history and close relatedness between them.  
 
VNTRs as a previous study has shown (Johansson et al., 2004), are extremely useful and 
powerful tool in estimating evolutionary relationships between world-wide populations of 
F. tularensis. Here in this study, we have shown the value of using whole-genome 
sequencing to detect SNPs in addition to VNTRs. As illustrated in Table 5-2, three 
European subsp. tularensis strains, FSC198, FSC199 and Sev 23, possess three identical 
SNPs, which differ from Schu S4. This result suggests that the European strains are more 
similar to each other than to Schu S4. Therefore, it is reasonable to conclude that the three 
European isolates are from the same lineage and that they share a more recent common 
ancestor with each other than with Schu S4. This was also confirmed by an examination of 
all the SNPs in a subspecies holarctica strain LVS. As shown in Table 5-2, LVS is 
identical to Schu S4 at all eight positions that represent SNPs in the European isolates. 
Since the two subspecies tularensis and holarctica are known to be genetically distant 
from each other (Johansson et al., 2004), the LVS/SchuS4 sequences are likely to represent 
the ancestral state, while the SNPs in the three European isolates are due to substitutions 
that have occurred in the European lineage. However, when these changes occurred is still 
a mystery.  
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In order to uncover the origin of the subspecies tularensis in Europe, the immediate 
questions are how did the common ancestor of the European isolates arise and how did it 
come to be in Europe, particularly as, according to the published VNTR results, FSC 198 
and other European isolates are the closest relatives of Schu S4, far closer than any other 
clade A.I isolates from central USA or elsewhere in North America. One possibility is that 
past human activities led to the establishment of Schu S4-like populations in Europe.  
 
The most plausible potential sources of FSC198 and the other European subspecies 
tularensis are laboratory stocks of Schu S4 in North America or in Europe. Since Schu S4 
is a recognised laboratory strain propagated in laboratories around the world, sub-culture in 
different laboratories might explain the differences between the European isolates. The 
most worrying scenario is that these isolates were released deliberately into the European 
environment. Alternatively, they could have entered the environment through inappropriate 
disposal of laboratory waste, or even escape of mammals or anthropods that have been 
infected in the laboratory.  
 
Another possibility is that FSC198 and other European isolates are derived not from the 
laboratory strain Schu S4, but from a related wild strain from the USA. It has been 
suggested that the Francisella tularensis clade A.I subgroup could be transferred via dogs 
within continental USA, and via the cotton tail rabbit from USA to Europe (Farlow et al., 
2005). Movements of animal or animal products might also carry insect vectors containing 
the progenitor of the European strains. However, it seems very unlikely, bearing in mind 
the published VNTR results (Johansson et al., 2004), that a randomly selected wild strain 
would be so similar to Schu S4. In this study (see Table 5-2), none of the eight SNPs 
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identified are specific to Schu S4. Therefore, it is most likely that Schu S4, rather than any 
other wild strain, represents an immediate precursor of the European strains. 
  
Another possibility is that a laboratory error occurred in Slovakia, so that the alleged 
environmental isolates represent contaminants derived from an existing laboratory stock of 
Schu S4. However, the three European isolates were distinct from each other at some SNPs 
and obtained at different times, so this explanation would require repeated contamination 
and sub-culture from the same laboratory stock, which seems very unlikely.  
 
In summary, the whole genome sequence of a European subspecies tularensis strain, 
FSC198, has been determined in this study. The most likely source of the European 
isolates of F. tularensis subspecies tularensis is the laboratory strain Schu S4. Given the 
pathogenic potential of this subspecies and its status as a public health threat, further 
environmental sampling to assess the distribution and prevalence of the subspecies 
tularensis in Europe is probably warranted.  
 
The FSC198 sequence is the first publicly available bacterial genome sequence to be 
determined in the United Kingdom outside of the Wellcome Trust Sanger Institute. 
Additional Francisella genome sequencing projects are now underway, with several new 
genome sequences appearing in the public databases (Table 5-4) and/or in the process of 
assembly and finishing. These new genome sequences will help prime the development of 
comparative genomics and proteomic studies and the search for new vaccine candidates 
(Titball and Petrosino, 2007). 
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Table 5-4 Current Francisella genome sequencing projects. 
 
F. tularensis strains Sequence 
status 
Length 
(bps)  
Sequencing Center GenBank 
Accession 
number 
F. tularensis subsp. 
tularensis SCHU S4 
Complete 1 892 819 Swedish Defence 
Research Agency 
AJ749949 
F. tularensis subsp. 
holarctica OSU18 
Complete 1 895 727 Baylor College of 
Medicine 
CP000437 
F. tularensis subsp. 
tularensis FSC198 
Complete 1 892 616 University of 
Birmingham 
AM286280 
F. tularensis subsp. 
holarctica LVS 
Complete 1 895 994 Lawrence Livermore 
National Laboratory 
AM233362 
F. novicida U112 Complete 1 910 031 University of 
Washington 
CP000439 
F. tularensis subsp. 
holarctica FTA 
Complete 1 890 909 US Department of 
Energy Joint Genome 
Institute 
CP000803 
F. tularensis subsp. 
tularensis WY96-
3418 
Complete 1 898 476 Translational Genomics 
Research Institute 
CP000608 
F. tularensis subsp. 
mediasiatica 
FSC147 
Complete 1 893 886 The U.S. Department of 
Energy (DOE) Joint 
Genome Institute  
CP000915 
F. tularensis subsp. 
holarctica FSC200 
Assembly 1 790 358 University of 
Washington 
AASP00000000 
F. tularensis subsp. 
tularensis FSC033 
Assembly 1 844 205 Broad Institute Genome 
Sequencing Platform 
AAYE00000000 
F. novicida GA99-
3548 
Assembly 1 845 491 Broad Institute Genome 
Sequencing Platform 
ABAH00000000 
F. novicida GA99-
3549 
Assembly 1 897 440 Broad Institute Genome 
Sequencing Platform 
AAYF00000000 
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CHAPTER SIX  
INVESTIGATION OF TWO POTENTIAL 
VIRULENCE FACTORS IGLA AND IGLB 
FROM FRANCISELLA TULARENSIS  
ISOLATE FSC198  
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6.1 Introduction 
6.1.1 Identification of Francisella virulence factors  
Very little is known about the mechanisms of Francisella virulence. Replication of the 
bacterium has been demonstrated in a range of cell types, but mainly in macrophages  
(Titball et al., 2003). Several factors needed for Francisella intra-macrophage growth are 
responsible for Francisella virulence. A biochemical study of the LVS of F. tularensis 
showed that four proteins are induced after F. tularensis entry into macrophages 
(Golovliov et al., 1997). The most prominently induced of these was identified as a 23 kDa 
protein. It has been cloned and sequenced in this study. However, this protein does not 
have any homologues within the databases at the present time.  
 
Genetic approaches have also been used to discover the factors that are needed for 
Francisella intracellular growth. A random transposon (Tn) mutagenesis approach 
identified five genetic loci that reduced the ability of F. tularensis to grow and replicate in 
mouse macrophages (Gray et al., 2002). One of these transposon insertions was located 
within the gene encoding the 23 kDa protein.  Not far from it (approximately 2 kb 
upstream), there was a second Tn mutant associated with growth in macrophages. The 
gene encoding the 23 kDa protein was found to be part of a putative operon consisting of 
four genes, namely iglABCD for intracellular growth locus (Gray et al., 2002). The 23 kDa 
induced protein was identified as IglC, while the upstream gene iglA was identified as the 
other locus revealed by Tn mutagenesis. Three other Tn mutants were found at the genetic 
loci that encode the ClpB heat-shock protease, and the homologues of glutamine 
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phosphoribosylpyrophosphate amidotransferase (purine biosynthesis), and alanine 
racemase (peptidoglycan biosynthesis). 
 
The role of IglC in Francisella virulence has been studied for several years. IglC was 
demonstrated to be necessary for F. tularensis to survive in phagocytes (Golovliov et al., 
2003a). It also affects the escape of F. tularensis from the phagosome via a mechanism 
that may involve degradation of the phagosomal membrane (Golovliov et al., 2003a; 
Lindgren et al., 2004), and it is essential for the induction of apoptosis in host cells (Lai et 
al., 2004). 
 
6.1.2 The Francisella Pathogenicity Island (FPI) is essential for 
Francisella virulence 
With the completion of the F. tularensis Schu S4 genome (Larsson et al., 2005), two 
identical copies of a large (30 kb) gene cluster were immediately apparent (see Figure 6-1). 
Each gene cluster contained a low G+C content of 26.6%, in contrast with the genomic 
average of 32.2%. The cluster was named the Francisella pathogenicity island (FPI), 
because Francisella strains with experimentally induced mutations in FPI genes are highly 
attenuated in virulence and show defects in Francisella intramacrophage growth (Nano et 
al., 2004). FPI was the first pathogenicity island discovered in the Francisella genome. 
Interestingly, two clinically important Francisella subspecies, tularensis and holarctica, 
have two copies of the FPI, but subspecies novicida, which is avirulent in humans, contains 
only one copy in its genome (Nano et al., 2004). This may be one reason for the lower 
virulence of F. novicida. Currently, the functions of the proteins encoded by the FPI are the 
focus of much research (Oyston, 2008). 
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Figure 6-1 The Francisella pathogenicity island (FPI). A. Two large duplicated 
regions were identified by low GC content in F. tularensis subspecies tularensis strain 
Schu S4 (image from http://xbase.ac.uk). B. The organisation of two identical copies 
of Francisella pathogenicity islands were revealed from subspecies tularensis strain 
Schu S4 genome (Larsson et al., 2005). The leftmost scale shows GC content. Blue 
represents RNA encoding regions; green represents open reading frames encoding 
hypothetical proteins; brown represents pseudogenes; and pink represents IS 
elements. Open reading frame labels refer to the corresponding annotated gene or 
FTT (for Francisella tularensis subsp. tularensis) number in the genome sequence of 
Schu S4 (Larsson et al., 2005). 
S 
Large duplicated 
regions - low GC 
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B. 
GC 
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The Francisella pathogenicity island consists of a cluster of 16-19 predicted genes. 
Tellingly, the iglABCD genes are part of the Francisella pathogenicity island. Besides the 
igl genes, two other virulence genes, pdpD and pdpA (for pathogenicity determinant 
protein), were also found in the FPI. Interestingly, pdpD was found in the highly virulent 
subspecies tularensis, but not in the moderately virulent subspecies holarctica (Nano et al., 
2004). Over-expression of PdpD affects the cellular distribution of the FPI-encoded 
proteins IglA, IglB, and IglC (Ludu et al., 2008). Disruption of the pdpA gene rendered F. 
tularensis unable to grow in macrophages and avirulent in mice (Nano et al., 2004). 
 
Transcriptional regulation of the FPI genes is thought to be affected by two factors: MglA 
and MglB (for macrophages growth locus) (Baron and Nano, 1998). MglA and MglB are 
homologues of SspA and SspB from Escherichia coli, which are global regulators of the 
stringent starvation response, and SspA and/or SspB influence the levels of multiple 
proteins under conditions of nutritional stress in E. coli (Williams et al., 1994). There is 
experimental evidence showing that an intact mglA gene was required for transcripts 
containing pdpD, iglA, iglC, iglD, and pdpA to be expressed (Lauriano et al., 2004). A 
microarray analysis of gene expression found a total of 102 MglA-regulated genes, 
including all of the FPI genes (Brotcke et al., 2006).  In the strain lacking an intact mglA 
gene, the FPI genes were repressed by about three to six- fold. IglC, together with its 
regulator MglA, was reported to be essential for interfering with phagosome biogenesis 
and subsequent bacterial escape into the cytoplasm (Santic et al., 2005).   
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6.1.3 iglA and iglB are conserved and have the same organisation in 
many other bacteria 
IglA and IglB orthologues have been reported in a variety of animal, plant pathogens or 
symbionts, most of which are living intimately with eukaryote cells (Nano et al., 2004). 
These two sets of orthologues are each characterised by a conserved domain with unknown 
function (DUF), i.e. Francisella IglA possesses DUF770 and IglB possesses DUF877, 
respectively. Using the COG (Clusters of Orthologous Groups of proteins) 
(http://www.ncbi.nlm.nih.gov/COG/) classification, IglA has strong identity to members of 
COG3516 and IglB has strong identity with COG3517.  
 
IglA and IglB homologues are most often encoded within a conserved gene cluster,  
encoding what are known as IcmF-associated homologous proteins (IAHPs) (Das and 
Chaudhuri, 2003). Within IAHPs, the homologues of IglA and IglB are encoded adjacent 
to each other and organised in the same gene order. Some large IAHP clusters also include 
ClpB, an ATP-dependent protease. IAHP gene clusters contain about 15-20 genes 
surrounding an icmF-like gene (Das and Chaudhuri, 2003). The deviant G+C% content of 
the IAHP cluster suggests that these genes were possibly transferred in a phage mediated 
manner (Das and Chaudhuri, 2003). The icmF gene was previously reported to encode a 
structural component of the type IV secretion system (T4SS) in the study of Leginella 
pneumophila. The L. pneumophila T4SS was encoded by 26 dot and icm genes (refer to 
Chapter 1) (Sexton et al., 2004).  
 
Recently, Pukatzki et al. demonstrated that a set of genes named vas genes (for Virulence-
Associated Secretion) were essential for the cytotoxicity of V. cholerae cells toward host 
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macrophages. The IAHPs from Vibrio cholerae were identified as the components of a 
novel protein secretion system. It was named a Type VI secretion system (T6SS), in 
addition to other Type I-V secretion systems (Pukatzki et al., 2006). The vas gene cluster-
encoded T6SS mediates the extracellular secretion of four distinct proteins [Hcp 
(hemolysin-coregulated protein) and VgrG (valine-glycine-repeats G) -1, -2 and -3], all of 
which are lacking recognised N-terminal leader sequences and are secreted in a sec-
independent manner. However, it is not entirely clear whether Hcp and VgrG are truly 
secreted effector proteins or are actually components of the T6SS (Filloux et al., 2008). 
The full picture of secretion by T6SS has yet to be elucidated. However, the lack of T6SS 
in non-pathogenic organisms strongly suggests a crucial role of T6SS in imparting 
pathogenicity (Shrivastava and Mande, 2008). 
 
The T6SSs have been reported in many other bacteria, representing the SCI (Salmonella 
enterica centisome 7 genomic island) locus from Salmonella enterica (Folkesson et al., 
2002),the Imp (impaired in nitrogen fixation) locus from Rhizobium leguminosarum 
(Bladergroen et al., 2003), the HSI-1 (Hcp1 secretion island -1) locus from Pseudomonas 
aeruginosa (Mougous et al., 2006) and the Evp (Ed. tarda virulence protein) locus from 
Edwardsiella tarda (Rao et al., 2004). In the E. tarda T6SS, the secretion of EvpC, an Hcp 
homologue, and EvpP, a secreted protein with no homology to either VgrG or Hcp proteins, 
were mediated by 13 other evp genes (Zheng and Leung, 2007). The insertion mutants of 
either evpA or evpB led to the lack of secreted protein EvpC, suggesting a role for evpAB in 
extracelluar protein secretion (Rao et al., 2004). EvpA and EvpB have 25% and 30% 
identity to Francisella IglA and IglB, respectively (Rao et al., 2004). Furthermore, iglA 
and iglB have similarities to impB and impC from R. leguminosarum respectively, which 
 157  
are thought to be involved in temperature-dependent protein secretion. The impB-encoding 
protein was implicated in pathogenicity and protein secretion (Bladergroen et al., 2003). 
The study on T6SS gene components of V. cholerae demonstrated that VCA0107 (IglA-
like) and VCA0108 (IglB-like) are inner membrane proteins (Shrivastava and Mande, 
2008). Though the mechanism of their assembly was not known, VCA0107 and VCA0108 
were predicted to assist in stabilising the T6SS gene complex and in bringing about other 
intracellular activities essential for the functioning of the T6SS. In addition, IglA and IglB 
homologues have been identified in many other gram-negative bacteria (see Table 6-1).  
 
In order to define whether the Francisella pathogenicity island encodes a T6SS, both IcmF 
and DotU-like proteins were searched (Nano and Schmerk, 2007). Two FPI-encoded 
protein, PdpB and PigF, exhibited low homology with IcmF and DotU, respectively (Nano 
and Schmerk, 2007). The existence of an icmF-like gene (pdpB) and a dotU-like gene 
(pigF) and the conserved gene pair iglA and iglB suggests the existence of a FPI-encoded 
T6SS. Importantly, the high conservation of IglAB homologues suggests that these 
proteins could be the major requirement for a functional T6SS.  
 158  
Table 6-1 IglA and IglB homologues identified in other bacterial species. 
 
Bacterial species  Protein name 
(possess conserved domain 
DUF770) 
Protein name 
(possess conserved domain 
DUF877) 
Francisella tularensis IglA IglB 
Salmonella enterica SciH SciI  
Edwardsiella tarda  EvpA EvpB 
Pseudomonas  aeruginosa  PA0083  PA0084  
Vibrio cholerae  VCA0107 VCA0108  
Rhizobium leguminosarum  ImpB  ImpC  
EAEC AaiA AaiB 
Burkholderia mallei  TssA TssB 
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6.1.4 Aims  
Previous studies have shown the important role of the Francisella pathogenicity island, 
and the igl locus within it, in virulence. The most convincing candidate virulence gene, 
iglC, has been widely investigated. In this project, interest was focused on another two 
potential virulence factors, iglA and iglB.  These genes have homologues in many bacterial 
species, which occur as conserved gene pairs with the same organisation. In many cases, 
the conserved gene cluster has been associated with a type VI secretion system.  
 
It has been suggested that proteins encoded by conserved gene pairs are likely to interact 
physically (Dandekar et al., 1998). This led us to the hypothesis that IglA and IglB 
physically interact with each other. Additionally, the project aimed to express the two 
proteins in E. coli, to facilitate further studies and to gain insight into the functions of IglA 
and IglB.  
 
The development of a licensable vaccine is a priority for F. tularensis research. Located in 
the FPI, both iglA and iglB have potential as vaccine candidates. In addition, deletion 
mutants of these genes are worth investigating as potential live rationally attenuated 
vaccines. Since a method for the construction of defined Francisella mutants through 
allelic replacement has been developed (Golovliov et al., 2003b), this study aimed to make 
constructs of the two genes for mutagenesis, using a F. novicida strain, which is closely 
related to F. tularensis, but carries only one copy of the FPI. 
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6.2 Materials and methods  
6.2.1 Bacterial and yeast strains, genomic DNA and plasmids 
The genomic DNAs of F. tularensis subsp. tularensis strain FSC198 and subsp. novicida 
strain U112 were used in this project. The yeast strain Saccharomyces cerevisiae PJ69-4A 
was kindly provided by Dr. Gad Frankel (Imperial College, UK). The plasmids used in this 
study are listed in Table 6-2. 
 
6.2.2 Yeast two-hybrid screen 
6.2.2.1 Principle 
The yeast two-hybrid assay was developed by Fields and Song (1989), and has been 
widely used for studying protein-protein interactions. UASGAL is the upstream activation 
sequence for the yeast GAL genes, which binds Gal4 (Figure 6-2). Gal4 functions as a 
transcriptional activator, which is required for the expression of genes encoding enzymes 
of galactose utilisation. The process of transcription requires two separate but functionally 
essential domains for binding to UASGAL DNA (BD) and for transcriptional activation (AD) 
(Figure 6-2).  
 
Unless the BD domain physically binds with the AD, Gal4 cannot function as a 
transcriptional activator. The two-hybrid assay was prompted by expressing two fusion 
proteins: the Gal4 DNA-binding domain fused to a protein “X” (bait) and a Gal4 activating 
region fused to a protein “Y” (prey) in yeast. The physical interaction of the two 
constructed proteins, “bait” and “prey”, can bring about the fusion of BD and AD, which 
leads to transcriptional activation of a reporter gene (Figure 6-2).  
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Table 6-2 Plasmid list. 
 
Plasmid Description Reference 
pGAD424 oriColE1 ori2µ LEU1 PADH : : GAL4' activator domain : : MCS AmpR 
(Bartel et al., 
1993) 
pGBT9 oriColE1 ori2µ TRP1 PADH : : GAL4' binding domain : : MCS AmpR 
(Bartel et al., 
1993) 
pMal-c2 maltose-binding protein (MBP) fusions, malE gene deletion 
New England 
Biolabs 
pPV2J AmpR, CmR, sacB, mob (Golovliov et al., 2003a) 
pDONR201 oriPUC, Km
R, Gateway entry cloning by BP 
recombination 
Invitrogen 
Gateway system 
pDEST17 
bacteriophage T7 promoter, N-terminal 
polyhistidine (6xHis) tag, CmR, AmpR, 
Gateway destination cloning by LR 
recombination 
Invitrogen 
Gateway system 
pCR 2.1 
bacteriophage T7 promoter, LacZa gene, 
AmpR, KmR 
 
Invitrogen TA 
Cloning system 
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Figure 6-2 The principle of the yeast two-hybrid assay (Sobhanifar, 2003). BD, 
binding domain; AD, activation domain. 
 
 
BD 
AD 
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Following the yeast two-hybrid screen, measurement of β–galactosidase (β-gal) activity is 
an important step for indicating transcription of the lacZ reporter gene. β-galactosidase is 
encoded by the lacZ gene and able to hydrolyze (cleave) β-D-galactosides, which 
facilitates growth on carbon sources like lactose. In the assay, the substrate o-nitrophenyl-
β-D-galactopyranoside (ONPG) was used in place of lactose. β-galactosidase cleaves 
ONPG to yield galactose and o-nitrophenol, which has a yellow colour and absorbs light at 
420 nm.  
 
6.2.2.2 Methods and protocols 
In this study, two plasmids pGBT9 and pGAD424 are used as the binding and activation 
domains (BD and AD), respectively, of the yeast transcriptional activator GAL4 (Bartel et 
al., 1993). Both vectors carry ampicillin resistance genes. The constructs were introduced 
into yeast strain PJ49-4A using the high-efficiency lithium acetate transformation 
procedure (Geitz and Schiestl, 1995). The pGBT9 “bait” plasmid carries the yeast TRP1 
marker gene, so the “bait” constructs were selected on medium lacking tryptophan, 
whereas the pGAD424 “prey” vector carries the yeast LEU2 marker gene and the “prey” 
constructs were selected on medium lacking leucine.  The yeast strain, PJ49-4A contains 
three separate reporter genes, HIS3, ADE2 and lacZ. Therefore, co-transformants were 
replica-plated onto medium with the omission of tryptophan, leucine, adenine and histidine 
to select for activation of both ADE2 and HIS3 reporter genes (Creasey et al., 2003). 
 
The iglA and iglB genes were amplified from FSC198 genomic DNA using primers that 
were designed to create in-frame fusion proteins and incorporate BamH1/PstI sites at both 
ends (Table 6-3). The genes were then cloned into the BamH1/PstI sites of the yeast two-
hybrid vectors pGBT9 and pGAD424, respectively. Four plasmids with DNA inserts were  
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Table 6-3 Primers used in IglA and IglB study. 
 
Primer name Sequence (5’-3’)* 
Y2H-IglA-F AACGGATCCATGGCAAAAAATAAAATCCCAAATTC 
Y2H-IglA-R AAACTGCAGCTACTTATCATCTACTTGTTGATTACTTAAGTCT 
Y2H-IglB-F TCAGGATCCAGATGATAAGTAGAGAGGATTTTGTTATGA 
Y2H-IglB-R CTCCTGCAGTTAGTTATTATTTGTACCGAATAATTCTGGT 
attB1-IglB  GGGGACAAGTTTGTACAAAAAAGCAGGCTTGGTAAGTAGGGAGGATTTTA 
attB2-IglB  GGGGACCACTTTGTACAAGAAAGCTGGGTTTAGTTATTATTTGTACCGAATAA 
 
Mt-iglA-up TTGATCTAGAGCGGCTATGTGCTTCGATTTGT 
Mt-iglA-down TTTAGTCGACGGATGCTCAAGCAAAGCTTCAA 
Mt-iglB-up TTATTCTAGAAGGAAGATCTGTGGATGCAAAA 
Mt-iglB-down TCTTGTCGACCACCCATAAGTTCTGTTGGCTCT 
Inv-iglA-F TTTTACGTACTTATTGTCCTTTTTTTCACAACACC 
Inv-iglA-R AGATACGTAGTAGGGAGGATTTTATTATGAC 
Inv-iglB-F CGCTACGTAGTAAGAGGTTCCAACTTTCAC 
Inv-iglB-R CGCTACGTATTACGCCCCGCCCTGCCACTCATC 
Inv-cat-F CGCTACGTAGTAAGAGGTTCCAACTTTCAC 
Inv-cat-R CGCTACGTATTACGCCCCGCCCTGCCACTCATC 
* The restriction site in each primer is underlined.  
 
 165  
constructed at this stage: pGAD424-IglA, pGAD424-IglB, pGBT9-IglA and pGBT9-IglB. 
The in-frame constructs were confirmed by sequencing the fusion plasmids with the vector 
primers (sequence not shown; primers were kindly provided by Helen Betts).  
 
A positive control was set up by using co-transformant yeast with plasmids pGAD424-
EspD and pGBT9-CesD. A negative control was established by the combination of 
plasmids pGAD424-CesD and pGBT9-EspD. The plasmid DNAs for both controls were 
kindly provided by Dr. Helen Betts from our laboratory. Both the positive and negative 
controls had previously been shown to work successfully (Betts, personal communication). 
 
To measure β-galactosidase activity, the accumulation of yellow colour (increase in 420 
nm absorbance)/minute is monitored (Miller, 1972). The following equation was used to 
calculate units of enzyme activity: 1 Miller Units = 1000 x OD420 / (T x V x OD600). T 
represents the reaction time in minutes, V represents the volume of culture used in the 
assays, and OD600 reflects the cell density. OD420 is the absorbance of the yellow o-
nitrophenol. 
 
6.2.3 Protein over-expression and purification 
Proteins IglA and IglB were over-expressed in E. coli. An N-terminal MBP-IglA (Maltose 
Binding Protein) fusion protein was created. The gene iglA was cloned into the 
BamH1/PstI sites of the MBP vector, pMal-c2 (Table 6-2).  
 
The His-tag-IglB fusion protein was made following the Gateway cloning procedure 
(Invitrogen, UK). The iglB gene was amplified by PCR with primers attB1-IglB and attB2-
 166  
IglB (Table 6-3). The gene was cloned into the Gateway entry vector (pDOR201), and then 
sub-cloned into the Gateway destination vector (pDEST17). The fidelity of all the 
constructs was confirmed by DNA sequencing. Next each plasmid DNA was transformed 
into E. coli BL21 competent cells and the cells containing the plasmid DNA were 
subsequently induced by 1 mM Isopropyl-β-D thiogalactopyranoside (IPTG) at mid log 
stage. The over-expressed proteins were examined using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), with the gels being stained with 
Coomassie blue. Once expression of protein was confirmed by SDS-PAGE, and then 1 
litre of the culture was prepared for protein purification. The purified protein was 
subsequently used to raise antibodies in rabbits.  
 
Protein purification was performed using column chromatography methods, using amylose 
resin for the MBP fusion protein (New England Biolabs, UK) and Ni-NTA resin for the 
His-tagged fusion protein (The QIAexpressionist kit, Qiagen, UK). The purified proteins 
were analysed by SDS-PAGE and Western blots.  
 
6.2.4 Creation of constructs for mutagenesis 
A PCR strategy known as inverse PCR was used for making chromosomal mutants of iglA 
and iglB (Figure 6-3 i). Regions containing ~500 bp upstream and downstream of the 
iglA/B gene were PCR amplified from F. novicida U112 genomic DNA using Taq DNA 
polymerase and  primers Mt-iglA/B-up/down containing SalI and XbaI restriction sites, 
respectively (Table 6-3). The PCR fragments obtained were cloned into pCR2.1 vector by 
the TA cloning technique (Invitrogen, UK). The insertion was confirmed by sequencing 
using the vector primers (M13 pairs) and extracted plasmid DNA. 
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Figure 6-3 The strategy used to make the iglA/B constructs. 
iglA/B upstream downstream 
cat downstream upstream 
chromosome 
construct 
Chromosome 
Construct  
Double crossover 
iii. The chromosomal iglA /iglB gene will be knocked-out and replaced by the cat gene following a double crossover  
event. 
U/stream 
D/stream cat 
pCR® 2.1- TOPO 
SalI 
 
XbaI 
 
cat downstream upstream   SalI  XbaI sacB 
pPV2J 
ii. The strategy used to clone the construct into the suicide vector pPV2J. The successful construct will  
survive in the presence of both chloramphenicol and sucrose.  
 
Enzyme cut 
Ligation 
i. The strategy used to generate inverse-PCR products.  
cat 
   pGEM 
Inv-cat-F  
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         3.9 Kbps 
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Inverse PCR primers were designed to incorporate a SnaB1 restriction site at both ends of 
the PCR product (Inv-iglA-F/R and Inv-iglB-F/R, Table 6-3). Amplification of the cat gene 
from the pGEM vector was performed using the primer pair Inv-cat-F/R (Table 6-3), 
which also incorporated SnaB1 restriction sites at both ends of the PCR product. Once the 
two products are ligated, a new circular plasmid was constructed, containing pCR2.1, the 
upstream and downstream regions of iglA/B, and the cat gene (Figure 6-3 ii). After enzyme 
treatment to remove the pCR2.1 vector, the constructs were cloned into the suicide vector 
(pPV2J) at the appropriate restriction sites (SalI/XbaI).  
 
The vector pPV2J carries a sacB selectable marker, which is toxic for Gram-negative 
bacteria in the presence of sucrose (Golovliov et al., 2003b). The desired construct will 
survive in the presence of both chloramphenicol (selects for the cat gene) and sucrose 
(selects for the sacB gene). Following a double crossover event, the chromosomal iglA/iglB 
gene will be replaced by the cat gene (Figure 6-3 iii).  
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6.3 Results 
6.3.1 IglA interacts with IglB but only in one direction 
The interaction between the proteins IglA and IglB was examined using the yeast two-
hybrid system. The genes iglA and iglB were cloned into pGBT9 (bait) and pGAD424 
(prey) yeast matchmaker vectors. The following pairs of the fusion plasmids were co-
transformed into yeast strain PJ69-4A:  
• test 1: pGAD424-IglA and pGBT9-IglB 
• test 2: pGAD424-IglB and pGBT9-IglA  
• positive control: pGAD424-EspD and pGBT9-CesD   
• negative control 1: pGAD424-CesD and pGBT9-EspD  
• negative control 2: pGAD424-IglA and pGBT9 
• negative control 3: pGAD424 and pGBT9-IglB 
The negative controls 2 and 3 aim to exclude the possibility that any detected interaction 
occurred between vectors rather than the fused proteins.  
 
Co-transformants were firstly selected on MUHA plates, which lack leucine and 
tryptophan. The “prey” vector pGAD424 carries a gene LEU2, encoding a protein that is 
required for the synthesis of leucine, while the “bait” vector pGBT9 carries a gene TRP1, 
encoding a protein that is required for the synthesis of tryptophan. After three days, the 
colonies from the MUHA plates were replicated onto MU plates, which lack tryptophan, 
leucine, adenine and histidine.  The omission of two of the amino acids, adenine and 
histidine, results in the activation of the reporter genes ADE2 and HIS3 once the two fusion 
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proteins interact.  Only co-transformants in which protein-protein interaction occurs can 
grow on MU plates. It took four to seven days for colonies to grow on MU plates.  
 
Both the positive and negative controls gave the expected results. Protein-protein 
interaction between IglA and IglB was indicated by the growth of the co-transformant of 
pGAD424-IglA and pGBT9-IglB on MU plates. In this experiment IglA was the activating 
domain (“prey”) while IglB was the binding domain (“bait”). However, the reciprocal 
experiment, in which pGAD424-IglB and pGBT9-IglA were co-transformed, failed to 
show growth on MU plates.  
 
6.3.2 IglA and IglB were expressed in vivo in E. coli cells 
A previous study predicted the molecular weights of IglA and IglB to be 20 kDa and 55 
kDa, respectively (Golovliov et al., 1997; Gray et al., 2002). The sequences of the iglA and 
iglB genes are 591 bp and 1,545 bp in length, respectively. In this study, the iglA gene was 
cloned into a pMal-c2 vector to express an N-terminal MBP fusion IglA, while iglB was 
cloned into a Gateway expression vector, pDEST17, for expression of an N-terminal His6-
tagged fusion IglB. 
 
The constructs were confirmed by DNA sequencing. The confirmed fusion plasmids were 
then transformed into E. coli BL21 cells. Upon induction with IPTG, the MBP-IglA fusion 
protein was visualised as a strong band with a molecular weight of ~60 kDa on a 
Coomassie blue-stained SDS-PAGE gel (Figure 6-4A). Expression was subsequently 
confirmed by a western blot, using an anti-MBP antibody (Figure 6-4B). The molecular 
mass of MBP is about 40 kDa, therefore, the predicted molecular weight of IglA is about 
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Figure 6-4 A and B. SDS-PAGE gel and Western blot illustrating the over-expression 
of IglA-MBP fusion protein. Lane 1: uninduced cells. Lane 2: induced cells. Lanes 3-5: 
three fractions of purified IglA-MBP protein eluted from the amylose column with 
maltose. Lane M: molecular weight marker (Invitrogen, UK) with 29, 55, 66 kDa 
marked. Lane P: prestained protein marker (New England Biolabs).  
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20 KDa in this study. The purified fusion protein was eluted from an amylose column with 
maltose following the manufacturer’s instructions (New England Biolabs). About 3 mg of 
purified MBP-IglA was recovered after elution, and stored at -20oC. 
 
His6-tag fused IglB protein was visualised as a large amount of product with a molecular 
weight of ~55 kDa on an SDS-PAGE gel (Figure 6-5A). The result was confirmed by a 
western blot using rabbit antiserum directly against the His6-tag (Figure 6-5B). The His6-
tagged IglB was purified using a Ni-NTA affinity chromatography column following the 
manufacturer’s instructions (Qiagen, UK). However, purification was only possible using 
8M urea under denaturing conditions. This suggested that IglB might be insoluble and exist 
in inclusion bodies. More than 3 mg of purified IglB fusion protein was obtained, and 
stored at -20oC.  
 
6.3.3 Antibody production using the purified proteins  
Polyclonal rabbit anti-IglA and anti-IglB antisera were obtained from Eurogentec 
(http://www.eurogentec.com). These were produced by immunisation with the purified 
fusion proteins MBP-IglA and His6 tag-IglB. To test the activities of each antibody, anti-
IglA and anti-IglB were used as the second antibody in western-blot assays. IglA protein 
can be detected by the antiserum at a maximal dilution of 1:1250 (Figure 6-6). Protein 
dimers of IglA were detected, suggesting that IglA might be hydrophobic and prone to 
unfolding. Under this circumstance, the protein could aggregate even in the presence of the 
detergent SDS. 
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Figure 6-5 A. SDS-PAGE gel showing the over-expression of His6-tagged IglB. Lane 
P, prestained protein marker (New England Biolabs) with 37, 47, and 62 kDa marked. 
Lane 1, uninduced cells. Lane 2, induced cells. B. Western-blot illustrating the 
overexpression of His6-tagged IglB. Lane P, prestained protein marker (New England 
Biolabs) with 37, 47, 62 kDa marked. Lane 1, uninduced cells; lane 2, induced cells; 
lane 3, supernatant from cleared cell lysate; lane 4, flow-through; lanes 5-6, purified 
protein fractions under native conditions; lane 7 cells resolved in urea; lanes 8-9, 
purified protein fractions under denaturing conditions. 
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Figure 6-6 A. and B. SDS-PAGE and western-blot of purified MBP fusion protein 
IglA. The antibody used in the western blot was the polyclonal rabbit antiserum 
produced against IglA. Lane P: prestained protein marker (New England Biolabs) 
with 37, 47, 62 kDa marked. Lane M: molecular weight marker (Invitrogen, UK) with 
66 and 116 kDa marked. Lanes 1-5 represent dilutions of purified MBP fusion 
protein IglA as 2x, 10x, 50x, 250x and 1250x, respectively. A dimer of MBP fusion 
protein IglA was observed in both SDS-PAGE and the western-blot as a band twice 
the molecular mass of IglA-MBP. 
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IglB protein was not detected by a western-blot using the anti-IglB antisera. When testing 
the stock IglB protein by SDS-PAGE, protein degradation was apparent (data not shown). 
Therefore, a fresh culture of His6-tagged IglB was prepared from the cell lysate of IPTG-
induced E. coli BL2l cells. The induced fusion IglB protein was detected by SDS-PAGE, 
but not identified by a western-blot at this stage, suggesting that the titre for the anti-IglB 
product is very low
.
 It is likely that the stock IglB protein was degraded during 
transportation prior to antibody production. 
 
6.3.4 Construction of IglA and IglB mutants 
Two large inverse PCR products (about 6 kb in size) were obtained in this study (Figure 6-
7), consisting of the sequence of pCR2.1 vector and the sequence of iglA/iglB upstream 
and downstream regions. The obtained inverse PCR product was ligated with the cat gene 
using SnaB1 restriction sites. The constructed plasmid was transformed into E. coli Top 10 
cells and grown on LB agar plates in the presence of chloramphenicol to select for the cat 
gene.  
 
One construct was identified in which the iglB gene was replaced by the cat gene. The 
derived construct showed 76 bp of the sequence of pCR2.1 vector, ~200 bp of the 
downstream iglC gene, and ~600 bp of the cat gene (Table 6-4). However, the construct 
was not in-frame. iglB was not truncated completely from the junction of iglB and iglC, but 
partially, with the deletion starting in the middle of the gene, 308 bp from the start codon 
of iglC. Unfortunately, no iglA mutants were confirmed by sequencing, and further efforts 
to obtain this construct are required. However, a method for creating Francisella gene 
fusions was demonstrated here.   
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Figure 6-7 Gel image illustrating the inverse-PCR products and the cat gene. M 
represents the 1 Kb DNA marker (Hyperladder I, Bioline) with 1kb and 5kb marked. 
The inverse-PCR products inv-iglA and inv-iglB are ~6 kb in size and the cat gene is 
~800 bp in size.
M      inv-iglA    inv-iglB   cat 
1kb 
5 kb 
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Table 6-4 Sequence of a construct in which the iglB gene was replaced by the cat gene. 
The first 76 bp of sequence (shown in blue) correspond to the pCR2.1 plasmid, the 
next ~200 bp (shown in orange) is the downstream iglC gene, followed by ~ 600 bp of 
the cat gene (shown in grey). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
1      GATCGCCAGC TTGGTACCGA GCTCGGATCC NNNAGTAACG GCCGCCAGTG TGCTGGAATT 
61     CGGCTTTCTT GTCGAGCACC CATAAGTTCT GTTGGCTCTA TACTAATACT AAAAGCCTTA 
121    GCACTTATTG GATATAACTC TAAATTAGAT AGATCTATCA TAATACCCCA TGCTTCATCA 
181    GTTTTGTACT CTTGTTTTTT ATTAGAATTA CCTAACTTAA TTTTCATATC TGTAGCACTT 
241    GCTTGTAATA TGCTCGAAAC TTTCTCTTCA AGTAGTAAGA GGTTCCAACT TTCACCATAA 
301    TGAAATAAGA TCACTACCGG GCGTATTTTT TGAGTTATCG AGATTTTCAG GAGCTAAGGA 
361    AGCTAAAATG GAGAAAAAAA TCACTGGATA TACCACCGTT GATATATCCC AATGGCATCG 
421    TAAAGAACAT TTTGAGGCAT TTCAGTCAGT TGCTCAATGT ACCTATAACC AGACCGTTCA 
481    GCTGGATATT ACGGCCTTTT TAAAGACCGT AAAGAAAAAT AAGCACAAGT TTTATCCGGC 
541    CTTTATTCAC ATTCTTGCCC GCCTGATGAA TGCTCATCCG GAATTCCGTA TGGCAATGAA 
601    AGACGGTGAG CTGGTGATAT GGGATAGTGT TCACCCTTGT TACACCGTTT TCCATGAGCA 
661    AACTGAAACG TTTTCATCGC TCTGGAGTGA ATACCACGAC GATTTCCGGC AGTTTCTACA 
721    CATATATTCG CAAGATGTGG CGTGTTACGG TGGAAAACCT GGCCTATTTC CCTAAAGGGT 
781    TTATTGAGAA TATGTTTTTC GCCTCAGCCA ATCCCTGGGT GAGTTTCACC AGTTTTGATT 
841    TAAACGTGGC CAATATGGGA CAACTTCTTC GCCCCCGTTT TCACCATGGG CAAATATTAT 
901    ACGCAAGGCG ACAAGGTGCT GATGCCGCTG GCGATCAGGT TCATCATGCC GTTTGTGATG 
961    GCTTCCTGTC GGCAGAAGGT T 
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6.4 Discussion 
The intracellular lifestyle of F. tularensis is well characterised (Oyston et al., 2004). With 
the completion of the genome sequence of F. tularensis strain Schu S4 (Larsson et al., 
2005), many potential virulence-associated genes have been identified that are possible 
vaccine candidates. In particular, there is evidence that the gene locus iglABCD within the 
Francisella pathogenicity island (Larsson et al., 2005) is associated with virulence (Gray et 
al., 2002; Nano et al., 2004). Within this gene cluster, the conserved gene pair, iglA and 
iglB, shows homology to components of a T6SS (Nano and Schmerk, 2007). In this project, 
the proteins encoded by the iglA and iglB genes were investigated.   
 
In order to understand the structure and function of each protein, it is worthwhile 
determining which proteins interact with each other. This is important in revealing the 
relevant biological pathway among the extensive networks of protein partners. In this study, 
a protein-protein interaction between IglA and IglB was identified using the yeast two-
hybrid assay. The interaction was found in only one orientation, when IglA was the “prey” 
and IglB was the “bait”, suggesting that the C-terminus of IglA could physically associate 
with the N-terminus of IglB, but not the reverse. However, the experiments reported here 
do not provide evidence about the strength of the interaction, since a subsequent β-
galactosidase assay was not successful. The yeast two-hybrid control reactions were set up 
with two proteins, EspD and CesD, from an EPEC strain. EspD is a translocator protein, 
whose secretion is dependent on a T3SS, whereas CesD functions as a chaperone to assist 
EspD secretion in EPEC (Wainwright and Kaper, 1998). Thus, the interaction between 
CesD and EspD is essential for the secretion of EspD, as well as of another effector protein, 
EspB. Interestingly, the interaction between CesD and EspD could also occur in one 
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orientation only, when the N-terminus of CesD interacts with the C-terminus of EspD 
(Wainwright and Kaper, 1998).  
 
In addition to the yeast two-hybrid system, the interaction could be discovered or 
confirmed using pull-down affinity chromatography. In this study, IglA and IglB have 
been expressed as fusion proteins with MBP and His6-tag, respectively. The His-tagged 
IglB (the bait) can be used to capture its protein-binding partner, MBP-IglA (the prey) in 
this case. In other words, the two fusion proteins will be added to the same affinity column 
sequentially: first, allow His-tagged IglB to bind to the Ni-NTA resin, which generates a 
“secondary affinity support” for capturing other proteins that interact with it; second, the 
prey protein, MBP-IglA, is added. If IglA physically interacts with IglB, the proteins will 
bind to each other and form a large protein complex. Once the complex has been eluted 
from the affinity column, it can be identified by SDS-PAGE according to its molecular 
mass. To correctly interpret the results, it is important to set up control experiments. In this 
case, a negative control (IglB- and IglA+) could be designed to examine a non-treated 
affinity support, while a positive control (IglB+ and IglA-) could be used to identify 
whether the affinity support is functional. However, the problem with the pull-down 
technique lies in the choice of protein candidates. For example, if a protein-protein 
interaction is transient, any interaction might be temporary and as proteins tend to 
disassemble over time, it is relatively difficult to capture the protein interaction at the right 
time.  
 
In a recent study, the interaction between IglA and IglB from F. novicida was 
demonstrated  by performing immunoprecipitation (de Bruin et al., 2007). Using anti-IglA 
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antibody, a co-precipitating protein with a molecular weight of about 60 KDa was detected 
on an SDS-PAGE gel. This protein was found to be absent in control reactions with non-
specific anti-IglA antibody and in immunoprecipitations with an iglA null mutant (de Bruin 
et al., 2007). The co-precipitated protein was excised from the gel and subjected to 
sequencing analysis, which suggested it was IglB from F. novicida. In addition, de Bruin et 
al. discovered that knocking out IglB led to the loss of IglA expression, confirming their 
interaction. Besides the interaction between IglA and IglB, complex protein interaction or 
co-secretion among the four T6SS-encoded proteins IglA, IglB, PdpB and DotU might 
exist, but as yet it is not clear. Two FPI-encoded virulence proteins, PdpD and IglC, have 
been shown to require those four proteins for their surface localisation (Ludu et al., 2008). 
On the other hand, overexpression of PdpD affects the cellular distribution of several 
proteins, including IglA, IglB, and IglC (Ludu et al., 2008).  
 
It is possible to suggest roles for IglA and IglB based on the interaction between them that 
has been identified in this study. It is likely that IglA and IglB act as chaperones involved 
in protein secretion, and that their interaction helps to secrete Francisella virulence 
proteins, eg, PdpD (Ludu et al., 2008). Alternatively, IglA and IglB possibly function in a 
complex signaling mechanism, where their interaction might be involved in signal 
mediation or a two-component regulatory system. An IglB homologue, VCA0108 from V. 
cholerae, was found to belong to the quorum-sensing regulatory protein family 
(Shrivastava and Mande, 2008). This family also includes staphylococcal accessory gene 
regulator AgrB, a transmembrane protein. The staphylococcal quorum-sensing regulatory 
system can upregulate the expression of many secreted virulence factors, while AgrB 
appears to be involved in processing signals to other protein products (Yarwood and 
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Schlievert, 2003). However, the exact roles of both the IglA and IglB proteins remain to be 
elucidated.  
 
In this study, polyclonal antibodies to IglA and IglB were raised in rabbits. Western blots 
and immunoprecipitation are two main applications of antibodies. In western blots, the 
antigen-specific antibody can be used as primary antibody to form a primary antibody-
antigen complex. This complex is then identified by incubating the blot with a secondary 
antibody against the primary antibody, which is often conjugated to an enzyme (i.e. HRP) 
to facilitate detection. In immunoprecipitation, the protein antigen is precipitated out of the 
solution using an antibody that specifically binds to that antigen. These methods are useful 
to establish whether a protein antigen exists in a prepared solution, i.e. in cell lysate, or 
sub-cellular fractions (membrane, periplasmic or cytoplasmic fractions). Therefore, the 
recognition of a protein antigen by an antibody also helps to identify the location of that 
particular protein in bacterial cells. Alternatively, the enzyme-linked immunosorbent assay 
(ELISA) can be used to analyze soluble protein antigens (Hornbeck et al., 2001). In ELISA, 
as well as the presence of antigen, the concentration of antibody used to detect the antigen, 
can be identified.  
 
One aim of this project was to construct iglA and iglB knock-out mutants. If expressed iglA 
or iglB gene product contributes to Francisella virulence, the hypothesis would be that a 
null iglA or iglB mutant would lead to a degree of loss of virulence-related phenotypes 
under some experimental conditions.  
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CHAPTER SEVEN  
GENERAL DISCUSSION AND CONCLUSIONS 
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7.1 PCR-based comparative genomics  
The scientific value of genome sequences, combined with the increasing capacity and 
decreasing cost of sequencing, has led to great emphasis being placed on bacterial 
genomics over the past decade (Binnewies et al., 2006). The availability of multiple 
genomes from closely related organisms has led to the field of comparative genomics, a 
powerful approach to evaluate genomic diversity and the processes of genome evolution. 
The work presented in this thesis has contributed to the field of genomics both directly, by 
obtaining sequence data to help the progress of two genome sequencing projects, and 
indirectly, by developing methods to investigate genomic diversity and identify novel 
genomic regions without the need for complete genome sequencing. 
 
Many bacterial species have shown an unexpected degree of genomic diversity (Ohnishi et 
al., 2002; Yang et al., 2005; Stavrum et al., 2008). Although the genomes of most model 
strains have now been sequenced, they have captured only a fraction of the full extent of 
bacterial genomic diversity. There are increasing needs to create avenues for assessing 
genomic diversity and for detecting large-scale chromosomal differences. Currently, many 
bacterial sequencing projects are underway that will not only help to expand the number of 
available genomes, but also enable many comparative studies that will link genotype and 
phenotype at the genomic level (Schuster, 2008). In this thesis, PCR techniques for 
exploring genomic diversity were developed - Tiling-path PCR, Whole-genome PCR 
scanning and long Single-Primer PCR - that facilitated the discovery of differences 
between genomes, and the discovery and analysis of pathogenicity islands. These 
approaches are simple, relatively cheap, provide quick results, and represent a shortcut to 
obtaining genomic information from non-sequenced strains. For large scale comparisons, 
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the benefit is greater, since the same primers can be applied to large numbers of test 
genomes. 
 
The Tiling-path PCR and deletion-scanning PCR used in this study are principally the 
same as the previously described systematic PCR scanning (Ohnishi et al., 2002). In that 
analysis, eight E. coli strains from the O157 serotype were compared at the whole genome 
level by PCR scanning. Similar PCR-based approaches were applied in this project but 
extended to a wide range of organisms, including the phylogenetically diverse E. coli 
strains, Campylobacter jejuni strains and Francisella tularensis strains. The results 
demonstrated that the methods are applicable to different organisms. Furthermore, the 
studies on ETT2 and Flag-2 showed that the tiling-path PCR is a powerful tool in genetic 
comparison of a single locus. For instance, by combining with deletion-scanning PCR, the 
8.7 kb deletion found in an EPEC2 strain B171-8 was also confirmed in another 31 E. coli 
strains, suggesting they are evolutionally related. 
 
Long single-primer PCR was firstly reported in this project. The previous length limitation 
of single-primer PCR has been improved under long PCR conditions, including the use of 
long PCR DNA polymerase. The S-P PCR employed three sets of conditions: the first and 
third 30 cycles used a stringent annealing temperature, while the second 30 cycles used a 
low annealing temperature (Karlyshev et al., 2000). In this study, the second PCR step was 
reduced from 30 to 2 cycles. Since the DNA polymerase is prone to become inactive 
during long PCR cycles, the reduction at this stage is necessary to remain DNA 
polymerase activity for the next step. In addition, the decreased number of PCR cycles in 
the second step also reduces the non-specific amplification of primer to template, 
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producing relatively clean PCR products. The PCR sequencing using a nested primer 
described in the previous study (Karlyshev et al., 2000) was modified to incorporate 
cloning technique in this study. The advantage was seen in that sequencing can be 
performed from both ends with the plasmid primers. This is particularly useful for 
characterising large genomic discrepancies. With these improvements, S-P PCR has 
expanded its applications in genetic studies. For example, to resolve those regions with an 
uncertain large insertion or rearrangement following whole-genome PCR scanning, long  
S-P PCR can compete with other methods, such as the use of a bacterial artificial 
chromosome (BAC) library.  
 
Comparative genomic hybridisation to microarrays has been used extensively in bacterial 
genomics (Dorrell et al., 2001; Stabler et al., 2003; Butcher, 2004; Witney et al., 2005; 
Lindsay et al., 2006). However, unlike microarray-based comparative genomics, the PCR-
based methods described here allow the discovery and characterisation of sequences 
present in a reference genome but absent from the test genome. They also allow the user to 
detect differences in genome organisation, and to rapidly identify the regions of a test 
genome that are co-linear with the reference genome. Furthermore, the creation and use of 
the microarrays relies on specialised equipment and reagents and demands a high capital 
expenditure, whereas PCR is a routine procedure. 
 
In Chapter Three, the remnants of two E. coli Type III secretion gene clusters (ETT2 and 
Flag-2) were found to be present in most strains, both pathogens and commensals. Using 
tiling-path PCR, the study of the distribution of entire genomic islands was performed by 
several long inter-locking PCRs, allowing investigation across the full length of the islands. 
 186  
Application of the PCR approaches to E. coli has added value to the current genome-
sequencing programme, allowing quick determination of the extent to which novel findings 
in genome sequences are typical of the entire species. 
 
The genomic study described in Chapter Four obtained sequence information from a novel 
C. jejuni strain, M1, and compared the genome organisation and content to a reference 
strain, C. jejuni11168. The genomes were shown to be broadly colinear and regions of 
difference were characterised. This work has provided background information that could 
be used in the assembly of the complete genome sequence of C. jejuni M1.  
 
Chapter Five describes the complete genome sequencing of the European F. tularensis 
subspecies tularensis FSC198. The sequencing of this strain, together with resequencing of 
SNPs and VNTR differences in several additional strains, indicated the most likely source 
of the reported European isolates of F. tularensis subspecies tularensis to be the laboratory 
strain Schu S4. This project highlights the utility of bacterial whole-genome sequencing for 
the purposes of public health epidemiology. Whole-genome PCR scanning allowed 
confirmation of the conserved genome organisation and facilitated the finishing of the 
genome sequence.   
 
There are limitations to the PCR-based methods developed. In all case studies, there 
remained unresolved PCR results, and it is in the nature of PCR that a reaction can fail for 
many reasons, for example low quality of primers, the use of an inappropriate DNA 
polymerase, poorly optimised reaction conditions or the presence of SNPs in the primer 
binding site. Therefore, a failed PCR cannot be interpreted due to an absence of the target 
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region from the test genome. The supplementary experiments required to resolve these 
failed PCRs can sometimes be laborious.   
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7.2 Next-generation sequencing 
More than 30 years after its invention, Sanger DNA sequencing still remains the most 
widely used technology in research today (Sanger et al., 1977 a and b). However, it 
remains expensive, labour intensive and time consuming when applied to large-scale 
sequencing projects. For the last five or six years, the incorporation of Sanger sequencing 
methods into comparative study, which focused on studying genomic differences among 
closely related genomes, has helped in the production of a de novo, high-quality, finished 
assembly of a given genome (Brown, 2008).  
 
Now, the emergence of next-generation sequencing technologies is starting to make cost-
effective and high-throughput, high-capacity whole-genome sequencing a reality 
(Marguerat et al., 2008). The latest next-generation sequencing instruments can generate as 
much data in 24 hours as several hundred Sanger-type DNA capillary sequencers, but are 
operated by a single person (Schuster, 2008). These instruments enable the generation of 
millions of sequence reads in parallel, rather than 96 or 384 at a time by conventional 
capillary-based sequencing. Currently, three commercially available next-generation DNA 
sequencers are the Roche (454) GS FLX sequencer (http://www.454.com/enabling-
technology/the-system.asp), the Illumina/Solexa genome analyzer 
(http://www.illumina.com/pages.ilmn?ID=203), and the Applied Biosystems SOLiD 
sequencer 
(http://marketing.appliedbiosystems.com/images/Product/Solid_Knowledge/flash/102207/s
olid.html) (Mardis, 2008b). Another two systems were announced: the Helicos Heliscope 
(www.helicosbio.com) and the Pacific Biosciences SMRT (www. pacificbiosciences.com).  
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Although these instruments are diverse in both sequencing biochemistry and generation of 
the cyclic-array, the work flows of next-generation DNA sequencing are similar in 
principle (Shendure and Ji, 2008). The first is to generate a single-stranded DNA library. 
Libraries can be constructed by any method that gives rise to randomly fragmented 
genomic DNA, followed by in vitro ligation of common adaptor sequences. The library is 
therefore established without the prerequisites of cloning and colony picking as in Sanger 
sequencing, which limit the parallel scale of sequencing. The second is to generate 
multiple clustered DNA copies/amplicons serving as sequencing templates. To do this, the 
454 FLX, SOLiD and Polonator systems rely on emulsion PCR, while the Solexa system 
relies on bridge PCR. Emulsion PCR is performed by adding the library fragments into an 
excess of DNA capture beads, exemplified by the Roche 454 FLX system. Each bead 
captures only a single molecule. The PCR reaction is performed in water-in-oil 
microreactors, where PCR reagents are present and thermal cycling occurs. As a result, 
approximately one million copies of a single DNA fragment are captured on the surface of 
each bead (Mardis, 2008b). After breaking the emulsion, beads bearing clonal amplicons 
can be selectively enriched prior to the sequencing process. Another approach is called 
bridge PCR, in which both forward and reverse PCR primers densely coat the surface of a 
flow cell, and two primers are attached at their 5’ ends by a flexible linker (Shendure and Ji, 
2008). On the Solexa platform, the flow cell is an 8-channel solid device. The bridge 
amplification of fragments is allowed on the surface, followed by the addition of 
nucleotides and enzyme. As a consequence, all amplicons originating from any single 
template molecule remain clustered and immobilised to the point of origin on an array. 
Each clonal cluster consists of ~1,000 copies of a single molecule (Shendure and Ji, 2008). 
Within each of eight independent channels on a flow cell, several million clusters can be 
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generated to the distinguishable locations, which greatly increase the ability of sequencing 
in parallel.  
 
After clonal cluster generation, the next step is referred to as sequencing by synthesis. This 
is enzyme-driven sequencing by either a polymerase or a ligase (Shendure and Ji, 2008). 
Of the currently available sequencing instruments, the 454, Solexa and HeliScope are 
driven by DNA polymerase, whereas the SOLiD and Polonator are driven by DNA ligase. 
For instance, the 454 system uses the pyrosequencing method, in which the amplicon-
bearing beads are preincubated with Bacillus stearothermophilus (bst) DNA polymerase. 
Other enzymes required for pyrosequencing include ATP sulfurylase, luciferase and 
apyrase, and the substrates adenosine 5´ phosphosulfate (APS) and luciferin. The enzyme-
containing beads can catalyse the downstream pyrosequencing reaction step, which relies 
on the detection of pyrophosphate (PPi) release on nucleotide incorporation rather than 
chain termination with dideoxynucleotides (Shendure and Ji, 2008). In brief, each 
sequencing cycle is initiated by the introduction of a single nucleotide, driven by DNA 
polymerase incorporating correct, complementary dNTPs into the template. The released 
PPi will be converted to ATP in the presence of ATP sulfurylase and APS. This is 
followed by the addition of substrates (luciferin and ATP) to drive light production 
(Shendure and Ji, 2008). The light is detected by a camera and the 454 base-calling 
software can calibrate the light emitted. The unincorporated dNTPs and ATP are washed 
with apyrase and the reaction cycle restarts and keeps going. In this case, however, the 
calibrated base-calling cannot properly interpret long stretches (> 6) of the same nucleotide 
(homopolymers) (Mardis, 2008b). Therefore, these areas are prone to base insertion and 
deletion errors. Other methods, using either polymerase or ligase to generate DNA 
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sequencing, and subsequent in situ interrogation after each cycle by fluorescence scanning 
or chemiluminescence, have been reviewed (Lizardi, 2008; Mardis, 2008b; Morozova and 
Marra, 2008; Shendure and Ji, 2008). However, the read lengths produced by next-
generation sequencing are very short compared to Sanger sequencing. This shortcoming 
shows up the difficulty in de novo sequence assembly. Currently, the Solexa, SOLiD and 
HeliScope systems can yield only about 35 bp independent reads, and the Polonator 
produces even shorter reads of about 13 bp. An average read length of 250 bp produced by 
the 454 system is still much shorter than the ~1,000 bp achieved by Sanger sequencing.  
 
Although there is some limitation in read length and accuracy, the next-generation DNA 
sequencing technologies have many advantages relative to Sanger methods. In addition to 
its high degree of parallelism of sequencing, next-generation DNA sequencing has greatly 
reduced the cost for sequencing. Sanger sequencing costs $0.5 per kilo base now, while 
with the massive parallel Polonator and HeliScope systems, the sequencing cost is only $1 
per mega base (Shendure and Ji, 2008). Moreover, it is believed that, with the gradual 
improvement of other informatics technologies, such as computational system, data storage 
and interpretation, next-generation sequencing will have even greater potential and more 
applications (Mardis, 2008b). Next-generation DNA sequencing is transforming today’s 
biology (Schuster, 2008). The major impacts of next-generation sequencing on the fields of 
biology and genomics have already been seen. 
 
The applications of next-generation sequencing are rapidly revolutionising bacterial 
genomic studies. In the near future, bacterial whole-genome sequencing with the next-
generation techniques is likely to be routine and simple. For example, the choice of isolates 
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for current sequencing is usually biased on clinical phenotype or simply availability, rather 
than universal sampling from reliable phylogenies. But once sequencing a whole genome 
is straightforward, the selection of sequencing targets would be broadly expanded. For 
example, one can imagine a time in the near future when all ECOR strains have been 
completely sequenced. In such a future, one assumes that genomic studies will be totally 
different from the methods listed in this thesis, although some of these approaches will still 
be of use in the finishing stage of a genome project. With direct access to rapid whole-
genome sequencing, comparative studies will allow us to (i) align the sequence reads with 
the reference genome(s); (ii) evaluate them for single nucleotide and/or in-del variants, and, 
to a wide scale, for copy number variants in large sequence blocks (>1000 bases); (iii) 
detect the presence of antibiotic resistance genes or pathogenicity islands by comparing 
novel sequences to the publicly available databases; and (iv) evaluate any discovered 
variation in a functional and a biological context (Mardis, 2008a). With next-generation 
sequencing, comparative bacterial genomics is about to enter a new era of discovery. It will 
expand our view on bacterial diversity, of which nearly 99% is still unknown today 
(Snyder et al., 2009). Furthermore, next-generation sequencing is likely to be used for 
resequencing projects, such as for those strains and isolates from the large-scale reference 
genomes, eg. C. elegans, Drosophila, and human (Mardis, 2008b). Resequencing studies 
will help to better characterise and catalogue genomic variations within complex genomes. 
The current bottlenecks in effectively identifying SNPs, copy number variations and 
chromosomal inversions may be overcome. Furthermore, the field of "meta-genomics” has 
been launched where entire biological communities are sequenced, en masse, to survey the 
variety of all the organisms of an ecosystem where they live (Marguerat et al., 2008). This 
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helps to explore the influence of environmental and temporal changes over time on the mix 
of the microbial species within the community (Snyder et al., 2009). 
 
The short read length production of next-generation sequencing has developed new 
applications in which sequencing of a small fraction of a DNA molecule is required, rather 
than of the entire chromosomal DNA (Morozova and Marra, 2008). For example, next-
generation technologies were applied to transcriptome sequencing, such as mRNA 
expression profiling and non-coding RNAs discovery (Morozova and Marra, 2008). One 
application of the transcriptome studies is to annotate the genomes through the 
identification of expressed genes, which remains a challenge in high-throughput genome 
projects. Currently, the most commonly used method is based on microarrys. However, 
several limitations of microarrays remain in that the synthesis of DNA probes does not fit 
well with large genome size, and in the possibilities of cross-hybridization (Wold and 
Myers, 2008). The sequencing-based methods could bypass these technical problems of 
microarrays. The shorter read lengths produced by next-generation DNA sequencing are 
compatible with the length of small RNA and could certainly be utilised with these 
approaches.  
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APPENDIX I 
Primers used for whole-genome PCR scanning on the Francisella tularensis FSC198 
genome (primers were designed by Dr. Chaudhuri). Gene names and nucleotide 
position numbers of each primer are specified relative to the F. tularensis Schu S4 
genome.  
 
Primer 
name* 
 
Sequence of primers(5’-3’) Gene name Start 
position 
1F GCTCTGGCTGAATTAGGACATCAAG FTT0008 8042 
1R TTGGCGTTTTGTTCAAGGACTCGGT figD 25517 
2F GCCAAAGATGACAAAAGCGTTACCC FTT0025c 23789 
2R TCGGACCCTCCATTGATCCTTCTAA nuoL 41339 
3F GCTATGAGAATGGCGAAGAGAGATG nuoI 39298 
3R GACCTACACCGCCCCACATATATAA FTT0054 56449 
4F AGGGTTGGGATTATGGTTGCCTTTC FTT0053 55817 
4R TATGGCGAACTCCCAACAGATGAAC gltA 73283 
5F ATCCACCCTGATGTTCTTGCTAGAG gltA 72388 
5R GCTCTCTAAACCTTCGCCATAGTAC acnA 89650 
6F CGCACGCACCAAGGAAAATGGATAT hemN 87279 
6R TGCTCCACCTCCTCCTTTTAAGAAC FTT0101 104836 
7F CCACAACCAACTCCTTGCTTTGAAC isftu1 102826 
7R TCCGATGAGGATAGCCTACCTGTTA polA 120243 
8F GTTGCTAAGTACGCTGCTGAAGATG polA 119708 
8R CGCATACCTCCAGAAAACTCATGTG oppD 137110 
9F TGGTGGTTACTGGTCTATCCATCTG oppC 136521 
9R GAGCATCAGCAAGACACTCAAACTC rplJ 154035 
10F GAGCTTCAGTTCTGCCTAATGGTAC rplA 153126 
10R TGGCACTATACGCTCTTTTGAACCC xerD 170606 
11F TGGTAGATACGAAGGGGTTGATGAG trmD tRNA 169146 
11R GCTTATTGTCACACCCCATCTCATC isftu1 186436 
12F AGCTTGATGAGGTCATGGAAGGTAG prfA 184561 
12R GCTGCTGACTTAGGCGATAGACTAT ddlB 201601 
13F GGTCTGCATTGCTTGATACCAAGAG rpsA 199105 
13R CGCACCCGCCACATAAGCATATTTA blc 216684 
14F TGAGGCACAGGATCTGAACCATCAA glnA 215054 
14R CCTGCTGTGGTTTAACCTCTTGTAG priA 232301 
15F GGGACCACTACTGATGGGATTTGTA rbn 230627 
15R CTGGAGCATTTACAGGTGCGACAAT yidC 247996 
16F TGGGAACGATGCGAACAGGAATGTA yidC 247329 
16R TCCATCATCCCAGGCATAGAAACTC ppdK 264374 
17F GGCAAATCTTACTGGCTGCTCTAGT feoB 263189 
17R CGCCAGAACAGTTTGTTAGAGGCTA FTT0265 280504 
18F CAGCAAAGGTTTCTCGCACAAAGTG FTT0265 278779 
18R GCGATACTCAGCATTAGCACCATCA cyoA 295904 
19F AGCACACCAGCGATACCAAAGTGAT yajR 294223 
19R TACCCAAGAGCATCACAGAGACTAG FTT0297 311486 
20F GGCGTGATGTTGCTATAGGGCTTTT FTT0295 310205 
20R CCAATGTCAGCTCAAGTCTCAGATG FTF0311c 327685 
21F CAGCGTAGATGGACTTGCTTTTGTG FTT0311c 326958 
21R GCCTTCTTCAAACCAGGAACATCAC rpsN 344009 
22F TGGCGAGCTTGTAGACTTATAGGAC rplX 343123 
22R ACCAGCCTGACCATATCCAGCATTA FTT0360 360295 
23F CCTAAACCTGATGTCAGTCGTACTG FTT0359 359734 
23R GGCGACATAATTGGCATGGTAAGAG FTT0375 377023 
24F TGCCGAGCTTCCAATCTTATCAGGA FTT0375 376523 
24R GCTCTGCGGTTGTAACTCCTTCTTT map 394044 
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25F GCAAAGGACCCTGAAATATGGACTC FTT0389 392390 
25R CCCATTCATAACCGACATCACTGTG lolC 409628 
26F GGGGAAGAACAACGCTTGATTTAGC Intergenic region 409083 
26R CCCAACCACGTTGTAAATGGCGTAA glgC 426551 
27F CCACTTGAGGATTTTGGAGGGTTTC pgm 425363 
27R CGGCACAGCATTATCACCGTGAAAT thrB 442670 
28F AGCAGTTGGTGAGGGTATGAAGTCT thrA 440970 
28R CGCCCGTTTGTGAAACTGTATAGCT Intergenic region 458384 
29F GCATTGCCAAAAGCCCAAGTGTAAG FTT0442c 456143 
29R AGGCTACGAGGAAGACCTACCAATA FTT0455c 473301 
30F GCGAAGGCTACTCTAATGTCTATGG yfdH 471987 
30R GCTGCCCAATGCCCAAAGATTATCT apaH 489359 
31F GCGAAAGATTGATCCTAGCACACTG ksgA 488560 
31R ACACCATCCTCAACTTGCGAGAGAA mutL 506147 
32F AACAAGTTGGTGATGCCCATCTGTG mutL 505559 
32R ATTGGTCCTAACTGTCCAGGGATCA sucD 523018 
33F CGATGAGGAGGAGTATGCTAGATTG FTT0502c 522314 
33R ACCTTTATCGCCAGCAAATCCACAG FTT0516 539728 
34F TGTGCGTAGAGCTGTATTGCCTTGT FTT0516 538229 
34R AGGAACAGGACGTAGAAATGCTCAC nrdA 555298 
35F GGCGAAGGACAAGTTAAGCCATTTG FTT0531 552842 
35R AGCCCAAGTTCGCCAGCTAATTTAG FTT0551 570000 
36F GAGCTAAAACAAGCAGCGACTGATG vanY 567658 
36R GCTGGATGCTTAGCACTGACAGTAA FTT0567c 584734 
37F CCTGAGATAAACGCCTTGGCTACAA potI 582260 
37R CACCTGTTGCTTGACCTGCTAGATT fopA1 599790 
38F GGGACCAGTGCTTATGACAGATGTT FTT0580 598318 
38R AAAACCAACTCGCTCCCACTCTGTT FTT0597 615427 
39F AACGCTGTTGTACCTGTACCAGATG FTT0594c 613214 
39R CCTAAGTGATAGTCCTGCCAGTAAC FTT0611c 630751 
40F CAACCTCAAGCAGTATCCACCAGTT FTT0610 629491 
40R ACCTCACCTGTCATTGCCACATCAT lon 646774 
41F TCGAGTGGCGGTGATGTTGTAGAAA lon 644814 
41R AGTCCCAGAACCTTTTGGTGCTACT ilvC 662329 
42F GGTGCAAAGATGGGCGTCAAAGATA ilvB 661101 
42R ACCTCTGCTACTGTAGTTGCATCAC ruvA 678177 
43F AGGTCCAGCACATGGTTCAGTCTTT ruvC 676125 
43R GCTTCTCTTTGCGGCACGATGATTT FTT0676 693607 
44F GTTGGCAGATACATTGGAGCACAAG FTT0673c 691693 
44R ACCTCATCCGCCCCTCTTTTGATAA tyrS 709098 
45F TGTCCTAATGTGGCTTGACCATCAC hslV 706999 
45R AGCATCACGAGCTAAAGCAGCAGTA rumA 724344 
46F TACCACCACTACGCACGAGTAATAC rumA 723470 
46R GGTCACCCTCCTTTTGGTCATAATG dgt 740793 
47F CCACTTGGTGCTTGGGGATTTAGTT FTT0719 738744 
47R GCCTGTTTGACAGCCACCATATTAC FTT0734 756123 
48F GCCAGGTAGTGACGAAGAAATCAAG FTT0733 755363 
48R ATTCGCTCTGGTAGCACTACAGGTA FTT0750 772884 
49F CCAAACCAGTCAACACAAGCCTGTA FTT0749c 771482 
49R ACGGCTTCTTTGAACTTGCTGCTCT secA 788892 
50F TGGAGACAGCGGCTTTATTTGCTAC deoD 786508 
50R TTGCCTTCACCTTGAGCTATTGGAC FTT0784 803592 
51F GGAGCCGAGCTTGCTTTTACTTATG fabI 801646 
51R CGCATCATCCCAAGCATAGTTGAAC FTT0800 818870 
52F TCAGCAAAACTCTGGGCAGGCATTA FTT0798 816847 
52R TGGCAGAATGGGACGTTGATGATAC FTT0816c 834131 
53F CTGCTCCAGCAAGTTCACTTGAGAT FTT0814c 833218 
53R TACCCTCAAACTCCTCAACCTCTGT ispH 850725 
54F CGTGCTGTTGAGACTGTAGAGAAAG ispH 849888 
54R GGATTACCAAGAGGACTCATCACAC FTT0853 866965 
55F AGCTGGTGGATATGGTGGCTATGAT FTT0852 866157 
 196  
55R AGAGCAAGTAGGCTGTAAGGCAAGA FTT0874c 883583 
56F CCGACCTTTACAAGAGGCTGAACTA FTT0872c 881575 
56R TGCTCTAGGTGGTGCTAAAGCTACA FTT0890c 898868 
57F GTACGTTGTTGCCATGCGTTTAGAG FTT0887c 896725 
57R CGCAAAGATGTTGTGCAAGAAGAGC topA 914267 
58F GGATGGTGAGGTTGTTTCCGAAGAT lpnB 911817 
58R CCAGATGCTGTTTGACCGAAAGTTG FTT0918 929197 
59F AGTGGAGCCTCTTCAACAACACAGA FTT0918 927828 
59R TCTCCCTCCGTTTCTGACCATTCTA FTT0932 944899 
60F AGACCAGTTGGTTTAAGAGGCTCTG FTT0930c 942503 
60R CCCTGTAATGATTGCGATGGCAGTA FTT0947c 959730 
61F GGCGGTATCACGGTATATTCGGATT FTT0945 957478 
61R TATGGGACTACCGTGTGCAACTGAA aroG 975023 
62F AAAGCAATAGAGGGTGGCTCGTATG FTT0960 972681 
62R AAGGCTAATGTGGTCGATGGCAGAA FTT0979c 989977 
63F GGTCCATGTAAGACACTAGCACCTA trxA2 987951 
63R CAACACGCCAAGCATAGTCATCACT FTT0995 1005266 
64F GACCACGCCAAATTACTGCTGATTC FTT0994c 1004313 
64R CGCTCACCGACAGGATTATGATAAC FTT1009 1021526 
65F GGCTCAACCTTACCTGCTGTTACTA FTT1006 1019488 
65R GGAACTGGTGTAAAGGGAAACTCTG FTT1026c 1036851 
66F CGCTCACCACCAGATAAACTCATAC yhbG 1035444 
66R TTCCCCAGCGATCATAAGAGTCAAG FTT1040 1052555 
67F TTGGCTCAACTAAAGCAGGTACGGA dacB1 1051965 
67R GCTGCTGAAACGACTTACTCTCTAG dnaB 1069496 
68F CGTGCCTGGATATGGATTAAATGGG FTT1058c 1067181 
68R TGACGGTATCCTTTCAAGGGCATAG FTT1072 1084480 
69F GTGGAACTCACAGGCAAAACCTTGA Intergenic region 1083474 
69R CGGATGAATGTCGATATCAGGAGAG FTT1091 1100632 
70F CAGCTATTGTTACAGCACCCCTTAG Intergenic region 1098786 
70R TGCGGTACACCACTATTTAGAGCTG msrA1 1116275 
71F TGGAGGTTTGACTGGTGGCTTATGT bcr1 1114992 
71R CTGCGTTATTGGAGGGTTGTGGTAA FTT1122c 1132514 
72F CCCTCTTCTGTTAGCTTACGCATCT tgt 1130857 
72R TCGCATCACCCATTTGAAACATCGG pilC 1148237 
73F AGGCGATGCAATAATAGGTAGTGGC pilB 1145765 
73R ACCGCAGATGTGATACGTTCAGCTT putA 1163354 
74F AGCTGTAGTCAGAACACCATCACTC FTT1149c 1161201 
74R GATGGGTAAATGGACAGAGCTAGAG era 1178521 
75F CCCCATTACGTGCTTTCCATAGAGT FTT1162c 1176283 
75R TAGGCACCGTAATCAAGAGCAGATG FTT1177c 1193637 
76F GCGTGGAGTCTTTGTATCATCTGAG hsdR1 1191774 
76R TGGCAAAGACAGATGATGGCACCAT FTT1192c 1209250 
77F AATCGCCCTTTCCTGCTGCTGTTAT xseA 1206834 
77R ACGAGGAGGCGTACCAGTTTTAAGT gidA 1224129 
78F AGCTACACAAGTAACCCGCACTAAG FTT1203c 1221836 
78R CGCTAGTAAAACCAACCATCGGTAC FTT1220 1239345 
79F GCAACCTTATCCCACAAACCAAGTG ubiH 1237831 
79R TGTTTGGGTGTTGGCGTGATAAGTG lpcC 1254976 
80F CCGTTTCTGGTAGAACTATGGAGTG FTT1234 1253053 
80R CGAGCCAACATTAAGCCCAGAGATA FTT1249 1270251 
81F GTCGCAAACAACTTCCCAACTAGAG FTT1247 1268450 
81R TGGTGCTCAAGGATGCGTGGAAATA FTT1263c 1285485 
82F GCTCTGCTTGACCAACCCATATCAT FTT1261c 1283223 
82R TAGCAGACACTTACCCTGATGTGAG ptsN 1300768 
83F TCGACACCTTCAAGAGCCTCTTCTA yfhQ 1300185 
83R GCTTGGTGTTGGTGGGTTAATCAGA FTT1292c 1317606 
84F TGGCGTCACTATCTTCTGCTTAGGA FTT1291 1317045 
84R GCTGGTGTTGATGAAGCCAAAGAAG hflB 1334418 
85F GTTTTACTGACTTGCCACCACTACC hflB 1333275 
85R GTTGCTAGAGCTAAAGAGGGGTTAC FTT1322 1350325 
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86F CGTGCCTCTTAGTATTGGTTCAACG FTT1320 1347901 
86R GCCCATAAGTATTGCTGACCATGCA cydC 1365491 
87F TCTCGTGGCTAGGACAAAACTCATC cydD 1364906 
87R CTGCGATTGAGCTTTCTTCTGGCTT pdpA1 1381969 
88F AATGGCGACACAACCTCTTCTTCTG pdpA1 1380031 
88R CAGCCATCAGCTATACGTTCGAGAT FTT1355 1397408 
89F CAGGATTGGTCCAAGATGGAGAGAA pdpC1 1395354 
89R GCTGGTGGAGCATTCTTAGAGTTTC pgk 1412849 
90F TAAGCACCATGCGAAGTACCGATAG fbaB 1410703 
90R TACCAGCAACGATCAAACCAGAGTC suhB 1427838 
91F CAGGCACTGCTCTTTCTACTACAAC FTT1380 1425732 
91R CAGCGAAACCCTATCTTAGCCTCAA FTT1395c 1442962 
92F TGCCCTGTAGCTCACCTTTTCCTAA recB 1441772 
92R TCGCCCTCAGAATGATGCTGTCAAT hemD 1458828 
93F TAGCACTTACACTCGCCACTCTACT FTT1407c 1457593 
93R AGTGGCTTCTTTGGTGCAGGACTTT FTT1426c 1475096 
94F TCAGCTTTGCTTTCGCCACCGATAA FTT1424c 1472987 
94R CATCGTGAGGGGAAGGAGTTTTATG FTT1443c 1490396 
95F CCCGTTTCAACACCTTCTGCTAAAG rpoA2 1489471 
95R TGACGAGCCCTTTGCTGATTCATCA wbtH 1506548 
96F CGGAATACCAAACCCCATCTTAGAC wbtH 1505882 
96R GGCGTGAAGGCACGTCAATTTCTTT deaD 1523179 
97F GCGTAGTTATCCTTGCCTATGTCAG gmk 1522280 
97R GCGAGGTTTTGTCACAGGGTATAGT FTT1486c 1539687 
98F GGAACTGCCAATAAGTCGGTTGTAG aceE 1538363 
98R CGGCTATAAGATAATCTGCGGAAGC FTT1501 1555584 
99F CTGGTCCAAATATGGGCGGTAAATC muts 1554085 
99R CTTTTGTTGTCGTTGTCGCTGCTAC FTT1517c 1571349 
100F CCACCAACGATCATCAAATGCTCAG merA 1570378 
100R TAGGGTGGCTATAGGAGCTAATGTG fadE 1587902 
101F GCCATTATGTTACCCAACCTGCTAC fadD2 1585742 
101R GCCTCATCGTTGCTGGCAATTTCAT FTT1539c 1603262 
102F CCATCTTGACGAACCTCATAGACAC FTT1538c 1601034 
102R TCGGTTTGCCTGGCGATGTAATTTC lepB 1618302 
103F CCGTTCCATCAAGATGAGGTTTGTC truB 1616418 
103R CATTTACCGCAGCGTATGCAGATAC ompH 1633576 
104F GTCCAGCTAGACCAACACCATTTAC lpxA 1631158 
104R TACGATCAAAGCCTGTGCTGGACTT Intergenic region 1648303 
105F GCTGTTGTCGGCTTTGGGTTACTAA FTT1582c 1646976 
105R CCCCACTAAGATATACATACGGTGC FTT1598 1664422 
106F CTTGGGGTGGTGTATCGTATATGAC FTT1598 1663535 
106R CCGCACCATCACCTTGCTTGAAATA cysS 1680731 
107F TGGCGGTTCTGATCTTAGATTCCCA cysS 1680175 
107R GCGACAAGGGTACTATGGCATTTAG FTT1633c 1697515 
108F CGATACGACCAGCTTGACCTTGAAT FTT1632c 1696946 
108R TGCTATGCGGAGCTGGTCTTAATCT FTT1649 1714253 
109F GCTAGGCAGTTTTGCATACCTGTTC Intergenic region 1712382 
109R CAGGCATAGTATAGTCAGAGGTAGC carA 1729871 
110F CGAAAGGCTGAAGGAATGACTGAAC tmpT 1727435 
110R GTGGTAACCCCAGCTTTTCGTAACT FTT1676 1744912 
111F GCACCATGATGAAAGCTGCTGAACT ribA 1742810 
111R CCACAGTCCATATAGCCGCTAATTC FTT1690 1759918 
112F TGCTACACCAACAGGCATACTAGGT FTT1688 1757906 
112R CTGCGATTGAGCTTTCTTCTGGCTT pdpA2 1775313 
113F AATGGCGACACAACCTCTTCTTCTG pdpA2 1773375 
113R CAGCCATCAGCTATACGTTCGAGAT FTT1710 1790752 
114F CAGGATTGGTCCAAGATGGAGAGAA pdpC2 1788698 
114R ATTCGCCAGTGGATTGGAGTAGATG purF 1806209 
115F GCACACCTTGTGGAGATTTCTCAGT purL 1805235 
115R AGCCTAATGCTAGAGCTGCTATGAG fopA2 1822673 
116F GCTATGTAAGCCCTGCTGTGGAATA FTT1732c 1821283 
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116R TTTGGCGTAAGTGCAGCAACAGAGT recA 1838698 
117F GCCAGAACTGCACACAGACCTAAAA secB1 1837883 
117R GATCGCCAGGGTATAAGAGCTTTAG purT 1854960 
118F GCAGAAGCAGATGGCTGTAATGTCT purT 1854326 
118R TTGCCACCTTGGGATGCTGATGTTA yjjK 1871777 
119F CCTAGCCTTTCTCCAGGTGGAATAT yjjK 1871275 
119R AGGTGTTTATGGCGGAGCTATAGGT trpE 1888788 
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APPENDIX II 
Primers used for finishing stage to sequence the Francisella tularensis FSC198 
genome (primers were designed by Dr. Chaudhuri). Gene names and nucleotide 
position numbers of each primer are specified relative to the F. tularensis Schu S4 
genome.  
 
Primer 
name 
Sequences (5’-3’) Gene name C 
strand* 
Start 
positio
n 
End 
poistion 
 
Primer1      ATCAATGAGCAAGCAAGTTTTG dnaN  1921     1942 
Primer2      GCAGGGCTATTTCCTGTTAGAA FTT0003c c 2874     2895  
Primer3      TTCTAACAGGAAATAGCCCTGC FTT0003c  2874     2895 
Primer4      TGTTTAAGTTTTACAAGCGAGGC gabD1 c 4101     4123  
Primer5      CTCTGGCTGAATTAGGACATC FTT0008  8044     8064  
Primer6      CCCGTCTCCGTTAGTATTAT FTT0010 c 9024     9043  
Primer7      GGTATTAAAGAGGTTCCGGATG FTT0011  9934     9955  
Primer8      TTCAAGAGTGTATGTAACTTCAAA FTT0012 c 10875    10898  
Primer9      ATCATTTGTATACTGGCCGAGG FTT0024c  22738    22759 
Primer10     CATGGACAGGTGGAATAACAAA FTT0025c c 23692    23713  
Primer11     GTTTGCATGCTTGATATTTGGA FTT0028c  27206    27227 
Primer12     CAGCAATGCTTTTCTCTCCTTT FTT0028c c 28154    28175  
Primer13     TTCGGGTTGCTTAGGATTAAAA FTT0056c  58942    58963 
Primer14     ATGCTTAGTTTCAAAAGCTCGC FTT0057 c 59910    59931  
Primer15     GTGCCTATCTTGTTCAAAAGGG FTT0057  60029    60050 
Primer16     ACGACCAAGTAACATTCCACCT atpE c 61105    61126  
Primer17     ATGGTTAAGCCTTTTTGGTTGA qseC  97724    97745 
Primer18     AACGAAGAGGATGGTCAGAAAA qseC c 98685    98706  
Primer19     CCTTTTATGGCAAGAGAAAAGA FTT0097  101867   101888 
Primer20     GTTCAAAGCAAGGAGTTGGTTG isftu1 c 102830   102851  
Primer21     TTCTTGGAATATCAGGGGCTAA isftu1  102717   102738 
Primer22     TTTGATTTACAAGGGATAACAGC isftu2 c 103650   103672  
Primer23     TTGTTGTCAGAGGATAAAACTCA isftu2  103512   103534 
Primer24     AATCTGTAGCAGCACAAGCAAA FTT0101 c 104583   104604  
Primer25     TCAATTTTAGTTGGTGAGGCTG Intergenic  105878   105899 
Primer26     AAGCTTTAAGCCTTGTTGCTCA FTT0102 c 106778   106799  
Primer27     TTCAACACAGCTTTCTCAGCAT nupC1  124764   124785 
Primer28     CCTGTTTCATAATCAGCATGGA nupC1 c 125678   125699  
Primer29     TTTTACAATCTGAAATCTCAAAAC glpK  143242   143265 
Primer30     ATTATTCAAAGGATAGTAGCAA Intergenic c 144420   144441 
Primer31     GGTTGTCGATGTGTCTGAAAGA FTT0136  149112   149133 
Primer32     TTGTACCTACGTTTACATGCGG tufA c 150075   150096 
Primer33     ATGGATGAAGGGTTACGTTTTG tufA  151149   151170 
Primer34     CCGATTTAACAAGATTCCAAGC nusG c 152123   152144 
Primer35     TTCCAATTTTGCATTTTATCGG FTT0170c  185687   185708 
Primer36     AACACTAGCCTCAAAATTCTCCA FTT0172 c 186955   186977 
Primer37     TTGCTGAAAAATATCAACGCTT FTT0179  195130   195151 
Primer38     CTTGCGGATAATTGTACTGCTG FTT0180 c 196055   196076 
Primer39     TAACCCTAAGGCAGGTGGAATA FTT0180  196506   196527 
Primer40     GTTCTAGTCGGAGTTGTTGCCT FTT0181c c 197526   197547 
Primer41     AGATCAATAAACGCACCGAAAT rpsA  199526   199547 
Primer42     GTTGCCTAGCTTTAATGCTGCT FTT0184 c 200499   200520 
Primer43     AAAAACTTTTCTTTTAAATTTCCC Intergenic  218631   218654 
Primer44     ATGGTCTTGACTCTTTTGCAGC FTT0201 c 219804   219825 
Primer45     GCTGCAAAAGAGTCAAGACCAT FTT0201  219804   219825 
Primer46     CCAAATACAAGACCAGATAAAGGC FTT0201 c 220711   220734 
Primer47     GCACAAAGAGAACTCAAGAATGG rbn  231088   231110 
Primer48     GCTTTCCGACCTGAACTAAGAC priA c 232062   232083 
Primer49     CATCTTAAGCGTAATAATGTGT priA  233967   233988 
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Primer50     CAGATTGGCCTTTTGTATTTCA FTT0217 c 235145   235166 
Primer51     TTGAGCTCTTTATTATCGCCGT FTT0220c  237199   237220 
Primer52    TACAAATTTTGGCTCACCCTCT acpA c 238129   238150 
Primer53     TAGTGAAGATTCTGCTTCTACC FTT0225c  242416   242437 
Primer54     CAAAGAGCCCAAGAGTTAGCTT FTT0227c c 243591   243612 
Primer55     CCGATGATCTCGATACAATGAA htrB  245855   245876 
Primer56     TTCCATACAAAATGCTAATGCG ddg c 247127   247148 
Primer57     ATCACCAGCAGGATCAAAATCT yidC  248242   248263 
Primer58     AGTAAGAAAACAGCAGCCCAAG rnpA c 249187   249208 
Primer59     CTAAAAACTGTATTTTTGAGCA Intergenic  259257   259278 
Primer60     ATTCACCATATCTTGGATTGGC Intergenic c 260490   260511 
Primer61     AGGCTGCTATAGCTCAGCAAAT leuA  269113   269134 
Primer62     CCTACTAAATGCTGACATCCTCT Intergenic c 270342   270364 
Primer63     TCGGACCTCTATCAGAAGCAAT FTT0268  283374   283395 
Primer64     CACGAGGATAAATAATCCCCAA FTT0268 c 284288   284309  
Primer65     TTTGCAATCACTTTTACTTTTGA FTT0272  287246   287268 
Primer66     GCTAGTGCGGTACAAAGTGCTA FTT0274 c 288511   288532  
Primer67     ATTAATGGCGCGATAATACCAC FTT0274  288576   288597 
Primer68     CGATCGATTTTATTAGCCCATC FTT0275c c 289459   289480 
Primer69     GCCAATTGCTAAACAAAAAGTTG cydA  293084   293106 
Primer70     AGTTTGATAATGGCAGAGCCTA yajR c 294162   294183 
Primer71     TCTAAGTTTGTTCTGGCACTTCTT cyoC  299173   299196 
Primer72     AGCATACGAATGAGGAATTTGC cyoE c 300137   300158 
Primer73     TGGGACCATATATCTTGCATCA FTT0308  323610   323631 
Primer74     AATGACTATATTTTGCTATCAACC Intergenic c 324773   324796 
Primer75     GGATTTGGGAGCATTTACTCAG pyrH  330731   330752 
Primer76     ATCAACACTCGAGACCGAATTT uppS c 331634   331655 
Primer77     GAAGATCAATGATTGTGCCAGA rpsS  340259   340280 
Primer78     TTGAGCAACACTTTCAGCAACT rpsC c 341141   341162  
Primer79     GAGCAATCGTTGAGCCTCTAGT rplQ  350748   350769 
Primer80     AATCAGGCAGCATATTCAAGGT isftu2 c 352283   352304 
Primer81     AGAAAAGAAATTCTCTATCAAATG isftu2  352178   352201 
Primer82     TGACACCAATTCTCTAATTCAAAA FTT0354 c 353134   353157 
Primer83     TGGACAGATAGACCAGAAGAAATG
GACAGATAGACCAGAAGAAA 
FTT0354  353027   353048 
Primer84     TGGACAGATAGACCAGAAGAAATG
GACAGATAGACCAGAAGAAA 
FTT0354 c 353982   354003 
Primer85     TGTTTTACATTTAAATTTCGGT Intergenic  353741   353762 
Primer86     GGAGGTGTTAACCAATCCATGT htpG c 355307   355328 
Primer87     ATCATCTTCGTTTAAAGCTGCG htpG  356994   357015 
Primer88     GATCCAATGGCTTTTGTTAAGC FTT0358 c 358228   358249 
Primer89     TAGCACACATAAGTCCAGCAGC FTT0362c  363214   363234 
Primer90     GAAATATACCTATTCGGCGGC FTT0364c c 364480   364501 
Primer91     TGCCTCAGGTCATGACTTACTT poxF  365715   365736 
Primer92     TGGTATTGTTCCATACAGAGCG gshA c 366619   366640 
Primer93     TGTTGTTAGGTGGGGTGTAATG gshA  366861   366882 
Primer94     TTAGCTGAAGGTGTTTGCGATA gshA c 367816   367837 
Primer95     ATACAGGAAGCAGATTTTGGGA FTT0369c  369798   369819 
Primer96     AACTTTGCTGCTCTTTGGTAGC FTT0369c c 370749   370770 
Primer97     TCATCATATGCAACTTTGGAGC Intergenic  378631   378653 
Primer99     TCCAGATATATCAAAAATCTCCC isftu1  379487   379509 
Primer98     GGCTATTTCAATCAGCTTAGAGGA isftu1 c 379596   379619 
Primer100    CAGCGGATATACCAATACTGAAA FTT0378c c 380419   380442 
Primer101    TTCTTTTCATAATATAGCTGGCAA FTT0378c  380317   380339 
Primer102    TCTATTAGCTCTCGACCAGTTTG Intergenic c 381283   381305 
Primer103    CACCAGTGTTTAAAATCTTTATG Intergenic  381172   381195 
Primer104    AGCAATGATGAAAATAAGTTGAGA gdh c 382131   382152 
Primer105    CAAATCATGGCTAACATTTTCC gdh  383337   383359 
Primer106    CGCTATCAATGTACTTCTGAGCA Intergenic c 384788   384809 
Primer107    CTAAATACTCGTTTCCGTTGGC Intergenic  385204   385226 
Primer108    TTAAATCTTCAATGTGTTTTGTT psd c 386679   386701 
Primer109    TTAGTTGAAGCTAAAGAAACCGA glmU  389997   390018 
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Primer110    AAGAGGGTGCTGTTATTGGAAA glmS c 390879   390900 
Primer111    CACCGCAACAATTTTATCAGAG pulB  420198   420219 
Primer112    TGGATAAACTTGCTGACCATTG pulB c 421168   421189 
Primer113    GCAGCAAAGGTATTAATGGGAG pulB  422259   422280 
Primer114    GCTTGGATGCGAAACCTAATAC glgB c 423194   423215 
Primer115    CTCTTGGCCAGATATTTCAACC glgB  423690   423711 
Primer116    GTAGGTTGATAGCCCCATGAAG pgm c 424639   424660 
Primer117    GTTGATACAGTTTGAATCGCCA malP  430724   430745 
Primer118    GCTATATCCAAAACCTGAACGC malQ c 431649   431670 
Primer119    ACCAGCAAAAGAAGAGCTTGAC FTT0424  438026   438047 
Primer120    ATCCAAACAATCAGGTTATGCC asd c 438993   439014 
Primer121    TGCCTAGTGGACAAACAAAAGA speA  447323   447344 
Primer122    TAGAGAAGTGTCGCTTGGTGAA FTT0434 c 448296   448317 
Primer123    ACTGCTCCACCCTCTAAAATCA yjfH  453023   453044 
Primer124    CAGTCAATGCAACGGTTAAAAA Intergenic c 454200   454222 
Primer125    AATTTAGCAAGAAAATCACAACT FTT0443  457332   457355 
Primer126    CTAAAAGAATAAGTTACAAAGAGC tet c 458400   458421 
Primer127    CAAGCGCTGTAGATAATCCCAT Intergenic  472838   472859 
Primer128    TTCAGAGTGGTGTTTCGATAGG FTT0455c c 473773   473794 
Primer129    TCCTAGCTCAAAAATCGTCAGC FTT0474  492504   492525 
Primer130    TACTTCAGCAGTTGCCTCAAAA msc c 493394   493415 
Primer131    GAGTTCGACGTGATGTTGTTGT poxA  494336   494357 
Primer132    TTTGCATTTCCTGCATTAGTTG birA c 495271   495292 
Primer133    GGCGATAAATGGATTTCTGAAG perM  497552   497573 
Primer134    CAGCTAAAAGGACCGCATAGTT xasA c 498526   498547 
Primer135    TGTTTTGGCTGTTTAGTAGCGA FTT0496  516548   516569 
Primer136    ACCAGATATAGCGCCAATGACT FTT0497c c 517495   517516 
Primer137    TAATTGCAAATGATGAAGGTCG Intergenic  519981   520002 
Primer138    AGTGAGCTTTTTCTTACGGCAG FTT0501c c 520910   520931 
Primer139    TGCTTGTCGGAACTATGATGAC FTT0505  525087   525108 
Primer140    CAGGTGCATTTGTTGTTGCTAT FTT0505 c 526065   526086 
Primer141    GTCGGCAATCCTAATAAAGCAG FTT0512  533876   533897 
Primer142    TCAAGTCTTTGGGAGTTGAGGT lldD2 c 535453   535474 
Primer143    TCTAAACGCTTGCTCATTCTCA FTT0516  538234   538255 
Primer144    CGTAGAGCTGTATTGCCTTGTG FTT0516 c 539116   539137 
Primer145    ACCGGTGTTTTCCCTAATACCT FTT0517  540665   540686 
Primer146    AAATGGCTTAATTGGTTCAGGA prmA c 541554   541575 
Primer147    TATAACCAAGCTGCTTCCCACT FTT0525  547805   547826 
Primer148    GAAAGAGCTTTTGTTGATGCAG FTT0527 c 548980   549001 
Primer149    AGGGGCAAAAGATTTTCTACTG vanY  567575   567596 
Primer150    AAAGAGCATGAGCTTATTTCGG FTT0550 c 568534   568555 
Primer151    TGCTTCATTCCTTCAGCAAGTA FTT0550  568846   568867 
Primer152    CAATGGGTATGGGTAGAGTGGT FTT0551 c 569821   569842 
Primer153    AAAACTGGCTTATCATCAGGGA FTT0553  573064   573085 
Primer154    GCTCTACCAAGGTTTTGTTGCT FTT0555 c 573981   574002 
Primer155    AAAGCCTCTGCAAATGGATAAA Intergenic  578095   578118 
Primer156    TTTTATCAGACTTAATCCATTTGA Intergenic c 579337   579358 
Primer157    GACTCGACAACTTCGATAAAGC potI  582250   582271 
Primer158    ATGGTCCTACGCCTGAGATAAA FTT0566 c 583425   583446 
Primer159    CCCCATCCTTTAACATCTTTTC FTT0572  589757   589778 
Primer160    TTCACCATGTGGATTTGAATGT alr c 590675   590696 
Primer161    ATCAAGCTCTTTGGCTATTTGC fdx  599096   599117 
Primer162    GCATTTCGAGGAGTCTCAATGT fopA1 c 600161   600183 
Primer163    AGCTTTATCATAAGCAAACTTAG FTT0584  604079   604100 
Primer164    TTAACTGATGGCGATTTTGATG FTT0585 c 604974   604995 
Primer165    CCGCATAACCCTCGTAACTAAG FTT0585  605030   605051 
Primer166    ATTTTTATCAGCGAGTTTTGCC FTT0586 c 605953   605974 
Primer167    CGGACAAAAACACCATTGTCTA Intergenic  606650   606671 
Primer168    TTCAGACGTGTCAAACAGAGGT aroA c 607824   607845 
Primer169    ATCTGTGATTTTATTTGAAGGA FTT0594c  612898   612919 
Primer170    TCGTTTGATTACCACTGACACC rubA c 613786   613807 
Primer171    AGATTGGGAATGTCCTGACTGT FTT0597  615037   615058 
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Primer172    ATTTAAAAGGAGCGGGCTTAAC FTT0597 c 615969   615990 
Primer173    CGGCAGACTTAAGTGCTTTTTC FTT0602c  621081   621102 
Primer174    TTTGTCTTTTAATGCCCGATTT FTT0602c c 622012   622033 
Primer175    CAGGTAACAATAGCATCCCCAT FTT0604  624131   624154 
Primer176    AAAGAGTTTAATAGTTTTTGGTCT FTT0606c c 625191   625213 
Primer177    TCAAAGATTACTGCCCTAATGGA FTT0612  631591   631612 
Primer178    TGTTGCTGCTAGAGGAATGTGT Intergenic c 632504   632525 
Primer179    AAGCAAAAATCCTGGTAATCCA FTT0619  638772   638793 
Primer180    TTGGCAGTACTGTCTTGAGCAT FTT0620 c 639690   639711 
Primer181    CTTTTTGCTCAATTATCCCCTG lon  645861   645882 
Primer182    GCCTGGTCAAATTATCCAAAAG lon c 646747   646768 
Primer183    CTGTCATTGCCACATCATTTCT hupB  647130   647151 
Primer184    CTAGATGCTACTATTGCGGCAG FTT0628 c 648009   648030 
Primer185    TTTGTAAATCTTGTTGGCTTGG FTT0651  671470   671491 
Primer186    GCGATAATCCAGTACATGCAAA FTT0651 c 672365   672386 
Primer187    TCCATCTTTAGGAAGAGCAACC FTT0668  685435   685456 
Primer188    TCTGATAGCAAATGTCATCGGT FTT0669 c 686373   686394 
Primer189    TTTGCCCTAGACGAGTCTTCAT prsA  692239   692260 
Primer190    AAAAGATCATCAGCAGAGAGGG rplY c 693176   693197 
Primer191    GATACCGCTTCTTTTTCACCAC Intergenic  694757   694779 
Primer192    AATGTGACACTGCTCTTGTATGA FTT0677c c 695647   695668 
Primer193    AGTTTGGTAATTCTGCAAACGA sthA  701447   701468 
Primer194    TGTGGGTCATACTCAACTCCAA Intergenic c 702488   702510 
Primer195    TTCAAATATTAACCAACCAAAAA Intergenic  710349   710370 
Primer196    TTTCAGCGATTATTAGTGCGAT mutM c 711595   711617 
Primer197    TTTTTGTAAAAAGTGTCAGAAAT udk  721341   721362 
Primer198    GGTGGTTCTGGTTCTGGTAAAA tRNA-Val 
(TAC) 
c 722310   722331 
Primer199    GCTTTTTAAATCATGGTGGGTG FTT0719  738726   738747 
Primer200    TGTTGGTTATATTGTACGCCCA FTT0719 c 739653   739674 
Primer201    TATTGTCAATGCTGGAACACCT Intergenic  743956   743977 
Primer202    AAAGCCATAACTAAGGATGTTA Intergenic c 745223   745244 
Primer203    GATAATGTCAAAGCATGGCAGA ybhR  752941   752962 
Primer204    TGCCATCGATATTACTGTCAGG Intergenic c 754109   754130 
Primer205    ATCTATGCAATGCTGATTGGTG FTT0744c  767705   767726 
Primer206    TAAATGCTAGCCAAAGTCCGAT FTT0746c c 768628   768649 
Primer207 AACTTTGAAAAACCATGCAACC glyS  784463   784484     
Primer208    ATTTTGCTGCGAGAGTAGAAGC deoD c 786009   786030 
Primer209    ATCGCCTGGCATAATTACTGTT FTT0778  798945   798968 
Primer210    AGACTTGGTATTTGTATTTTACAT Intergenic c 800122   800144 
Primer211    TCGTTCTCAGCTAAAGTAACACG FTT0793  812649   812670 
Primer212    TGAGGCTAAGGTTTGGAAATGT FTT0794 c 813566   813587 
Primer213    CCTCAAAAATAGCATAGTCCGC FTT0796  814908   814931 
Primer214    CGTAAAATAAAATTATCTCTTCGT FTT0797 c 815886   815907 
Primer215    TCTAAACCCACATTTCTTGCAC FTT0797  816282   816303 
Primer216    ATTTTCAAAGACCGACAAGCAT FTT0798 c 817256   817279 
Primer217    CGCTGATAATAAAAATAACGCACA FTT0799  818484   818505 
Primer218    CGGGGTTGTATTTTGATCCTTA Intergenic c 819430   819451 
Primer219    CACGGGGCTCTCTTAAATACTG capB  825630   825651 
Primer220    TTTGCTAATGCTTTTGCTGCTA FTT0807 c 826565   826586 
Primer221    TAGCGCGATAAAAATTTACGGT FTT0807  826694   826715 
Primer222    TAACTAACGACGCATTTGCATT FTT0807 c 827607   827628 
Primer223    ATGACCTGGTGGTGTGACAGTA spoT  829265   829286 
Primer224    TCGTGGCAAAGATATAGTCGAA recR c 830186   830207 
Primer225    CTCCACTAGATGGCATAGGTCC infC  837187   837206 
Primer226    ATGCTAATCCGCCAGTGTGT FTT0821 c 838464   838485 
Primer227    TCCAAATAAAATTCCAGCTAAA FTT0821  838866   838887 
Primer228    AGGATTATTAACTTTGTTGGCA Intergenic c 840116   840137 
Primer229    TTGCAATCATAAAAAGTTCTCA FTT0830c  847315   847336 
Primer230    AGCGTAATGGTCCTGTTCCTAA FTT0831c c 848250   848271 
Primer231    GTTTCACAACAACTGCCAGAAC tolB  854874   854895 
Primer232    TTATCAAAAGCTTACGGGCAAT FTT0841 c 855846   855867 
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Primer233    ACTACCGTTTGCATTAGGCATT FTT0846  860262   860283 
Primer234    CAAGTACAAATGCAATCTGGGA FTT0847 c 861151   861172 
Primer235    ATCATAATTCCACTGTCCACCC FTT0855c  868347   868368 
Primer236    CATGGAGTGCTTTTAAACATGA ubiA c 869291   869312 
Primer237    GTGGCCAACACTTACAGCATTA FTT0866c  876412   876433 
Primer238    ATAGCCTTCGCAGTTGCAGTAT FTT0866c c 877548   877571 
Primer239    CATTGGTAAAGGTGTAACTGGAGA FTT0874c  884057   884078 
Primer240    CATCAATGCGTTGTTGAGATTT aroC c 885026   885047 
Primer241    AGCAAGGCTTTTTATCAAACCA FTT0890c  898802   898823 
Primer242    CTTGAGATGCATCACCATTGTT FTT0891 c 899737   899758 
Primer243    AGTTGCTAAGATAAAACCGGCA FTT0900  909786   909807 
Primer244    GTGTTGATTTTATGGCGAGTGA FTT0902 c 910742   910763 
Primer245    TTGTAGTTGGTCTGCTTCGAGA FTT0902  910742   910763 
Primer246    TCTCGAAGCAGACCAACTACAA lpnB c 911710   911731 
Primer247    ACTACAGCCTGCTAAAGTTGCC lpnB  912113   912134 
Primer248    GAGCTTGCTAAAGCCTCTCTTG FTT0905 c 913065   913086 
Primer249    AAGCCAGCATAAACTAAAGCCA maeA  927093   927114 
Primer250    AATTGCTGCAGGTAGTCCATTT FTT0918 c 928045   928066 
Primer251    CTTTACTCTCACCATTGCCTCC FTT0919  930643   930664 
Primer252    TTTTCTAGCAGCTTCAGGGATT Intergenic c 931916   931937 
Primer253    CGTAATTTCTCTCGATTACGCC Intergenic  931970   931991 
Primer254    CACCTTTAGAGGCGAGAGAAAA FTT0922 c 932917   932938 
Primer255    TCACTCCAATAGCCAGTGCTAA FTT0933  945325   945346 
Primer256    AGCGTAGATGGATTTCACCATT bioD c 946207   946228 
Primer257    CTCTTTATTGAGGGTGCTGGAG bioC  947216   947237 
Primer258    GCGAACTTGATTTTGAATAGCC bioF c 948160   948182 
Primer259    CAACAGTTTGAACATGAGTTTGC bioA  950071   950092 
Primer260    TGCTGGGGGTATGTTGATTTAT add1 c 950996   951017 
Primer261    AGCAATTTATCTAGCCGTCCTG add1  951251   951272 
Primer262    GATTTCCGAACTCATAGCCATC FTT0940c c 952312   952333 
Primer263    TTGCAACTGGTGGTGAGATAGT folK  953957   953978 
Primer264    CTTCAATCGATATAGGCTTGGC folB c 954924   954945 
Primer265    AGTCTTGGTTGCTCAGGAGAAG FTT0945  957369   957390 
Primer266    GAGTTTATACCGGAAGCATTGG trpG1 c 958259   958280 
Primer267    CATCGACACTTGATAGCCAAGA rhlE  964325   964346 
Primer268    CCAAAGACTTCTTGATCAACCC rhlE c 965253   965274 
Primer269    TTGCCTCAAAGCCTTCTAGTTC FTT0953c  965589   965610 
Primer270    ATAGCAGCAATTACAGCGACAA FTT0953c c 966544   966565 
Primer271    GCTTTAGATGGGGCTATGACAC FTT0967c  978884   978906 
Primer272    TTTTCTAATTTGAGTAAAGCGCC FTT0968c c 979853   979874 
Primer273    ATGATTTCACCTGCAAGAGGAT Intergenic  988455   988476 
Primer274    TGCTTGTGAACTTGGTCAAGAA FTT0978c c 989352   989373 
Primer275    CGTGATGTTTTTGCTTATTCCC FTT0979c  989681   989702 
Primer276    AGGTATCAAAGGAAATCCCCAT FTT0979c c 990613   990634 
Primer277    TCAGGATTCCTAACAGGTTGGT FTT0980  991896   991917 
Primer278    CATTAACTAAAGCCTTCGGTGG FTT0981 c 992826   992847 
Primer279    ATGCATTATCGTGAGCTCCTTT FTT0989  997564   997585 
Primer280    TCACTGTTAACGAGCCAGAAAA FTT0989 c 998629   998650 
Primer281    ATCCATGGTGTTGATAGTGTCG FTT0991  1001797  1001818 
Primer282    ATTCTGGTACACAGCTTGCTCA FTT0992 c 1002769  1002789 
Primer283    CACGCCAATTTTGGACACTAT FTT0996  1006138  1006159 
Primer284    CATGGATTTTGGCGATATTGTT FTT0996 c 1007016  1007037 
Primer285    TGAAGTAAATCAAGCGATGGAA FTT0996  1007006  1007027 
Primer286    CCCTATTTAATTCCATCGCTTG ybhO c 1007923  1007944 
Primer287    GCAGATTCAATTGCTTGCATAA ybhO  1007918  1007939 
Primer288    AGCTTTTATGCAAGCAATTGAA ybhO c 1008859  1008880 
Primer289    TTTTGCGTTGAGTCAGCTAAGA ybhO  1008363  1008384 
Primer290    CACTTTGCGACAAATCAAGAAA FTT0998 c 1009263  1009284 
Primer291    CATATTGCTCATCAAAAGCAGC FTT1008c  1020911  1020932 
Primer292    AAAATCTCTGGCAATTGCTTTG FTT1010 c 1021830  1021851 
Primer293    ATCTCCAGGTTGACATTCAAGA FTT1015  1025217  1025238 
Primer294    CCAGCTTTAGATGTGTTTCGTG FTT1016c c 1026190  1026211 
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Primer295    TTGGTGATAGTCTCACAGCAGG FTT1025c  1036098  1036119 
Primer296    CCTTTTCGCCACGATATACATT FTT1026c c 1037065  1037086 
Primer297    AAACATGCTCAGCAATTAGCAA lipB  1040660  1040681 
Primer298    AAGCTTGGTGCCAAAAAGTTAG FTT1032 c 1041585  1041606 
Primer299    GCCAATATGGGAGATAAACCAA Intergenic  1057601  1057622 
Primer300    GTTGGCGATGGAAGTGTAGATT FTT1048c c 1058579  1058600 
Primer301    TGAAATTGGTGATCAAAAGCAG Intergenic  1062932  1062953 
Primer302    ACCATCTGCACCAAAAGAAGAT rimI c 1064461  1064482 
Primer303    GATGGTAGTCAAAGTGATGCGA rpsF  1070558  1070579 
Primer304    CCTTTTTCTTCGATTATGCCAC hemF c 1071503  1071524 
Primer305    TTCAAATATTTCGCCACCTTCT Intergenic  1073046  1073067 
Primer306    CCAGCACAATCAGATGGATTTA Intergenic c 1074290  1074311 
Primer307    TGTTAGTAATGCGTATGCTCGC Intergenic  1074285  1074306 
Primer308    TACTTGCGAGCATACGCATTAC res c 1075256  1075277 
Primer309    TCTTACCATAGCACTGGCGATA FTT1073c  1084855  1084876 
Primer310    GAGCTTTAGCTTGATCTGGCAT Intergenic c 1086329  1086351 
Primer311    GCTTGCTTTAGACTTCTTAGCTG Intergenic  1086875  1086896 
Primer312    CCCTTTGGTCTTTACTTGTTGC hipA c 1087781  1087802 
Primer313    CATCATTTTATCTTGAGCACCG rdgC  1093050  1093071 
Primer314    TACCTTGGCATGATATGTTTGC FTT1085 c 1093975  1093996 
Primer315    TGCAACAGTACCATTGATTCCT rep  1097372  1097393 
Primer316    GCTGCCTGCTCTTCTAATTCAT FTT1088c c 1098341  1098362 
Primer317    AAAAAGTACGGGATGTTTTCCA FTT1091  1100780  1100801 
Primer318    TTCAGCATTTGATGGTTTTGAC talA c 1101748  1101769 
Primer319    ATCTCCAGTTTTGCTTGAGGAG FTT1110  1121173  1121194 
Primer320    TCACCTTCATCATGAGCACAAT rpoH c 1122345  1122367 
Primer321    GCCAAATTGAAGAAGATGCTCTA yajC  1127020  1127041 
Primer322    CTCCTTGTGCAAATGAAGTTGA FTT1117c c 1127997  1128018 
Primer323    AGAGTGCTCCAAAGTATCTCCG metN  1134275  1134296 
Primer324    GCACTTGCACTAAATCCACTTG metIQ c 1135236  1135257 
Primer325    GTCTTTTAATTGCTCCCATTGC phrB  1151248  1151269 
Primer326    TCGTCAAGATTTACGCTTAGCA phrB c 1152132  1152153 
Primer327    TCTGTCCTTTTTGCCATTTCTT FTT1140  1153576  1153599 
Primer328    GAAAGCATACTATAAAGCCAAAGA FTT1141 c 1154752  1154773 
Primer329    ATGCTACCTCTCCTGTATTGGT hsdS  1187690  1187711 
Primer330    AGTTGTTGCCACATCATCAAAC Intergenic c 1188641  1188662 
Primer331    AAAATAACGGATACAAGGGCAA Intergenic  1189157  1189178 
Primer332    CTCGGCTTTTCAGGTTTCTCTA hsdR1 c 1190050  1190071 
Primer333    GGCGAGGGAGTTTCTACTTTTT FTT1201c  1220088  1220109 
Primer334    CAATCGGATCTTGGGTATCAAT FTT1202 c 1220966  1220987 
Primer335    TAGCAACAGTACGTAAAGGCGA FTT1209c  1228498  1228519 
Primer336    CAATCTCATTCATTTCCGGATT FTT1209c c 1229405  1229426 
Primer337    TAGCCAGGGTTCTCTTGGTTTA FTT1209c  1229569  1229591 
Primer338    AATTTGCTAGTGGTTTTAAGCCT FTT1211c c 1230826  1230847 
Primer339    TTGGTGCATACTTGCTTTTGTT FTT1213  1231794  1231815 
Primer340    GCAGCAAACATCCAAGTTAATA FTT1214c c 1233172  1233193 
Primer341    GAAACTTTTCCCACAAAGTGCT FTT1220  1239199  1239220 
Primer342    ATAAAACATGGGCTTTGGTTTG dedA2 c 1240080  1240101 
Primer343    TGAGAATTCGTGCGTGTGTACT rne  1243672  1243693 
Primer344    AAACAAGAATTGCCACCCTAGA rne c 1244606  1244627 
Primer345    AAGTTGACGAGCAACTTCTTCC mesJ  1250227  1250248 
Primer346    ATCGTGGCAGAAATAAGCCTAA yjdL c 1251399  1251420 
Primer347    GTTGTTCCAAGGGCTATTTACC yjdL  1251418  1251439 
Primer348    AACTGCGCCTGCTTAATTAGAT yjdL c 1252310  1252331 
Primer349    TTATACTTGGGTGGGAATTTCG yjdL  1252310  1252331 
Primer350    CGAAATTCCCACCCAAGTATAA FTT1234 c 1253283  1253304 
Primer351    TTTTTGATATTCGGCAAATCCT FTT1236  1256083  1256104 
Primer352    TGATGAAATTGAAAATGCCAAC FTT1237 c 1257024  1257045 
Primer353    ATGGTAGCGATTTAATTTTGCG FTT1238c  1257898  1257920 
Primer354    AAACAATATAGCACTTAGACTGA FTT1239 c 1259041  1259062 
Primer355    CAGAAATTCTTCCCGTCAGAGA FTT1239  1260071  1260092 
Primer356    ATGAAGATCCGAATGAATACGC glyA c 1260986  1261007 
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Primer357    CTTTTACCATGATAGCCTTCGG glyA  1261923  1261944 
Primer358    AACGACGAGAGGTTTCAAAGAG FTT1242 c 1262838  1262859 
Primer359    ACTGAGCGATTTTCTCTTCAGC FTT1252  1272553  1272574 
Primer360    TCAAAAAGCTACCGAACTAGGG FTT1253 c 1273437  1273458 
Primer361    GTTTAGCGCCAAGAACTTTGTC FTT1253  1273213  1273234 
Primer362    AGGAGAAAATGCCTATGCAAAA FTT1253 c 1274114  1274135 
Primer363    GACATGCCAACCAAATACAGAA FTT1261c  1283453  1283474 
Primer364 AATCATCAAGAACGTCAACACT Intergenic c 1285027  1285050   
Primer365 GGCGGTATTATTCAACTATTTCCT Intergenic  1284867  1284889    
Primer366 CTCGGATTAACTATAAACCAAGA FTT1263c  1285821  1285843    
Primer83     GATTGATTTGACACCAATTCTCT FTT1263c c 1285938  1285959 
Primer367    GAAATTCTCTATCAAATGTCTTTC isftu2 c 1286779  1286802 
Primer368    TCCATGCTATGACTGATGCTTT isftu2  1286537  1286558 
Primer369    AGGTGATTGATGAAAGCGAGAT yhhW c 1287877  1287898 
Primer370    TCAAATCCATAATGAGGCATGA yhhW  1288354  1288375 
Primer371    CTTTGCTATGCCTAAGCCATCT FTT1267 c 1289309  1289330 
Primer372    AGTTGCTGAACCCTTGATGATT FTT1284c  1302959  1302980 
Primer373    TCGAAGTAACCACAGAAGGACA FTT1285c c 1303857  1303878 
Primer374    GCTTTGGAGCAACAAGGTTATC FTT1285c  1303714  1303735 
Primer375    TTCAACCATGTAGTGAACTGGG FTT1286 c 1304670  1304691 
Primer376    TCCTGGTAACCCTGTCTTCTGT cbs  1306132  1306153 
Primer377    TGTCTGCGTAATTCATATTGCC FTT1288 c 1307017  1307038 
Primer378    AATAGATATCTCATAAATTACCCC Intergenic  1307330  1307353 
Primer379    ATCGTGCCAAGAGTATAAAGGC 23S rRNA c 1308306  1308327 
Primer380    TACCTTTTATCCGTTGAGCGAT 23S rRNA  1308199  1308220 
Primer381    TGGTTGTCCAGGTGAAAGTATG 23S rRNA c 1309156  1309177 
Primer382    TAGAAGCTTTTCCTGGAAGCAT 23S rRNA  1309048  1309069 
Primer383    CGTAGCGAAAGCGAGTTTTAAT 23S rRNA c 1309982  1310003 
Primer384    ATCCACAGCTCATCCCATACTT 23S rRNA  1309853  1309874 
Primer385 TGTAGCTCAGTTGGTTAGAGCG tRNA-Ala 
(TGC) 
c 1310818 1310839 
Primer386    TAAAATATTGGTGGAGCCAAGC tRNA-Ile 
(GAT) 
 1310670  1310691 
Primer387    GAGTACTAGCTGTTGGAGTCGG 16S rRNA c 1311639  1311660 
Primer388    CAAGACCAGGTAAGGTTCTTCG 16S rRNA  1311485  1311506 
Primer389    TCAGAATTTGAGAATTAAACTGA 16S rRNA c 1312461  1312483 
Primer390    AGATTCCTACGCGTTACTCACC 16S rRNA  1312343  1312364 
Primer391    TACGGTTTTAGCACCTCTTGGT FTT1289 c 1313302  1313323 
Primer392    TAGCAGAGCATAATGGTGCCTA FTT1289  1313181  1313202 
Primer393   TGATTGCCTTGTAGTTTTTGGA metG c 1314158  1314179 
Primer394    AAAAATGCGAAAGATACTCGTTA metG  1314054  1314076 
Primer395    CCATTTACAGTTAAGAAACCATT metG c 1315018  1315040 
Primer396    GGGGGTGCTACCCTATATTTTC ispZ  1318832  1318853 
Primer397    ATGGCTCAGTTGCTGGTAATTT glk1 c 1319729  1319750 
Primer398    GCTGTGTAACATTATCCCACCA FTT1301c  1324845  1324866 
Primer399    GTGCCTTACGTACAGCATAACC FTT1302 c 1325816  1325837 
Primer400    CCTCCTCAACATAAAATTAACAA Intergenic  1331918  1331940 
Primer401    CAGAAATAGCTGATGATTCTAGCC hflB c 1332982  1333005 
Primer402    CATGGATTCACTCGAAACTCAA FTT1321  1349196  1349217 
Primer403    GCTGTTTGTTTACTTGGGAAGC FTT1322 c 1350074  1350095 
Primer404    CCACCTAAGGTTGCTCGATTAC FTT1328c  1356626  1356647 
Primer405    TCAATAGCTGCACAGATTGCTT gpmI c 1357602  1357623 
Primer406    TTTCTTTAGCTTAAGCCTTGCG cydC  1365873  1365894 
Primer407    GACCGCCTGATAATTGTCTACC cydC c 1366822  1366843 
Primer408    GATAATCACAATACCCGCAACA dctA  1367183  1367204 
Primer409    AGGTAAAATAGGTGGAGTGGCA dctA c 1368074  1368095 
Primer410    TGCCACTCCACCTATTTTACCT dctA  1368074  1368095 
Primer411    TCTGGAGCTGAAGCAATAGATG FTT1339c c 1368963  1368984 
Primer412    CCAACCGTAGGAGATACTCCAG FTT1339c  1370228  1370249 
Primer413    CCATTCAGAGCTATAAAACAAGAA FTT1341 c 1371404  1371427 
Primer414    TGATAGCGCCTATAGATTGGGT FTT1341  1371534  1371555 
Primer415    TGGTTTCCAACCTTCAAAAACT FTT1342 c 1372466  1372487 
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Primer416    CATGTGAACTAGCATTAGCAGA FTT1343c  1374203  1374224 
Primer417    ATTTAAAGTGGTACGCGAGCTGAT
TTAAAGTGGTACGCGAGCTG 
23S rRNA c 1375180  1375201 
Primer418    ATTTAAAGTGGTACGCGAGCTGAT
TTAAAGTGGTACGCGAGCTG 
23S rRNA  1375072  1375092 
Primer419    ACACCAGTGGTTCGTTCACTCACA
CCAGTGGTTCGTTCACTC 
23S rRNA c 1376019  1376040 
Primer420    ACACCAGTGGTTCGTTCACTCACA
CCAGTGGTTCGTTCACTC 
23S rRNA  1375894  1375915 
Primer421    TGATGGTGATGAGACTTGCTCTTG
ATGGTGATGAGACTTGCTCT 
23S rRNA c 1376851  1376872 
Primer422    TGATGGTGATGAGACTTGCTCTTG
ATGGTGATGAGACTTGCTCT 
23S rRNA  1376723  1376744 
Primer423   CTTCAATTAACCTTCCAGCACCCT
TCAATTAACCTTCCAGCACC 
23S rRNA c 1377681  1377702 
Primer424    CTTCAATTAACCTTCCAGCACCCT
TCAATTAACCTTCCAGCACC 
23S rRNA  1377552  1377573 
Primer425    ATGGGGGTTTTACGACCTTACTAT
GGGGGTTTTACGACCTTACT 
16S rRNA c 1378515  1378536 
Primer426    ATGGGGGTTTTACGACCTTACTAT
GGGGGTTTTACGACCTTACT 
16S rRNA  1378387  1378408 
Primer427    CCCACTTAGCTATGACTTTGGGCC
CACTTAGCTATGACTTTGGG 
16S rRNA c 1379343  1379364 
Primer428    CCCACTTAGCTATGACTTTGGGCC
CACTTAGCTATGACTTTGGG 
16S rRNA  1379227  1379248 
Primer429    CGATGAAGGACGTGATAATCTGCG
ATGAAGGACGTGATAATCTG 
pdpA1 c 1380183  1380206 
Primer430    CGATGAAGGACGTGATAATCTGCG
ATGAAGGACGTGATAATCTG 
pdpA1  1380056  1380077 
Primer431    TAGATGTTTCAGTTCCCCTCGTTA
GATGTTTCAGTTCCCCTCGT 
pdpA1 c 1381131  1381154 
Primer432    TAGATGTTTCAGTTCCCCTCGTTA
GATGTTTCAGTTCCCCTCGT 
pdpA1  1380943  1380964 
Primer433    GTCAGCTCGTGTTGTGAAATGTGT
CAGCTCGTGTTGTGAAATGT 
pdpA1 c 1381961  1381982 
Primer434    GTCAGCTCGTGTTGTGAAATGTGT
CAGCTCGTGTTGTGAAATGT 
pdpA1  1381770  1381791 
Primer435    GTAAGGGCCATGATGACTTGACGT
AAGGGCCATGATGACTTGAC 
pdpB1 c 1382823  1382844 
Primer436    GTAAGGGCCATGATGACTTGACGT
AAGGGCCATGATGACTTGAC 
pdpB1  1382679  1382700 
Primer437    GTTGGATTAGCTAGTTGGTGGGGT
TGGATTAGCTAGTTGGTGGG 
pdpB1 c 1383657  1383678 
Primer438    GTTGGATTAGCTAGTTGGTGGGGT
TGGATTAGCTAGTTGGTGGG 
pdpB1  1383553  1383574 
Primer439    ATTGTCCAATATTCCCCACTGCAT
TGTCCAATATTCCCCACTGC 
pdpB1 c 1384526  1384547 
Primer440    ATTGTCCAATATTCCCCACTGCAT
TGTCCAATATTCCCCACTGC 
pdpB1  1384403  1384424 
Primer441    CGCAATATCTTTTATATTTTTCGT
CGCAATATCTTTTATATTTTTCGT 
pdpB1 c 1385351  1385374 
Primer442    CGCAATATCTTTTATATTTTTCGT
CGCAATATCTTTTATATTTTTCGT 
pdpB1  1385232  1385255 
Primer443    GCCAAGTTTGCTTGTGAAATTAGC
CAAGTTTGCTTGTGAAATTA 
FTT1347 c 1386195  1386217 
Primer444    GCCAAGTTTGCTTGTGAAATTAGC
CAAGTTTGCTTGTGAAATTA 
FTT1347  1386083  1386104 
Primer445    TTTGCTCAAGTTGTTGAATAAAAA
TTTGCTCAAGTTGTTGAATAAAAA 
FTT1348 c 1387018  1387040 
Primer446    TTTGCTCAAGTTGTTGAATAAAAA
TTTGCTCAAGTTGTTGAATAAAAA 
FTT1348  1386882  1386904 
Primer447    CCCACTAAAAGCACTTTGGACTCC
CACTAAAAGCACTTTGGACT 
FTT1348 c 1387839  1387860 
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Primer448    CCCACTAAAAGCACTTTGGACTCC
CACTAAAAGCACTTTGGACT 
FTT1348  1387711  1387734 
Primer449    TTTCTTGAAATTCTGCGATTGATT
TCTTGAAATTCTGCGATTGA 
FTT1349 c 1388660  1388681 
Primer450    TTTCTTGAAATTCTGCGATTGATT
TCTTGAAATTCTGCGATTGA 
FTT1349  1388556  1388579 
Primer451    ACCCTAGTCTGACACATGACAAAC
CCTAGTCTGACACATGACAA 
FTT1350 c 1389531  1389554 
Primer452    ACCCTAGTCTGACACATGACAAAC
CCTAGTCTGACACATGACAA 
FTT1350  1389420  1389443 
Primer453    TGGATATATCGAAGCAAAAGTTTG
GATATATCGAAGCAAAAGTT 
FTT1350 c 1390376  1390398 
Primer454    TGGATATATCGAAGCAAAAGTTTG
GATATATCGAAGCAAAAGTT 
FTT1351  1390231  1390253 
Primer455    AAACCTCAAGCTCAAATCATTGAA
ACCTCAAGCTCAAATCATTG 
FTT1352 c 1391209  1391230 
Primer456    AAACCTCAAGCTCAAATCATTGAA
ACCTCAAGCTCAAATCATTG 
FTT1352  1391021  1391042 
Primer457    TACTTGGGGTCGTATACTTGATTA
CTTGGGGTCGTATACTTGAT 
FTT1352 c 1392064  1392086 
Primer458    TACTTGGGGTCGTATACTTGATTA
CTTGGGGTCGTATACTTGAT 
FTT1352  1391956  1391979 
Primer459    TTTTTGAGTATTTGGATAACAATT
TTTGAGTATTTGGATAACAA 
FTT1353 c 1392918  1392941 
Primer460    TTTTTGAGTATTTGGATAACAATT
TTTGAGTATTTGGATAACAA 
pdpC1  1392820  1392839 
Primer461    TTTAAGAGCACCCTTGTTAGATTT
TAAGAGCACCCTTGTTAGAT 
pdpC1 c 1393763  1393784 
Primer462    TTTAAGAGCACCCTTGTTAGATTT
TAAGAGCACCCTTGTTAGAT 
pdpC1  1393644  1393665 
Primer463    AGAACCCGACTTTATGATTGCTAG
AACCCGACTTTATGATTGCT 
pdpC1 c 1394610  1394632 
Primer464    AGAACCCGACTTTATGATTGCTAG
AACCCGACTTTATGATTGCT 
pdpC1  1394508  1394530 
Primer465    TCATTATCTTTGTTTGGTATAGGA
TCATTATCTTTGTTTGGTATAGGA 
pdpC1 c 1395464  1395487 
Primer466    TCATTATCTTTGTTTGGTATAGGA
TCATTATCTTTGTTTGGTATAGGA 
pdpC1  1395337  1395358 
Primer467    AAAGATTTTTCAAAACCTGAGGAA
AAAGATTTTTCAAAACCTGAGGAA 
pdpC1 c 1396313  1396335 
Primer468    AAAGATTTTTCAAAACCTGAGGAA
AAAGATTTTTCAAAACCTGAGGAA 
pdpC1  1396190  1396213 
Primer469    TCGATTCAGTTGCATTATGAGTGT
CGATTCAGTTGCATTATGAGTG 
FTT1355 c 1397139  1397160 
Primer470    TCGATTCAGTTGCATTATGAGTGT
CGATTCAGTTGCATTATGAGTG 
FTT1355  1397036  1397057 
Primer471    TTCTTATGTCAAAAGCAGACCATT
CTTATGTCAAAAGCAGACCA 
iglD1 c 1398011  1398032 
Primer472    TTCTTATGTCAAAAGCAGACCATT
CTTATGTCAAAAGCAGACCA 
iglD1  1397900  1397921 
Primer473    CATCATAAGCGCTGATACTATGGC
ATCATAAGCGCTGATACTATGG 
iglC1 c 1398841  1398862 
Primer474    CATCATAAGCGCTGATACTATGGC
ATCATAAGCGCTGATACTATGG 
iglC1  1398727  1398748 
Primer475    GCCTTATGAAGAATTTAAAGGTTG
CCTTATGAAGAATTTAAAGGTT 
iglB1 c 1399676  1399698 
Primer476    GCCTTATGAAGAATTTAAAGGTTG
CCTTATGAAGAATTTAAAGGTT 
iglB1  1399564  1399585 
Primer477    AGCTTTTCTTGATTAAACTGTGAG
CTTTTCTTGATTAAACTGTG 
iglB1 c 1400499  1400520 
Primer478    AGCTTTTCTTGATTAAACTGTGAG
CTTTTCTTGATTAAACTGTG 
iglB1  1400364  1400387 
Primer479    CCAAATACTGCTAGACATAGCAAC
CCAAATACTGCTAGACATAGCAAC 
iglA1 c 1401331  1401354 
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Primer480    CCAAATACTGCTAGACATAGCAAC
CCAAATACTGCTAGACATAGCAAC 
iglA1  1401205  1401228 
Primer481    ATACCCAAGGAAAGCTAAATGGAT
ACCCAAGGAAAGCTAAATGG 
pdpD1 c 1402162  1402185 
Primer482    ATACCCAAGGAAAGCTAAATGGAT
ACCCAAGGAAAGCTAAATGG 
pdpD1  1402021  1402042 
Primer483    CACTAACGAACAACTTACCAGCTT
CACTAACGAACAACTTACCAGCTT 
pdpD1 c 1402986  1403009 
Primer484    CACTAACGAACAACTTACCAGCTT
CACTAACGAACAACTTACCAGCTT 
pdpD1  1402872  1402894 
Primer485    TTTCGTCATTATGGTTTTCAGTTT
TTTCGTCATTATGGTTTTCAGTTT 
pdpD1 c 1403843  1403864 
Primer486    TTTCGTCATTATGGTTTTCAGTTT
TTTCGTCATTATGGTTTTCAGTTT 
pdpD1  1403736  1403759 
Primer487    TTCTCAATATCCATTCTCCTAGCC
TTCTCAATATCCATTCTCCTAGCC 
pdpD1 c 1404688  1404709 
Primer488    TTCTCAATATCCATTCTCCTAGCC
TTCTCAATATCCATTCTCCTAGCC 
pdpD1  1404586  1404606 
Primer489    CGATGGTATGATATTTTCTCATTC
GATGGTATGATATTTTCTCATT 
FTT1361c c 1405555  1405576 
Primer490    CGATGGTATGATATTTTCTCATTC
GATGGTATGATATTTTCTCATT 
FTT1361c  1405445  1405466 
Primer491    TCAAAACACCTTTAGCTTTATTAT
CAAAACACCTTTAGCTTTATTA 
FTT1361c c 1406378  1406401 
Primer492    TCAAAACACCTTTAGCTTTATTAT
CAAAACACCTTTAGCTTTATTA 
Intergenic  1406266  1406287 
Primer493    TGATGGACTAATTCTTGTGAAATG
ATGGACTAATTCTTGTGAAA 
FTT1362 c 1407240  1407261 
Primer494    TGATGGACTAATTCTTGTGAAATG
ATGGACTAATTCTTGTGAAA 
FTT1362  1407133  1407154 
Primer495    CAAGCAAAATATGAAAACGCTGCA
AGCAAAATATGAAAACGCTG 
isftu1 c 1408097  1408119 
Primer496    CAAGCAAAATATGAAAACGCTGCA
AGCAAAATATGAAAACGCTG 
isftu1  1407974  1407994 
Primer497    TGTCAAAAAGATCTTCAAAATAGT
GTCAAAAAGATCTTCAAAATAG 
treA c 1408936  1408957 
Primer498    TGTCAAAAAGATCTTCAAAATAGT
GTCAAAAAGATCTTCAAAATAG 
FTT1384c  1429607  1429629 
Primer499    TGCAGATACAGATGCTATCAAAGA
TGCAGATACAGATGCTATCAAAGA 
Intergenic c 1430882  1430905 
Primer500    TGCAGATACAGATGCTATCAAAGA
TGCAGATACAGATGCTATCAAAGA 
FTT1395c  1443820  1443841 
Primer501    CATATTGAAATCTGCTGTTTTAGG
CATATTGAAATCTGCTGTTTTAGG 
recC c 1444755  1444776 
Primer502    CATATTGAAATCTGCTGTTTTAGG
CATATTGAAATCTGCTGTTTTAGG 
recC  1445618  1445639 
Primer503    TTAATTTATGAAAAATCCGATTAA
TTTATGAAAAATCCGA 
recC c 1446528  1446549 
Primer504    TTAATTTATGAAAAATCCGATTAA
TTTATGAAAAATCCGA 
FTT1399  1450410  1450431 
Primer505    TTCATAAACTGAGTAAACTGCTTT
CATAAACTGAGTAAACTGCT 
FTT1401 c 1451337  1451358 
Primer506    TTCATAAACTGAGTAAACTGCTTT
CATAAACTGAGTAAACTGCT 
FTT1417  1468391  1468412 
Primer507    AAAATCAAACGCGACATAATTGAA
AATCAAACGCGACATAATTG 
nusB c 1469343  1469364 
Primer508    AAAATCAAACGCGACATAATTGAA
AATCAAACGCGACATAATTG 
Intergenic  1475775  1475796 
Primer509    TCCATTCGATTAGAAACATTTGCT
CCATTCGATTAGAAACATTTGC 
FTT1428c c 1477025  1477046 
Primer510    TCCATTCGATTAGAAACATTTGCT
CCATTCGATTAGAAACATTTGC 
yagD  1482916  1482937 
Primer511    AAACTTCTAAAACAGACATCATCA
AACTTCTAAAACAGACATCATC 
FTT1437c c 1484066  1484087 
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Primer512    AAACTTCTAAAACAGACATCATCA
AACTTCTAAAACAGACATCATC 
Intergenic  1498112  1498135 
Primer513    TGAGAATAGGAGTATTTTGCACCA
TGAGAATAGGAGTATTTTGCACCA 
wbtM c 1499086  1499109 
Primer514    TGAGAATAGGAGTATTTTGCACCA
TGAGAATAGGAGTATTTTGCACCA 
wzx  1502871  1502892 
Primer515    GTAAGAAGAAAGCGGAGACAGGGT
AAGAAGAAAGCGGAGACAGG 
wzx c 1503770  1503791 
Primer516    GTAAGAAGAAAGCGGAGACAGGGT
AAGAAGAAAGCGGAGACAGG 
wzx  1503718  1503739 
Primer517    TGAGTTTCTGCTCTTCATGTTCAT
GAGTTTCTGCTCTTCATGTTCA 
wbtI c 1504669  1504690 
Primer518    TGAGTTTCTGCTCTTCATGTTCAT
GAGTTTCTGCTCTTCATGTTCA 
wbtG  1508410  1508431 
Primer519    TGCTCTTAATAGAGCCTCAAAACC
TGCTCTTAATAGAGCCTCAAAACC 
wzy c 1509353  1509374 
Primer520    TGCTCTTAATAGAGCCTCAAAACC
TGCTCTTAATAGAGCCTCAAAACC 
wbtA  1516305  1516326 
Primer521    AAGTCTTTAACTGATTTGCTGGAA
GTCTTTAACTGATTTGCTGG 
Intergenic c 1517427  1517448 
Primer522    AAGTCTTTAACTGATTTGCTGGAA
GTCTTTAACTGATTTGCTGG 
galP1  1527296  1527317 
Primer523    ATAGCAGCATGCAAAGATGAGAAT
AGCAGCATGCAAAGATGAGA 
galT c 1528178  1528199 
Primer524    ATAGCAGCATGCAAAGATGAGAAT
AGCAGCATGCAAAGATGAGA 
FTT1477c  1529847  1529868 
Primer525    CGCAGAATCTAATAGGGCAAATCG
CAGAATCTAATAGGGCAAAT 
kdsB c 1530808  1530829 
Primer526    CGCAGAATCTAATAGGGCAAATCG
CAGAATCTAATAGGGCAAAT 
Intergenic  1575969  1575990 
Primer527    AGGCTTTTGGAAATCAAATTCAAG
GCTTTTGGAAATCAAATTCA 
Intergenic c 1577116  1577139 
Primer528    AGGCTTTTGGAAATCAAATTCAAG
GCTTTTGGAAATCAAATTCA 
FTT1538c  1601033  1601054 
Primer529    TCCAATAAGTGCTAAGGCTTTTTC
CAATAAGTGCTAAGGCTTTT 
FTT1539c c 1602004  1602025 
Primer530    TCCAATAAGTGCTAAGGCTTTTTC
CAATAAGTGCTAAGGCTTTT 
FTT1547  1609461  1609482 
Primer531    GCAACATACTGGCAAACTTCCTGC
AACATACTGGCAAACTTCCT 
FTT1547 c 1610739  1610760 
Primer532    GCAACATACTGGCAAACTTCCTGC
AACATACTGGCAAACTTCCT 
FTT1558c  1620464  1620485 
Primer533    TTGTAGATGGATTTGACTCAGCAT
TGTAGATGGATTTGACTCAGCA 
proC c 1621419  1621440 
Primer534    TTGTAGATGGATTTGACTCAGCAT
TGTAGATGGATTTGACTCAGCA 
ispA  1624174  1624195 
Primer535    TCGACTCGACATCCACAATACTTC
GACTCGACATCCACAATACT 
pcs c 1625125  1625146 
Primer536    TCGACTCGACATCCACAATACTTC
GACTCGACATCCACAATACT 
FTT1564  1626401  1626422 
Primer537    TGCAAGAGGTTTGTCAAGAAGATG
CAAGAGGTTTGTCAAGAAGA 
FTT1565c c 1627336  1627357 
Primer538    TGCAAGAGGTTTGTCAAGAAGATG
CAAGAGGTTTGTCAAGAAGA 
FTT1579c  1643832  1643853 
Primer539    CCATATTGATCAAATTCTGAAACG
CCATATTGATCAAATTCTGAAACG 
FTT1579c c 1644790  1644811 
Primer540    CCATATTGATCAAATTCTGAAACG
CCATATTGATCAAATTCTGAAACG 
FTT1579c  1645109  1645130 
Primer541    TGTTGATGGTGTCTTAAAGAAAAA
TGTTGATGGTGTCTTAAAGAAAAA 
FTT1580c c 1646001  1646022 
Primer542    TGTTGATGGTGTCTTAAAGAAAAA
TGTTGATGGTGTCTTAAAGAAAAA 
Intergenic  1648268  1648289 
Primer543    TCTTCTAAAACCCTATCAACACCA
TCTTCTAAAACCCTATCAACACCA 
FTT1585 c 1649776  1649797 
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Primer544    TCTTCTAAAACCCTATCAACACCA
TCTTCTAAAACCCTATCAACACCA 
FTT1594  1659019  1659041 
Primer545    TGTTGAGTTTTATGGATAGCCTTG
TGTTGAGTTTTATGGATAGCCTTG 
FTT1595 c 1659997  1660017 
Primer546    TGTTGAGTTTTATGGATAGCCTTG
TGTTGAGTTTTATGGATAGCCTTG 
FTT1598  1664836  1664859 
Primer547    TCGATTCAACCACTATTCCTGTTC
GATTCAACCACTATTCCTGT 
Intergenic c 1666014  1666035 
Primer548    TCGATTCAACCACTATTCCTGTTC
GATTCAACCACTATTCCTGT 
FTT1609  1675051  1675072 
Primer549    TGATGCTCTAGAAAATACCACTTC
TGATGCTCTAGAAAATACCACTTC 
FTT1611 c 1675988  1676009 
Primer550    TGATGCTCTAGAAAATACCACTTC
TGATGCTCTAGAAAATACCACTTC 
FTT1613  1676976  1676997 
Primer551    GAACCTAGGGATACAGAAGATGCG
AACCTAGGGATACAGAAGATGC 
FTT1614c c 1677892  1677913 
Primer552    GAACCTAGGGATACAGAAGATGCG
AACCTAGGGATACAGAAGATGC 
FTT1614c  1677973  1677994 
Primer553    TGAAAGCTTTAAGTCTCCTTTTTG
AAAGCTTTAAGTCTCCTTTT 
cysS c 1679538  1679559 
Primer554    TGAAAGCTTTAAGTCTCCTTTTTG
AAAGCTTTAAGTCTCCTTTT 
FTT1619  1683196  1683217 
Primer555    GGAATAGAGATTCTTATGGTCCTC
GGAATAGAGATTCTTATGGTCCTC 
Intergenic c 1684370  1684391 
Primer556    GGAATAGAGATTCTTATGGTCCTC
GGAATAGAGATTCTTATGGTCCTC 
hsdR3  1707462  1707483 
Primer557    CAAGTGCTTGGTGGTGGTAATACA
AGTGCTTGGTGGTGGTAATA 
Intergenic c 1708631  1708654 
Primer558    CAAGTGCTTGGTGGTGGTAATACA
AGTGCTTGGTGGTGGTAATA 
FTT1652c  1719283  1719304 
Primer559    TTGCTCCAGTAGCTGCAAGATTTG
CTCCAGTAGCTGCAAGAT 
FTT1653 c 1720253  1720274 
Primer560    TTGCTCCAGTAGCTGCAAGATTTG
CTCCAGTAGCTGCAAGAT 
emrA2  1720614  1720636 
Primer561    CCTAAATCAACAGGTCGAGAGCCC
TAAATCAACAGGTCGAGAGC 
FTT1655 c 1721689  1721712 
Primer562    CCTAAATCAACAGGTCGAGAGCCC
TAAATCAACAGGTCGAGAGC 
Intergenic  1738196  1738218 
Primer563    GGCTCTTACGATACTTTGTGCCGG
CTCTTACGATACTTTGTGCC 
napH c 1739661  1739683 
Primer564    GGCTCTTACGATACTTTGTGCCGG
CTCTTACGATACTTTGTGCC 
FTT1682  1751153  1751174 
Primer565    GCTTAAACAAGTTTTAAGATTGCG
GCTTAAACAAGTTTTAAGATTGCG 
FTT1682 c 1752116  1752137 
Primer566    GCTTAAACAAGTTTTAAGATTGCG
GCTTAAACAAGTTTTAAGATTGCG 
FTT1682  1752472  1752493 
Primer567    TCCCATCTAGTGATGTTCCAGATC
CCATCTAGTGATGTTCCAGA 
FTT1683c c 1753350  1753371 
Primer568    TCCCATCTAGTGATGTTCCAGATC
CCATCTAGTGATGTTCCAGA 
FTT1691  1760581  1760604 
Primer569    AAACCAAAAATGATTCTGCCTGAA
ACCAAAAATGATTCTGCCTG 
Intergenic c 1761850  1761871 
Primer570    AAACCAAAAATGATTCTGCCTGAA
ACCAAAAATGATTCTGCCTG 
groL  1765804  1765825 
Primer571    AGAACAAAGCGTACAATCATGGAG
AACAAAGCGTACAATCATGG 
fdh c 1767018  1767039 
Primer572    AGAACAAAGCGTACAATCATGGAG
AACAAAGCGTACAATCATGG 
fdh  1767573  1767594 
Primer417    AAGCGTACAGTTGTTTCATGGATA
AGCGTACAGTTGTTTCATGGAT 
23S rRNA c 1768524  1768545 
Primer418    AAGCGTACAGTTGTTTCATGGATA
AGCGTACAGTTGTTTCATGGAT 
23S rRNA  1768416  1768436 
Primer419    GCACTTGCATCTGGATGATCTGCA
CTTGCATCTGGATGATCT 
23S rRNA c 1769363  1769384 
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Primer420    GCACTTGCATCTGGATGATCTGCA
CTTGCATCTGGATGATCT 
23S rRNA  1769238  1769259 
Primer421    GGGGTTTGGTAAGGGTATAGGA 23S rRNA c 1770195  1770216 
Primer422    TCAAAATCTTTAGCTGTGGCTTC 23S rRNA  1770067  1770088 
Primer423    TGTTCAGAACTAATTCATGCTGCT 23S rRNA c 1771025  1771046 
Primer424    CCAATGATTAAAATACCGCCAT 23S rRNA  1770896  1770917 
Primer425    AACAGGCTTGGCAAAAAGTAAT 16S rRNA c 1771859  1771880 
Primer426    TCCCCAATCGTAGTTCAAATTC 16S rRNA  1771731  1771752 
Primer427    CGCTACTTGATTCAGAGCCTTT 16S rRNA c 1772687  1772708 
Primer428    AGTTGGTCCAGTATTTGCATTG 16S rRNA  1772571  1772592 
Primer429    CTTAACACTGGGACATTCGTGA pdpA2 c 1773527  1773550 
Primer430    GATGTATCGCCAAGTAAAAGGC pdpA2  1773400  1773421 
Primer431    ACCGCTAGAGCTCGAAATAATG pdpA2 c 1774475  1774498 
Primer432    CTCTCTTCGGAGTAGCAAGCAT pdpA2  1774287  1774308 
Primer433    GGACAAACTGTCTACTATGCCG pdpA2 c 1775305  1775326 
Primer434    CCTAAAGTTGTCGACTTACCCG pdpA2  1775114  1775135 
Primer435    GGTGCAAGTATTTTGCTGATGA pdpB2 c 1776167  1776188 
Primer436    AAAACCTAAATAACTTTGATATTG pdpB2  1776023  1776044 
Primer437    AAGATGTTTAGACAAACTATTGAG pdpB2 c 1777001  1777022 
Primer438    GCAATTTCCATACTTCCTGTCC pdpB2  1776897  1776918 
Primer439    AAGTCATGATGCATTTGGTCTG pdpB2 c 1777870  1777891 
Primer440    TACCAACATCCAACAACCGTAA pdpB2  1777747  1777768 
Primer441    TGTTTGCCAATTTATGCAGAGT pdpB2 c 1778695  1778718 
Primer442    TCCAAGCATGAATAACATCAGG pdpB2  1778576  1778599 
Primer443    GAGGGGATGGTTTAGGATTTTC FTT1702 c 1779539  1779561 
Primer444    AGATGACAAGCATCTCAGCAAA FTT1702  1779427  1779448 
Primer445    TGAATCTAAATGCTGCAAGAGC FTT1703 c 1780362  1780384 
Primer446    ACATGTCCACTTTGCTCAACAC FTT1703  1780226  1780248 
Primer447    TGGTAAACGATTCGGTCTTCTT FTT1703 c 1781183  1781204 
Primer448    TGCATTTGCCTAACAACATTTC FTT1703  1781055  1781078 
Primer449    CCAGGCTTAAATCAACTCGTCT FTT1704 c 1782004  1782025 
Primer450    AAGCATGTTGTTGGGAATTCAT FTT1704  1781900  1781923 
Primer451    GCTTTCATATGTTAGTGGTTTAGC FTT1705 c 1782875  1782898 
Primer452    CACCATCTTGACGAACCTCATA FTT1705  1782764  1782787 
Primer453    ATGGGATCCTAAGCAAGTAGCA FTT1705 c 1783720  1783742 
Primer454    GATGGCTATTGGGAGACTTCTG FTT1706  1783575  1783597 
Primer455    CAACCACAACCTACCTCGATTA FTT1707 c 1784553  1784574 
Primer456    GGTGGAAGTTTTCCTGTCTTTG FTT1707  1784365  1784386 
Primer457    GCAGCACAGATGGCATTAAATA FTT1707 c 1785408  1785430 
Primer458    TCGAAATTTTTGCTGAAAAGGT FTT1707  1785300  1785323 
Primer459    GAACACGGCACCTAATGATGTA FTT1708 c 1786262  1786285 
Primer460    TCAGTTAGCCAGCAAGAACAAA pdpC2  1786164  1786183 
Primer461    ATGCTATGGAAATGAAGGCTGT pdpC2 c 1787107  1787128 
Primer462    TTTCATTTTCTGCCAAGGTTTT pdpC2  1786988  1787009 
Primer463    TGCCACAGTTGAAGCTTTAGAA pdpC2 c 1787954  1787976 
Primer464    TTAATGGCTGTACGAGGTAGCA pdpC2  1787852  1787874 
Primer465    AAACAATATCTCGTATGGCACG pdpC2 c 1788808  1788831 
Primer466    CGATACTGAATCAAGTCCAGCA pdpC2  1788681  1788702 
Primer467    AATTCTTAGGCATGACAAACCC pdpC2 c 1789657  1789679 
Primer468    CCGCAGTTTCAAAAATTATTTCC pdpC2  1789534  1789557 
Primer469    ATCTGAAACTTCAGCATAACT FTT1710 c 1790483  1790504 
Primer470    TCAGTCTTTTGATGGTATTGATGG FTT1710  1790380  1790401 
Primer471    ATTTATCGATTGACTCGGCATT iglD2 c 1791355  1791376 
Primer472    TTTGCTTTTATAACTGCGTGGA iglD2  1791244  1791265 
Primer473    CGCGATCAACAAGACGTAGTAG iglC2 c 1792185  1792206 
Primer474    TCCTTTCTGGAGAGTTACATGC iglC2  1792071  1792092 
Primer475    ATATCTGGATTACCAGAGGGCA iglB2 c 1793020  1793042 
Primer476    CATTCGTAGGTTCAGCATTTGT iglB2  1792908  1792929 
Primer477    CCTCAATCGGCTTAAATTGTTC iglB2 c 1793843  1793864 
Primer478    AAGCTTGAGAGTTTTTGATTTT iglB2  1793708  1793731 
Primer479    TGCAGCTGAATTTACTGATAGG iglA2 c 1794675  1794698 
Primer480    ATCAGCTGAAATAGTCCCTGCT iglA2  1794549  1794572 
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Primer481    CAAAAGAGATTACAGAGTTATTTT pdpD2 c 1795506  1795529 
Primer482    TTACGCTTGAATGAGCAAAAGA pdpD2  1795365  1795386 
Primer483    CAGAAGACCTAATTGAATCGCC pdpD2 c 1796330  1796353 
Primer484    AGATATATAACAAAAGAGCTGAA pdpD2  1796216  1796238 
Primer485    GCCAATAAAAAGAAGAAAATAACC pdpD2 c 1797187  1797208 
Primer486    GCCTAAGCATGTAGATCCAAAGA pdpD2  1797080  1797103 
Primer487    TGCTATCGCTAGTGATTAGTGGA pdpD2 c 1798032  1798053 
Primer488    AAAGCAGATGTTGACAATGCAC pdpD2  1797930  1797950 
Primer489    ATTCCCAGTGGTCAGAAGTGAT FTT1716c c 1798899  1798920 
Primer490    TCAACGTTTTACTGCCACTAGC FTT1716c  1798789  1798810 
Primer491    TAAATAATTCGGTTGCTGCTGA FTT1716c c 1799722  1799745 
Primer492    GATAGCTACCAAATTGACAACCTT Intergenic  1799610  1799631 
Primer493    TCACACTTGGAGAAAAACCACC FTT1717 c 1800584  1800605 
Primer494    CTCGTTCAGCTCTACAACATGC FTT1717  1800477  1800498 
Primer495    CCAAAGAATGTAGAGCAAGAGC isftu1 c 1801441  1801463 
Primer496    CACCCGGTCTAAAATCTATTGC isftu1  1801318  1801338 
Primer573    CATACAATCCAAATGGTGCAGT purL c 1802283  1802304 
Primer574    ACTCAGGATAATCCCCACAGAA abcZ  1817368  1817389 
Primer575    TAGTTTCACGTATTCACCGTGG FTT1730c c 1818246  1818267 
Primer576    CAAATATGATCTTTTGGAGCGG FTT1741c  1831541  1831562 
Primer577    AGCCAAGTAGTAAGCCCAACAC FTT1743 c 1832798  1832819 
Primer578    TTTACCGGCTCTACAAGAGTTG gabD2  1844468  1844489 
Primer579    AAGTTATGTTAGGGTAGTTTTGT Intergenic c 1845645  1845667 
Primer580    ATGCCAGCCTTAAGTGGTTAGA FTT1761  1849769  1849790 
Primer581    GCAATGAAATTGGCAACTGTTA FTT1762c c 1850709  1850730 
Primer582    TTTAGCTTTGGATACGGTTGGT FTT1779  1868481  1868502 
Primer583    CATTTCTTTCAAAACCTTTGGC Intergenic c 1869759  1869780 
Primer584    TTCCAAAATTGGATAATTGGTTC FTT1783  1873321  1873343 
Primer585    GGCTACCAGGAGGGTTAGAAAA FTT1786 c 1874298  1874319 
Primer586    ATTACTTGGTTGGGAGATGCTG FTT1786  1874463  1874484 
Primer587    TGGTGTTGCAAGTTTAGTTTGG FTT1787c c 1875385  1875406 
Primer588    AAAATTTGGGGCATCTGTATTG iciA  1876086  1876107 
Primer589    CTCAATAGCATCCAGCCTTTCT Intergenic c 1877014  1877035 
Primer590    TGTATCTTTTGGCGATTTAGCA Intergenic  1876928  1876949 
Primer591   TTCTGAGGAAATGATGCTGTTG FTT1789 c 1877868  1877889 
Primer592    AGATAGTATTTCTGGTGGGGCA FTT1791  1878601  1878622 
Primer593    GTTTAGGATACGCTTTCATGGC pepN c 1880040  1880061 
Primer594    GTTCAAGGTTACGTTCACCCAT trpC  1883679  1883700 
Primer595    AGGTGAGTTACCTGATGCGATT FTT1796c c 1884628  1884649 
Primer596    CCCAAATTTGTTGCCACTTATC FTT1796c  1884603  1884624 
Primer597    AGCTATATTTGCAGGTGGTGGT msrA2 c 1885511  1885532 
Primer598    TAGAATCTAAAACCACGCCTGC trpE  1888656  1888677 
Primer599    TGATCATCAAGAGCAGAAAACG trpE c 1889545  1889566 
Primer600    TTTCAAAGCTAGCAACAACATCA trpE  1889640  1889662 
Primer601    GTTTTCCCCTTTTTACTTCTGA Intergenic c 1890618  1890639 
Primer602    TACAATGTTCACATGGCTGACA rng  1891141  1891162 
Primer603    TGGTTACGTGAAGGTCAAGAAG rng c 1892062  1892083 
* C strand represents complementary strand. 
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